{"meta":{"query_hash":"21f2b16fd884","filters":{"venue":"Clinical Pharmacokinetics"},"cohort_total":145,"direct_labels_cover":0,"predictions_cover":145,"exported":145,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/21f2b16fd884","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Pharmacokinetics"},"results":[{"id":"W1477312507","doi":"10.1007/s40262-015-0321-z","title":"A Qualitative Review on the Pharmacokinetics of Antibiotics in Saliva: Implications on Clinical Pharmacokinetic Monitoring in Humans","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Saliva; Antibiotics; Pharmacokinetics; Medicine; Drug; Distribution (mathematics); Pharmacology; Intensive care medicine; Internal medicine; Microbiology; Biology","score_opus":0.5099288036103374,"score_gpt":0.6233919368026989,"score_spread":0.11346313319236145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1477312507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023005543,0.9977837,0.00022636309,0.00097049883,0.00014912954,0.00002165841,0.00007509668,0.0000025598513,0.00054095365],"genre_scores_gemma":[0.0017264152,0.9968413,0.0005291896,0.0005990697,0.00007957506,0.000026935137,0.000032756165,0.0000018807907,0.00016290104],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975078,0.0011801872,0.00048988784,0.00017544458,0.00055297225,0.00009372182],"domain_scores_gemma":[0.99061346,0.0076892176,0.00072858186,0.00008476211,0.00079920905,0.00008469537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005221738,0.0009799579,0.0017293731,0.004078905,0.000508391,0.0022217024,0.0010773732,0.0012309449,0.003321697],"category_scores_gemma":[0.010701409,0.00042660275,0.0014858199,0.0039503626,0.0010366223,0.0023961735,0.0015929686,0.0013638149,0.00042420794],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015416952,0.00007366835,0.00072847214,0.34187862,0.00046975556,0.00027453055,0.0024072423,0.00024397958,0.0011391847,0.0065294625,0.017230632,0.62887025],"study_design_scores_gemma":[0.000035403464,0.00014511489,0.0037868153,0.35988304,0.0014173863,0.0015044205,0.0033585918,0.000089601825,0.0007865812,0.0032628514,0.625635,0.00009522632],"about_ca_topic_score_codex":0.005195888,"about_ca_topic_score_gemma":0.012728387,"teacher_disagreement_score":0.005221738,"about_ca_system_score_codex":0.0026324426,"about_ca_system_score_gemma":0.00692996,"threshold_uncertainty_score":0.027615547},"labels":[],"label_agreement":null},{"id":"W1564744230","doi":"10.1007/bf03261932","title":"Fundamentals of Population Pharmacokinetic Modelling","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Population; Pharmacokinetics; Context (archaeology); NONMEM; Physiologically based pharmacokinetic modelling; Terminology; Medicine; Computer science; Intensive care medicine; Pharmacology; Biology","score_opus":0.9077627310124843,"score_gpt":0.7051695231200288,"score_spread":0.2025932078924555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1564744230","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004795368,0.75613385,0.2272802,0.004407716,0.0015177533,0.00007796718,0.00030923155,0.00034103854,0.00945274],"genre_scores_gemma":[0.015272933,0.900967,0.07453708,0.0016235051,0.0028878504,0.00025188964,0.0003163139,0.00006799013,0.00407549],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99866056,0.0006190038,0.00014509803,0.00013891497,0.00039074456,0.000045669098],"domain_scores_gemma":[0.9972619,0.002122577,0.00021519355,0.00012832208,0.00023407384,0.000037958784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002625537,0.0018130065,0.0027838952,0.0020164023,0.00025696994,0.002317783,0.0016595285,0.0020830391,0.0044777887],"category_scores_gemma":[0.0050635333,0.0005793753,0.0015238153,0.0026411642,0.0019942883,0.0023027873,0.0011021837,0.0037197096,0.0032592923],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004874067,0.00008584541,0.000309906,0.00908873,0.00018573384,0.00017077805,0.00013140743,0.02502118,0.0007575654,0.19112793,0.032630354,0.74044186],"study_design_scores_gemma":[0.00004340126,0.00012364482,0.0007796987,0.004193763,0.00019488194,0.00093046506,0.00005326109,0.02187174,0.0009397772,0.35731602,0.61345965,0.00009376335],"about_ca_topic_score_codex":0.001729002,"about_ca_topic_score_gemma":0.00087117724,"teacher_disagreement_score":0.0044777887,"about_ca_system_score_codex":0.0011406118,"about_ca_system_score_gemma":0.002875127,"threshold_uncertainty_score":0.01497972},"labels":[],"label_agreement":null},{"id":"W16164951","doi":"10.2165/00003088-200241090-00002","title":"Lithium in Bipolar Disorder","year":2002,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Lithium (medication); Mania; Bipolar disorder; Therapeutic index; Medicine; Depression (economics); Internal medicine; Adverse effect; Gastroenterology; Pharmacology; Drug","score_opus":0.14085561981592512,"score_gpt":0.4608201781186104,"score_spread":0.31996455830268533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W16164951","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017784965,0.99832016,0.00009527816,0.00028670224,0.00020809096,0.000008484877,0.000016927852,0.0000085545,0.00087790354],"genre_scores_gemma":[0.0015818701,0.99587184,0.00027276046,0.00049863674,0.00039673262,0.00001827667,0.00003870522,0.0000023382227,0.0013187791],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9996246,0.00010184172,0.00010935455,0.000041029198,0.000105324325,0.000017808601],"domain_scores_gemma":[0.9995752,0.00013147324,0.00015421878,0.000016707632,0.00008895365,0.000033439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007873211,0.0010894928,0.0024450526,0.0031188799,0.00028691068,0.0011835813,0.00092136295,0.0010557113,0.0042010546],"category_scores_gemma":[0.001215117,0.00037885582,0.000537922,0.0034412486,0.000538112,0.0014437174,0.0008111553,0.0013944427,0.0018392316],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028458636,0.00008861415,0.00028097164,0.020595867,0.000145043,0.00028827426,0.00006807949,0.00017875594,0.00084811106,0.001095298,0.031941496,0.9441849],"study_design_scores_gemma":[0.00033287425,0.0003667663,0.002011421,0.0074449414,0.0007643672,0.0042516976,0.00010235199,0.00021184841,0.0005687561,0.0014594599,0.9824462,0.000039337603],"about_ca_topic_score_codex":0.0016252279,"about_ca_topic_score_gemma":0.0052049193,"teacher_disagreement_score":0.0042010546,"about_ca_system_score_codex":0.00060852146,"about_ca_system_score_gemma":0.0015563308,"threshold_uncertainty_score":0.014053941},"labels":[],"label_agreement":null},{"id":"W178626500","doi":"10.2165/00003088-200746020-00002","title":"Efavirenz and Nevirapine in HIV-1 Infection","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Nevirapine; Efavirenz; Medicine; Virology; Pharmacotherapy; Human immunodeficiency virus (HIV); Reverse-transcriptase inhibitor; Antiretroviral therapy; Pharmacology; Viral load; Internal medicine","score_opus":0.21109861450931747,"score_gpt":0.5207145243752711,"score_spread":0.30961590986595366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W178626500","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001848112,0.99806637,0.00011662145,0.00019492125,0.00014560105,0.000007854869,0.000017147679,0.000009670236,0.0012569474],"genre_scores_gemma":[0.0010589063,0.9972698,0.0002757552,0.00018675583,0.00018812978,0.000009130568,0.00002788332,0.0000016048817,0.0009820743],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980015,0.000043923013,0.000035768568,0.000022588789,0.0000826701,0.000014931672],"domain_scores_gemma":[0.99966013,0.00015576028,0.00008543445,0.000009131606,0.00006271285,0.000026827182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005283338,0.00087453396,0.0016961658,0.0023520486,0.00019869336,0.00078548474,0.0007586491,0.0009031882,0.004173067],"category_scores_gemma":[0.0008155692,0.0002809627,0.00038365956,0.0020294837,0.00034360596,0.0009342635,0.00049915543,0.0012586891,0.0017166588],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008406777,0.00008069358,0.00010034676,0.009427552,0.00006274087,0.00017036888,0.000023212595,0.00020107754,0.00094389584,0.0008770272,0.019194016,0.96883494],"study_design_scores_gemma":[0.00008930088,0.00020468797,0.0012331075,0.004187952,0.00032197515,0.0031030634,0.00004409951,0.0002057242,0.0007319428,0.0012044586,0.9886518,0.000021835922],"about_ca_topic_score_codex":0.0009458723,"about_ca_topic_score_gemma":0.0024548525,"teacher_disagreement_score":0.004173067,"about_ca_system_score_codex":0.00041144545,"about_ca_system_score_gemma":0.001062109,"threshold_uncertainty_score":0.013960302},"labels":[],"label_agreement":null},{"id":"W186511383","doi":"10.2165/0003088-200847120-00002","title":"Does Oxcarbazepine Warrant Therapeutic Drug Monitoring?","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Oxcarbazepine; Medicine; Therapeutic drug monitoring; Carbamazepine; Drug; Therapeutic effect; Active metabolite; Pharmacotherapy; Intensive care medicine; Pharmacology; Pharmacokinetics; Epilepsy; Internal medicine; Psychiatry","score_opus":0.1793149649316613,"score_gpt":0.5085096684981516,"score_spread":0.3291947035664903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W186511383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002485608,0.99656016,0.00022135788,0.0015684976,0.00026017491,0.000004860791,0.000016864618,0.000009021652,0.0011104847],"genre_scores_gemma":[0.0031738027,0.9938929,0.0004661192,0.0011582073,0.0006155823,0.000009798317,0.000036177433,0.0000025769536,0.0006448319],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996662,0.000082113045,0.00008962136,0.000052252697,0.000088685425,0.000021128315],"domain_scores_gemma":[0.99882966,0.0005715474,0.00033787644,0.000032356133,0.0001815907,0.00004689874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011942583,0.0008422823,0.0029431724,0.0011093651,0.00016736268,0.00095956365,0.0007791021,0.0013982687,0.0034057864],"category_scores_gemma":[0.0026814665,0.0002368287,0.00053650286,0.0012047178,0.00066857773,0.0018361247,0.0004029242,0.0016662602,0.0013609533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002576772,0.00003691793,0.00034821455,0.008274388,0.00010277607,0.000330454,0.000023541283,0.0001357506,0.0007477635,0.0016535026,0.019197062,0.9688919],"study_design_scores_gemma":[0.0003944089,0.00037642065,0.0034719126,0.011243394,0.0010189046,0.006442999,0.00013988437,0.0003912387,0.0014772179,0.0044426173,0.9705593,0.000041668056],"about_ca_topic_score_codex":0.000918422,"about_ca_topic_score_gemma":0.0023166288,"teacher_disagreement_score":0.0034057864,"about_ca_system_score_codex":0.0006600922,"about_ca_system_score_gemma":0.0015291222,"threshold_uncertainty_score":0.011393487},"labels":[],"label_agreement":null},{"id":"W1965458832","doi":"10.2165/00003088-200544050-00001","title":"Pharmacokinetics of Proton Pump Inhibitors in Children","year":2005,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Lansoprazole; Omeprazole; Pantoprazole; Esomeprazole; CYP2C19; Pharmacokinetics; Pharmacology; Rabeprazole; Proton-pump inhibitor; Medicine; Enteric coating; CYP3A4; Population; Oral administration; Gastroenterology; Chemistry; Internal medicine; Cytochrome P450; Dosage form; Metabolism","score_opus":0.09888409871956902,"score_gpt":0.4787984253831883,"score_spread":0.37991432666361924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965458832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023355546,0.9992347,0.00008431307,0.000085644315,0.00004239665,0.0000033852475,0.000021325308,0.0000041509134,0.00029061845],"genre_scores_gemma":[0.0011168824,0.99835926,0.00019013455,0.000077330034,0.000058010388,0.000004309895,0.000027753005,8.986461e-7,0.00016548157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997222,0.000053541276,0.000070972346,0.000041406412,0.00009629621,0.000015475103],"domain_scores_gemma":[0.9992017,0.00041736758,0.00023549491,0.000014122473,0.00010322083,0.00002811183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076023146,0.0008584846,0.00248186,0.0016759273,0.00011921089,0.0007090623,0.00070499565,0.0006824307,0.0019103033],"category_scores_gemma":[0.0013560246,0.0003553417,0.0008469712,0.001958447,0.0002882308,0.000892326,0.00031921666,0.0013250381,0.0006565339],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039905348,0.00008779026,0.0007278658,0.033132512,0.00046947313,0.00035315592,0.000055374905,0.0006759523,0.0016248155,0.0008134835,0.013096213,0.9485641],"study_design_scores_gemma":[0.00047820556,0.0008652168,0.008454123,0.012681662,0.0023446984,0.007878422,0.0001215862,0.00051593845,0.0026513243,0.0009896057,0.96294415,0.00007517151],"about_ca_topic_score_codex":0.0014847536,"about_ca_topic_score_gemma":0.0027382062,"teacher_disagreement_score":0.00248186,"about_ca_system_score_codex":0.0005407767,"about_ca_system_score_gemma":0.0009962365,"threshold_uncertainty_score":0.0063905716},"labels":[],"label_agreement":null},{"id":"W1968114154","doi":"10.1007/s40262-013-0110-5","title":"Clinical Pharmacokinetic Drug Interactions Associated with Artemisinin Derivatives and HIV-Antivirals","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Nevirapine; Dihydroartemisinin; Artemether; Lumefantrine; Artesunate; Artemether/lumefantrine; Pharmacology; Artemisinin; Pharmacokinetics; Medicine; Drug; Ritonavir; Malaria; Plasmodium falciparum; Virology; Human immunodeficiency virus (HIV); Immunology; Viral load; Antiretroviral therapy","score_opus":0.15551299804731164,"score_gpt":0.47791693531647056,"score_spread":0.32240393726915895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968114154","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042359484,0.9979418,0.00023194584,0.00014799893,0.00007226207,0.000008097226,0.000024916653,0.000009855408,0.0011395524],"genre_scores_gemma":[0.003645425,0.99443406,0.00048515125,0.00023617814,0.00019576923,0.000013101582,0.000055640347,0.000003131607,0.0009315108],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995654,0.00012324422,0.00007279075,0.000044788154,0.00016908467,0.00002467782],"domain_scores_gemma":[0.99924767,0.0003866414,0.0002065706,0.000014286713,0.00011812499,0.000026710903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007840721,0.0007678926,0.0014600216,0.0015594965,0.00015193621,0.00080550043,0.0006630111,0.000813874,0.004137523],"category_scores_gemma":[0.0014474674,0.00025522267,0.00073790585,0.001716989,0.0002819905,0.00076563586,0.00055249705,0.0012663908,0.0012338179],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026918706,0.00012285239,0.00044552342,0.016468944,0.00027659192,0.00039393775,0.000040950545,0.00055884244,0.002621486,0.0013479134,0.014805903,0.96264786],"study_design_scores_gemma":[0.00015694014,0.0005520207,0.0032396642,0.0045252875,0.0010750067,0.006484116,0.00007270156,0.0006788808,0.003436944,0.001891174,0.9778421,0.000045121797],"about_ca_topic_score_codex":0.00059672253,"about_ca_topic_score_gemma":0.0014702793,"teacher_disagreement_score":0.004137523,"about_ca_system_score_codex":0.00040484607,"about_ca_system_score_gemma":0.0007537589,"threshold_uncertainty_score":0.013841391},"labels":[],"label_agreement":null},{"id":"W1973260414","doi":"10.2165/00003088-200038040-00001","title":"Metabolism and Pharmacokinetics of Oxazaphosphorines","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":212,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"","keywords":"Ifosfamide; Pharmacology; Pharmacokinetics; Metabolite; Metabolism; Chemistry; Cyclophosphamide; Prodrug; Drug metabolism; Drug; Active metabolite; Nitrogen mustard; Pharmacodynamics; Metabolic pathway; Cytochrome P450; Hydroxylation; Biochemistry; Biology; Enzyme; Medicine; Chemotherapy; Internal medicine; Etoposide","score_opus":0.11347648268276742,"score_gpt":0.4578059872238493,"score_spread":0.3443295045410819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973260414","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009607867,0.99742573,0.0004420643,0.00013826993,0.000051764808,0.0000052880378,0.000025542846,0.000012033951,0.0009385507],"genre_scores_gemma":[0.0036583596,0.9945128,0.0004800706,0.00011683975,0.00008003657,0.000009381647,0.000055211352,0.0000024706117,0.0010848556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986947,0.000030380474,0.000020657035,0.00002806138,0.00004203819,0.000009409286],"domain_scores_gemma":[0.9998271,0.00007677623,0.000047541143,0.0000075419484,0.000033757788,0.000007361262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044157525,0.0007441307,0.0013219783,0.00091661315,0.00011597042,0.0006463517,0.0006389554,0.0006364772,0.0015671141],"category_scores_gemma":[0.00049966294,0.0002449046,0.000329234,0.0011927328,0.00024067247,0.00070205634,0.00022904197,0.0008134414,0.0009982194],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002516721,0.00008789368,0.00028153055,0.0050117797,0.00008391386,0.0002550497,0.000031103933,0.00094385544,0.0063641565,0.0009916663,0.00662798,0.9790693],"study_design_scores_gemma":[0.000110687964,0.0006604581,0.0035446116,0.0017447664,0.00038755377,0.0059184176,0.0000644322,0.00067606696,0.010199076,0.0018289895,0.97482467,0.000040311803],"about_ca_topic_score_codex":0.00093986234,"about_ca_topic_score_gemma":0.001322402,"teacher_disagreement_score":0.0015671141,"about_ca_system_score_codex":0.0005206391,"about_ca_system_score_gemma":0.00052152417,"threshold_uncertainty_score":0.005242586},"labels":[],"label_agreement":null},{"id":"W1980131079","doi":"10.1007/s40262-015-0256-4","title":"A Compartmental Analysis for Morphine and Its Metabolites in Young Children After a Single Oral Dose","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; Western University; SickKids Foundation; BC Children's Hospital; Child and Family Research Institute","funders":"","keywords":"Morphine; Medicine; Codeine; Pharmacokinetics; Analgesic; Acetaminophen; Opioid; Oral administration; Anesthesia; Pharmacology; Internal medicine","score_opus":0.10864416972639676,"score_gpt":0.4092486706350109,"score_spread":0.3006045009086141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980131079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957896,0.0018850738,0.0012844044,0.000034388104,0.000009179921,0.000056848265,0.00039801028,0.00004096787,0.0005015892],"genre_scores_gemma":[0.99735814,0.0006321282,0.0011821125,0.00003214913,0.000008709947,0.00004420147,0.00023137752,0.000027872842,0.00048331756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960726,0.00010023315,0.000024439954,0.000075972304,0.00012290828,0.00006929307],"domain_scores_gemma":[0.9991703,0.00040621983,0.00018347011,0.00003815334,0.000114770184,0.00008711891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004234262,0.00038453963,0.0008494572,0.0006656373,0.00045474488,0.00081452535,0.00030440165,0.0003894219,0.001327057],"category_scores_gemma":[0.0017867254,0.00033815007,0.00064213295,0.0006870915,0.00054518075,0.0005128095,0.00032146505,0.0008812777,0.00025511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06443362,0.0006308371,0.5836547,0.0011087809,0.0007747465,0.0056052003,0.003988405,0.0055700177,0.23652406,0.0015547945,0.0011355815,0.09501928],"study_design_scores_gemma":[0.00027746957,0.0074656853,0.8365264,0.00008222434,0.0006379429,0.009458793,0.0016096188,0.012466772,0.12492725,0.00019584743,0.0062009688,0.0001510469],"about_ca_topic_score_codex":0.013848116,"about_ca_topic_score_gemma":0.0069085313,"teacher_disagreement_score":0.013848116,"about_ca_system_score_codex":0.0008928733,"about_ca_system_score_gemma":0.0017833181,"threshold_uncertainty_score":0.027535021},"labels":[],"label_agreement":null},{"id":"W1981591556","doi":"10.2165/11318040-000000000-00000","title":"Evaluation of Bioequivalence for Highly Variable Drugs with Scaled Average Bioequivalence","year":2009,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bioequivalence; Sample size determination; Replicate; Econometrics; Sample (material); Computer science; Statistics; Medicine; Mathematics; Pharmacology; Bioavailability","score_opus":0.7578223706805757,"score_gpt":0.6614144956818232,"score_spread":0.09640787499875247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981591556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002144628,0.977404,0.019184224,0.0003238812,0.00008363607,0.000060072016,0.000051382372,0.000027402753,0.00072065665],"genre_scores_gemma":[0.068434335,0.8922953,0.037581388,0.00038481274,0.00036857778,0.00021667444,0.0001740525,0.00002848057,0.0005164574],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9949846,0.0026458958,0.0005971518,0.00031717244,0.0014010422,0.000054029235],"domain_scores_gemma":[0.9799723,0.017336115,0.0016389071,0.00032437846,0.0006700312,0.000058358088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011314943,0.0010497726,0.0058853966,0.0019603933,0.00011057174,0.0012114282,0.0014828643,0.0009217287,0.0016561876],"category_scores_gemma":[0.022349956,0.0003792088,0.0024549013,0.0019328089,0.00093099487,0.0013274123,0.0005502297,0.0014211945,0.0002416635],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006891516,0.00010207418,0.0006295617,0.030774271,0.0026872316,0.00008805179,0.00004262741,0.008086315,0.0012595817,0.011061044,0.0023056637,0.9422745],"study_design_scores_gemma":[0.0049650003,0.012087933,0.022648768,0.049256347,0.041394364,0.009733449,0.00042781164,0.121105134,0.028384222,0.16612564,0.54328156,0.00058985944],"about_ca_topic_score_codex":0.0006984084,"about_ca_topic_score_gemma":0.0007228078,"teacher_disagreement_score":0.011314943,"about_ca_system_score_codex":0.00089462794,"about_ca_system_score_gemma":0.0016401862,"threshold_uncertainty_score":0.059839845},"labels":[],"label_agreement":null},{"id":"W1981592939","doi":"10.2165/00003088-200140090-00005","title":"Comparison of the Plasma Pharmacokinetics of Lamivudine During Twice and Once Daily Administration in Patients with HIV","year":2001,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Cmin; Pharmacokinetics; Cmax; Lamivudine; Medicine; Pharmacology; Trough Concentration; Internal medicine; Gastroenterology; Immunology; Virus","score_opus":0.038506566473534634,"score_gpt":0.3774059128336198,"score_spread":0.3388993463600852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981592939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968579,0.002265831,0.0002286845,0.000075199845,0.000017281307,0.00001689266,0.00007937613,0.000016594562,0.00044225593],"genre_scores_gemma":[0.9990589,0.00037937931,0.00017222935,0.00005668477,0.000033044515,0.00001125944,0.00007913764,0.0000060474363,0.00020327242],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994894,0.0002547378,0.000034745466,0.00007058019,0.0000969118,0.00005357912],"domain_scores_gemma":[0.9981438,0.0009634514,0.00036062335,0.00010464147,0.000157174,0.00027030802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000671957,0.00034850277,0.0011844407,0.00029594978,0.00028421835,0.0007766781,0.0001814501,0.0005196864,0.0007508347],"category_scores_gemma":[0.005374385,0.00026579964,0.00031526704,0.00044360437,0.0002514252,0.000713743,0.00013820505,0.0009354152,0.00015342921],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33092204,0.0019196603,0.27140668,0.000676161,0.0014632584,0.0015704664,0.0021310395,0.003972352,0.09889114,0.00065349357,0.0016278836,0.28476587],"study_design_scores_gemma":[0.0066780155,0.099442616,0.85689676,0.00006887991,0.0010729718,0.005599919,0.0008376571,0.0075663854,0.01686422,0.00047316708,0.0043859216,0.00011354309],"about_ca_topic_score_codex":0.0011327475,"about_ca_topic_score_gemma":0.0010383852,"teacher_disagreement_score":0.0011844407,"about_ca_system_score_codex":0.0005429584,"about_ca_system_score_gemma":0.00040979867,"threshold_uncertainty_score":0.00393945},"labels":[],"label_agreement":null},{"id":"W1981902086","doi":"10.1007/s40262-015-0236-8","title":"Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":172,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Memorial University of Newfoundland; St. Michael's Hospital; University of Ottawa; University of Toronto; Sunnybrook Health Science Centre; University of Waterloo; University of Manitoba; Children's & Women's Health Centre of British Columbia; Ottawa Hospital","funders":"National Medical Research Council; National Health and Medical Research Council; University of Ottawa","keywords":"Medicine; Statement (logic); Pharmacotherapy; Intensive care medicine; MEDLINE; Pharmacokinetics; Medical physics; Pharmacology; Internal medicine; Chemistry; Political science","score_opus":0.9819514435848298,"score_gpt":0.8061165991694247,"score_spread":0.1758348444154051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981902086","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012978513,0.02162826,0.7940605,0.08103472,0.01276845,0.0195701,0.035315923,0.009789425,0.02453472],"genre_scores_gemma":[0.010614415,0.018461363,0.82826805,0.04963892,0.006367112,0.049716663,0.023092756,0.0034612666,0.010379483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.58309025,0.25850022,0.110660076,0.005264185,0.039740607,0.0027447285],"domain_scores_gemma":[0.3188814,0.41112196,0.07078428,0.06714947,0.12699078,0.00507216],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.24024324,0.0037813867,0.006585793,0.011437004,0.002154364,0.013410889,0.010195563,0.018057115,0.01619126],"category_scores_gemma":[0.55553734,0.0062789824,0.008564467,0.015158543,0.005105594,0.0051248935,0.00787639,0.026655735,0.024079984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010164382,0.00045981558,0.0015684512,0.01291584,0.0009016354,0.00040019787,0.00087270065,0.004416253,0.0015744503,0.042485435,0.70448476,0.22890396],"study_design_scores_gemma":[0.0015532537,0.00059048884,0.004146308,0.022404898,0.0013170054,0.0015416418,0.0003296659,0.008725266,0.0058617983,0.07062155,0.8825761,0.00033214016],"about_ca_topic_score_codex":0.005443592,"about_ca_topic_score_gemma":0.0036804194,"teacher_disagreement_score":0.75975674,"about_ca_system_score_codex":0.0039434885,"about_ca_system_score_gemma":0.03315513,"threshold_uncertainty_score":0.93691534},"labels":[],"label_agreement":null},{"id":"W1983727955","doi":"10.2165/0003088-200948010-00001","title":"Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":525,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Rivaroxaban; Apixaban; Dabigatran; Discovery and development of direct thrombin inhibitors; Pharmacodynamics; Medicine; Fondaparinux; Pharmacology; Thrombin; Pharmacokinetics; Anticoagulant; Warfarin; Internal medicine; Venous thromboembolism; Atrial fibrillation; Thrombosis; Platelet","score_opus":0.2171734329349795,"score_gpt":0.4745278795971007,"score_spread":0.25735444666212115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983727955","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00073595234,0.99838424,0.00021811163,0.00011116863,0.000038433693,0.0000045345314,0.0000203388,0.000005795983,0.00048142512],"genre_scores_gemma":[0.0032125155,0.99561876,0.00046370382,0.00012757006,0.0000904376,0.000008101484,0.000043745782,0.0000019977067,0.00043316715],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997203,0.000049957293,0.00005162629,0.000048473215,0.000112544316,0.000017182714],"domain_scores_gemma":[0.9994741,0.00027836947,0.00012550889,0.000012674896,0.00008439747,0.000025063768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009693077,0.0007414444,0.002200627,0.0016075631,0.00012457067,0.0009888145,0.00091863197,0.00090240967,0.0019982336],"category_scores_gemma":[0.0011146155,0.00028364934,0.00066333124,0.0020989438,0.00036850196,0.0010096802,0.00029759877,0.001226372,0.00080303877],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005281731,0.000120062934,0.00038720694,0.01038643,0.00019128434,0.0002777351,0.000039203525,0.00055471715,0.0030278976,0.000981174,0.0050131893,0.9784928],"study_design_scores_gemma":[0.00061036577,0.0020382705,0.009610547,0.004985377,0.0020396668,0.010438728,0.00018968048,0.00084607175,0.007078038,0.002664922,0.9594023,0.00009604603],"about_ca_topic_score_codex":0.00076445047,"about_ca_topic_score_gemma":0.001344713,"teacher_disagreement_score":0.002200627,"about_ca_system_score_codex":0.00049007544,"about_ca_system_score_gemma":0.00083555235,"threshold_uncertainty_score":0.00668478},"labels":[],"label_agreement":null},{"id":"W1983958707","doi":"10.2165/11538690-000000000-00000","title":"Population Pharmacokinetic Evaluation with External Validation and Bayesian Estimator of Voriconazole in Liver Transplant Recipients","year":2011,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"NONMEM; Medicine; Pharmacokinetics; Covariate; Population; Statistics; Dosing; Confidence interval; Area under the curve; Internal medicine; Mathematics","score_opus":0.10715141225350172,"score_gpt":0.39380757758989754,"score_spread":0.2866561653363958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983958707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9404274,0.0002795867,0.058026437,0.00017022231,0.000015022647,0.00009028445,0.00019526677,0.00014494259,0.00065074966],"genre_scores_gemma":[0.99040717,0.00005460176,0.008814338,0.000048007867,0.000008119163,0.0000590383,0.0003438008,0.000027303575,0.00023772498],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9863331,0.011979763,0.0002822916,0.0006181149,0.0006219392,0.00016480486],"domain_scores_gemma":[0.96292084,0.030064905,0.001946326,0.0026425929,0.0021136145,0.000311688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033784553,0.0007018546,0.0010429587,0.0004635754,0.00045622673,0.0012919473,0.00086071773,0.0011190904,0.00070779177],"category_scores_gemma":[0.059280913,0.00060843886,0.0010207726,0.00035347266,0.0008050086,0.0008232661,0.0010111424,0.0011346899,0.00021429909],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01908446,0.002105865,0.22252832,0.00022266062,0.0032155789,0.00030857962,0.0009428768,0.6156785,0.007025319,0.006711715,0.0017376011,0.12043848],"study_design_scores_gemma":[0.0006868905,0.0017152696,0.034866385,0.000031200478,0.0005534205,0.00019269346,0.00007012653,0.95427686,0.003732373,0.0030807734,0.00073209195,0.00006187335],"about_ca_topic_score_codex":0.003676802,"about_ca_topic_score_gemma":0.00204699,"teacher_disagreement_score":0.033784553,"about_ca_system_score_codex":0.00093788904,"about_ca_system_score_gemma":0.0016578095,"threshold_uncertainty_score":0.17867196},"labels":[],"label_agreement":null},{"id":"W1985187934","doi":"10.1007/s40262-013-0090-5","title":"Development of a Paediatric Population-Based Model of the Pharmacokinetics of Rivaroxaban","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Bayer HealthCare; Bayer","keywords":"Medicine; Rivaroxaban; Physiologically based pharmacokinetic modelling; Dosing; Population; Pharmacokinetics; Clinical trial; Pharmacology; Intensive care medicine; Internal medicine; Warfarin","score_opus":0.08869458188294198,"score_gpt":0.3721436355699694,"score_spread":0.2834490536870274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985187934","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27617532,0.0010873262,0.6850851,0.001168613,0.00021375236,0.00036242412,0.004383871,0.00080299325,0.030720603],"genre_scores_gemma":[0.9080407,0.0010308496,0.07757965,0.00021468275,0.000049271282,0.00071618473,0.0020825819,0.0001419444,0.010144183],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998454,0.000056857974,0.000008176886,0.000033218646,0.00003939402,0.000016805036],"domain_scores_gemma":[0.9995497,0.00023296764,0.000052035968,0.000020808404,0.00011963965,0.000024825315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036650273,0.000543365,0.00057036214,0.00029691376,0.00027990792,0.00072966533,0.00095976656,0.0011493936,0.0029465351],"category_scores_gemma":[0.0015191387,0.00040391737,0.00094876817,0.00041323653,0.00032837916,0.00039974626,0.00054809777,0.0010042556,0.00054679037],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019756375,0.000008706259,0.00073616364,0.000019670835,0.0000115550665,0.00006192906,0.000018674036,0.9963207,0.00039167274,0.0007593122,0.00023983758,0.001411957],"study_design_scores_gemma":[0.000017017812,0.000020435145,0.00031567842,0.0000063380216,0.000010931784,0.00002759896,0.0000062255776,0.9978878,0.00015980819,0.0004972788,0.0010454941,0.000005482894],"about_ca_topic_score_codex":0.026522577,"about_ca_topic_score_gemma":0.009645151,"teacher_disagreement_score":0.026522577,"about_ca_system_score_codex":0.00081329176,"about_ca_system_score_gemma":0.0019465735,"threshold_uncertainty_score":0.0527364},"labels":[],"label_agreement":null},{"id":"W1986077106","doi":"10.2165/00003088-200038050-00001","title":"Choosing the Right Nonsteroidal Anti-Inflammatory Drug for the Right Patient","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Pharmacokinetics; Enterohepatic circulation; Volume of distribution; Pharmacology; Free fraction; Albumin; Distribution (mathematics); Drug; Chemistry; Medicine; Internal medicine; Metabolism","score_opus":0.04598313820310822,"score_gpt":0.3963797105658518,"score_spread":0.3503965723627436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986077106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019078728,0.996944,0.00034957542,0.00082877965,0.00023811685,0.000007028152,0.000016193411,0.000013828534,0.0014116402],"genre_scores_gemma":[0.0012487082,0.995948,0.00082492677,0.0006476733,0.0002988435,0.000008601862,0.000029049068,0.0000028026395,0.0009914667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972457,0.000068073336,0.000044636647,0.000046388926,0.00010034046,0.000015859838],"domain_scores_gemma":[0.99954516,0.00024386762,0.000077756195,0.000012206074,0.00008430597,0.0000365614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061401824,0.0009129085,0.002406406,0.0014580118,0.00032918315,0.0009300984,0.0008516569,0.0012470251,0.004363076],"category_scores_gemma":[0.0011230519,0.0002552964,0.0004692448,0.0017211877,0.00049116934,0.0012925762,0.00037148938,0.0020584203,0.002919533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015163312,0.00009545076,0.0002970806,0.0063632596,0.00007770445,0.0003922009,0.00002340103,0.00018995108,0.0013112526,0.0007848253,0.021587493,0.96872574],"study_design_scores_gemma":[0.0001867191,0.0002941378,0.0032867938,0.0075017945,0.00039600386,0.008607041,0.00016939016,0.00032075244,0.001895032,0.003887367,0.9733979,0.000056997615],"about_ca_topic_score_codex":0.0010748595,"about_ca_topic_score_gemma":0.0036466485,"teacher_disagreement_score":0.004363076,"about_ca_system_score_codex":0.00054210826,"about_ca_system_score_gemma":0.0009771587,"threshold_uncertainty_score":0.014595985},"labels":[],"label_agreement":null},{"id":"W1989930316","doi":"10.2165/00003088-200847030-00006","title":"Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban – an Oral, Direct Factor Xa Inhibitor – in Patients Undergoing Major Orthopaedic Surgery","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":243,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital; McGill University Health Centre","funders":"","keywords":"Rivaroxaban; Medicine; Pharmacodynamics; Pharmacokinetics; Population; Anesthesia; Internal medicine; Pharmacology; Warfarin; Atrial fibrillation","score_opus":0.11709606034631777,"score_gpt":0.40146987980002125,"score_spread":0.2843738194537035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989930316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988194,0.0002220714,0.00030958845,0.00007184653,0.000010346793,0.000010483804,0.00010391476,0.0000108502045,0.00044143666],"genre_scores_gemma":[0.9992781,0.00010564931,0.00014045842,0.000074876014,0.000034608634,0.000013293307,0.00018615581,0.0000064621286,0.00016033606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993548,0.00021931114,0.00005631817,0.00015567782,0.00012692343,0.000087017244],"domain_scores_gemma":[0.99817145,0.00081720605,0.0004585702,0.00019581115,0.00012516601,0.00023177962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072980474,0.000304406,0.0008421274,0.00032438297,0.0002928737,0.0007293101,0.00022744833,0.0006570585,0.0011844886],"category_scores_gemma":[0.004390504,0.0003747424,0.00070105813,0.0004549226,0.00036057233,0.000852116,0.0002572246,0.0013776106,0.00023341498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014917907,0.00087868504,0.9499294,0.000060928614,0.0014139179,0.0010606281,0.00043590568,0.0028334642,0.0070895976,0.00038587255,0.00091238355,0.020081418],"study_design_scores_gemma":[0.0003487169,0.005554324,0.98489386,0.0000073474766,0.00033742597,0.0019933241,0.0003151879,0.004446019,0.000812167,0.0005717102,0.0006706611,0.00004913484],"about_ca_topic_score_codex":0.0009669266,"about_ca_topic_score_gemma":0.0006962479,"teacher_disagreement_score":0.0011844886,"about_ca_system_score_codex":0.00038141478,"about_ca_system_score_gemma":0.0003513242,"threshold_uncertainty_score":0.003962517},"labels":[],"label_agreement":null},{"id":"W1994438706","doi":"10.2165/00003088-200241080-00001","title":"Impact of Stereoselectivity on the Pharmacokinetics and Pharmacodynamics of Antiarrhythmic Drugs","year":2002,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Propafenone; Mexiletine; Flecainide; Stereoselectivity; Chemistry; Pharmacology; Debrisoquine; Verapamil; Pharmacokinetics; Quinidine; Disopyramide; Procainamide; Antiarrhythmic agent; Enantiomer; CYP2D6; Metabolism; Medicine; Internal medicine; Stereochemistry; Cytochrome P450; Biochemistry; Calcium","score_opus":0.29272726509544517,"score_gpt":0.5554188054718815,"score_spread":0.2626915403764363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994438706","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047765,0.9907754,0.0010258446,0.00028118383,0.00010256709,0.000007864162,0.000061826766,0.00001756226,0.0029512136],"genre_scores_gemma":[0.019180594,0.97753567,0.0008298266,0.00027128163,0.00021102947,0.000007583543,0.00008622953,0.0000053035556,0.0018725503],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974006,0.000069367146,0.00003124348,0.00004832923,0.00009370769,0.000017380597],"domain_scores_gemma":[0.999597,0.00021505821,0.00008236751,0.000014105577,0.000078454694,0.000013147192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007844585,0.00044843188,0.0011511846,0.0004782063,0.00008194746,0.00050530845,0.00059438276,0.00040540815,0.0020312953],"category_scores_gemma":[0.00064624334,0.00015823361,0.00032299708,0.0006178702,0.00026287316,0.0005364065,0.00020845055,0.000568861,0.0008701066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039084558,0.00006715426,0.00086329854,0.0052578603,0.000113518756,0.0003438849,0.00003072427,0.00063015183,0.016263884,0.0019531809,0.0033856363,0.9706999],"study_design_scores_gemma":[0.00022348562,0.0016310697,0.016052043,0.0015262249,0.0010184706,0.010514093,0.00012179406,0.0009474179,0.046767432,0.0063414085,0.91477937,0.00007723884],"about_ca_topic_score_codex":0.0008179725,"about_ca_topic_score_gemma":0.0014802451,"teacher_disagreement_score":0.0020312953,"about_ca_system_score_codex":0.00032075116,"about_ca_system_score_gemma":0.0005927735,"threshold_uncertainty_score":0.0067953467},"labels":[],"label_agreement":null},{"id":"W1996261168","doi":"10.2165/00003088-200443110-00004","title":"Risperidone Does Not Affect Steady-State Pharmacokinetics of Divalproex Sodium in Patients with Bipolar Disorder","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Centre for Addiction and Mental Health; University of Alberta Hospital; Alberta Hospital Edmonton; University of Toronto","funders":"","keywords":"Risperidone; Cmax; Divalproex; Pharmacokinetics; Placebo; Bipolar disorder; Medicine; Anticonvulsant; Pharmacology; Drug interaction; Carbamazepine; Internal medicine; Mania; Psychiatry; Schizophrenia (object-oriented programming); Lithium (medication); Epilepsy","score_opus":0.02271253406040022,"score_gpt":0.33944674164337013,"score_spread":0.3167342075829699,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996261168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552286,0.0010746883,0.00013886692,0.00016981845,0.00003504164,0.00002362599,0.00014907583,0.00008383053,0.0028022637],"genre_scores_gemma":[0.99892884,0.00021392496,0.00012952123,0.00012102932,0.000020049232,0.000008256785,0.000120399374,0.000010943117,0.0004469842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935275,0.00029099756,0.00007943331,0.00008158158,0.00012756413,0.000067609],"domain_scores_gemma":[0.99772006,0.0010791181,0.0005209095,0.00017034328,0.00017805779,0.00033141134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005295267,0.0003782488,0.0013523555,0.0001955171,0.0004110754,0.0008097744,0.00025577587,0.0006682331,0.0017950825],"category_scores_gemma":[0.00504045,0.0004110701,0.0005923076,0.00021558364,0.00030527991,0.00079119595,0.00019466682,0.0010277159,0.00048780523],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19129913,0.0036551757,0.49492726,0.00063505163,0.0035425606,0.0038069247,0.0020196184,0.0023018445,0.0815263,0.0004947499,0.0056265867,0.21016479],"study_design_scores_gemma":[0.0049686152,0.019225366,0.9561475,0.000059346454,0.0015216103,0.0040576993,0.00038445488,0.0034694863,0.0070440387,0.00033742868,0.0027121925,0.00007217991],"about_ca_topic_score_codex":0.0024618967,"about_ca_topic_score_gemma":0.004917963,"teacher_disagreement_score":0.0024618967,"about_ca_system_score_codex":0.0007355199,"about_ca_system_score_gemma":0.00061186694,"threshold_uncertainty_score":0.006005168},"labels":[],"label_agreement":null},{"id":"W2000092715","doi":"10.2165/11319320-000000000-00000","title":"Multiple Peaking Phenomena in Pharmacokinetic Disposition","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Gastrointestinal tract; Enterohepatic circulation; Drug; Xenobiotic; Secretion; Reabsorption; Pharmacology; Chemistry; Distribution (mathematics); Medicine; Internal medicine; Biochemistry; Mathematics; Metabolism","score_opus":0.10447947642254363,"score_gpt":0.4522095953047637,"score_spread":0.34773011888222005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000092715","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030843358,0.9969591,0.0011437332,0.0002351937,0.00017122149,0.00000987915,0.000018166274,0.000024546665,0.0011297122],"genre_scores_gemma":[0.0022474555,0.9952992,0.0008370654,0.00022535241,0.0002842702,0.000014323703,0.000030808118,0.0000054185844,0.00105599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996754,0.000066790075,0.000050151044,0.00007405562,0.000107007865,0.00002660354],"domain_scores_gemma":[0.9994049,0.00030123882,0.00012578526,0.000024316032,0.00011507883,0.000028698762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009335566,0.0016374595,0.0024715262,0.0023038336,0.00022178657,0.0012906779,0.0010097865,0.0012341111,0.0034368543],"category_scores_gemma":[0.001228184,0.0005419008,0.0006967534,0.002246186,0.0006878964,0.0025479272,0.00097472937,0.0020074465,0.0021637226],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001772375,0.00010338084,0.00019457417,0.010391877,0.0000853952,0.00028736735,0.000032925826,0.0008020573,0.0026990492,0.002538786,0.011570533,0.9711168],"study_design_scores_gemma":[0.00011592501,0.00048477037,0.0015313636,0.0034791338,0.000541113,0.005732767,0.000072372226,0.001412288,0.004934586,0.0056700082,0.97595304,0.000072578965],"about_ca_topic_score_codex":0.0006494555,"about_ca_topic_score_gemma":0.000991289,"teacher_disagreement_score":0.0034368543,"about_ca_system_score_codex":0.0007451398,"about_ca_system_score_gemma":0.0012750895,"threshold_uncertainty_score":0.011497438},"labels":[],"label_agreement":null},{"id":"W2000740780","doi":"10.2165/00003088-200544070-00001","title":"Buprenorphine","year":2005,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":332,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Buprenorphine; Pharmacology; (+)-Naloxone; Sublingual administration; Medicine; Opioid; Bioavailability; Thebaine; Pharmacokinetics; Partial agonist; Morphine; Anesthesia; Agonist; Codeine; Internal medicine; Receptor","score_opus":0.1657355958720424,"score_gpt":0.5085472259869853,"score_spread":0.3428116301149429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000740780","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018898497,0.99773276,0.00014797752,0.00019499513,0.00012301204,0.000022304032,0.000034828186,0.000010249053,0.001544763],"genre_scores_gemma":[0.0017138283,0.9960616,0.00031393932,0.00034883863,0.00014495428,0.000028112408,0.000052788444,0.0000018637737,0.0013339622],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961424,0.00010403147,0.000084148975,0.00005466745,0.000119093995,0.000023910197],"domain_scores_gemma":[0.9994765,0.00023197467,0.00018113545,0.000017612452,0.00006552,0.000027306734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074807607,0.0011059184,0.002078819,0.0022119884,0.00022973417,0.0008140385,0.0008867558,0.00090405514,0.008524484],"category_scores_gemma":[0.0013815206,0.00038089664,0.0007518217,0.001863888,0.0004101772,0.0010024813,0.00065598293,0.0016039427,0.0022136918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024107489,0.00012380876,0.000111037676,0.022308012,0.00021291936,0.0001578588,0.000027577718,0.00012414549,0.0010374465,0.0006931766,0.0154485945,0.9595144],"study_design_scores_gemma":[0.00063678843,0.00077957765,0.003160474,0.015262181,0.0015711681,0.0045194114,0.000085606865,0.00024275467,0.0015406681,0.0013232265,0.97082776,0.000050306484],"about_ca_topic_score_codex":0.0009035458,"about_ca_topic_score_gemma":0.0030578603,"teacher_disagreement_score":0.008524484,"about_ca_system_score_codex":0.00048058326,"about_ca_system_score_gemma":0.0010760818,"threshold_uncertainty_score":0.028517246},"labels":[],"label_agreement":null},{"id":"W2001075984","doi":"10.2165/11587240-000000000-00000","title":"Does Olanzapine Warrant Clinical Pharmacokinetic Monitoring in Schizophrenia?","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; Fraser Health; University of British Columbia","funders":"","keywords":"Olanzapine; Therapeutic drug monitoring; Medicine; Adverse effect; Schizophrenia (object-oriented programming); Antipsychotic; Pharmacokinetics; Population; Pharmacology; Drug; Pharmacotherapy; Atypical antipsychotic; Antipsychotic Agent; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.2435201226149672,"score_gpt":0.5125452565259843,"score_spread":0.26902513391101707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001075984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058337604,0.9970253,0.0002485649,0.0011888086,0.00015904725,0.0000061500396,0.00002494496,0.000012985212,0.00075087236],"genre_scores_gemma":[0.007233573,0.990669,0.0004826654,0.0008173003,0.00026226352,0.000013059324,0.00005226241,0.0000039487322,0.00046578847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954885,0.00012302236,0.00012856007,0.000051279872,0.00012005433,0.00002809431],"domain_scores_gemma":[0.9986785,0.00055741816,0.00044779942,0.000031748874,0.00022126344,0.000063193664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015843402,0.0008858044,0.0028879603,0.00096631,0.00017865315,0.0012184347,0.00077050755,0.0012986931,0.0021278185],"category_scores_gemma":[0.0027366115,0.0003119412,0.00086568895,0.0011618115,0.0005584653,0.0016516682,0.00052641483,0.0016703798,0.0009948432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078075536,0.000048834754,0.0006018162,0.00918241,0.00020820618,0.00029180275,0.00003227851,0.00023424436,0.0015331254,0.0008715527,0.010641944,0.9755731],"study_design_scores_gemma":[0.001568699,0.001419168,0.010770762,0.017381225,0.0034192149,0.008543713,0.00036415338,0.0013416015,0.0034832745,0.006234099,0.94531083,0.00016323819],"about_ca_topic_score_codex":0.0017230142,"about_ca_topic_score_gemma":0.004928863,"teacher_disagreement_score":0.0028879603,"about_ca_system_score_codex":0.0008653212,"about_ca_system_score_gemma":0.0020604017,"threshold_uncertainty_score":0.008378863},"labels":[],"label_agreement":null},{"id":"W2001348958","doi":"10.2165/00003088-200443030-00004","title":"Bayesian Pharmacokinetics of Gentamicin in a Haemodialysis Population","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; St. Boniface Hospital; University of Manitoba","funders":"Abbott Laboratories","keywords":"Medicine; Pharmacokinetics; Gentamicin; Pharmacotherapy; Intensive care medicine; Population pharmacokinetics; Population; Pharmacology; Anesthesia; Internal medicine; Antibiotics; Chemistry","score_opus":0.05083563210827415,"score_gpt":0.41038753714105847,"score_spread":0.35955190503278434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001348958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837368,0.00043999744,0.014580598,0.00038903975,0.000006749587,0.00001875141,0.00016063983,0.000038110393,0.00062927534],"genre_scores_gemma":[0.9965481,0.00023437255,0.002653231,0.00006616482,0.0000149065145,0.000011747439,0.00017168596,0.000010027172,0.0002898363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987612,0.0008074668,0.00004616042,0.00017560222,0.00013903074,0.00007056313],"domain_scores_gemma":[0.9939719,0.004622799,0.00063579826,0.00031604082,0.00024348024,0.00020996036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035918257,0.0003643208,0.0011857293,0.00042278488,0.00025972273,0.0010526327,0.0005719139,0.00096639467,0.00087144255],"category_scores_gemma":[0.015419463,0.0004728533,0.00064755813,0.00030820433,0.0005280954,0.0007357906,0.00045797817,0.0010385865,0.00019116116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013115438,0.0016135626,0.46820635,0.000252764,0.0022916577,0.0014934746,0.0016998837,0.3822546,0.013168676,0.020864014,0.0034215655,0.09161804],"study_design_scores_gemma":[0.0004361059,0.002295002,0.19882928,0.00003666478,0.00073490234,0.0018470668,0.00020324548,0.77696824,0.0014098993,0.0156061705,0.0014858027,0.00014762484],"about_ca_topic_score_codex":0.005351905,"about_ca_topic_score_gemma":0.0036705534,"teacher_disagreement_score":0.005351905,"about_ca_system_score_codex":0.0008283696,"about_ca_system_score_gemma":0.00064286194,"threshold_uncertainty_score":0.018995583},"labels":[],"label_agreement":null},{"id":"W2002514824","doi":"10.2165/00003088-200039020-00003","title":"Impact of Absorption Profiling on Efficacy and Safety of Cyclosporin Therapy in Transplant Recipients","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Therapeutic drug monitoring; Immunosuppression; Pharmacokinetics; Pharmacology; Therapeutic index; Bioavailability; Drug; Therapeutic window; Dose; Intensive care medicine; Internal medicine","score_opus":0.14315532254687366,"score_gpt":0.49168334381813805,"score_spread":0.34852802127126437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002514824","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016409422,0.9977095,0.00010867682,0.00009834354,0.000023986893,0.000004254216,0.000019604979,0.00000434774,0.00039031697],"genre_scores_gemma":[0.008516352,0.9908379,0.00030396006,0.00011134732,0.000050436574,0.000005453532,0.0000344907,0.0000013673258,0.00013870408],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99958056,0.00014694015,0.000084850275,0.00005066994,0.00012194041,0.000015070379],"domain_scores_gemma":[0.9989594,0.0006907394,0.00019779487,0.00001750554,0.00011605271,0.000018368213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011104959,0.00043639346,0.0020519628,0.0009362293,0.0001020732,0.0006234245,0.0005127532,0.000515544,0.0009189734],"category_scores_gemma":[0.0016467919,0.00017060562,0.0007434928,0.0012804626,0.00019473903,0.00050044653,0.0002168823,0.0005183556,0.00027105073],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070720917,0.00009305166,0.0015216685,0.01600222,0.000707619,0.0001900585,0.00003404177,0.00033695923,0.0021774436,0.00032209128,0.0024142868,0.97549325],"study_design_scores_gemma":[0.0011759822,0.0044436273,0.084929176,0.02834393,0.019243956,0.012784288,0.0003728798,0.0015706455,0.01656619,0.0032028016,0.8271719,0.00019461139],"about_ca_topic_score_codex":0.0009310273,"about_ca_topic_score_gemma":0.0016235952,"teacher_disagreement_score":0.0020519628,"about_ca_system_score_codex":0.00036228946,"about_ca_system_score_gemma":0.0008734268,"threshold_uncertainty_score":0.0058729053},"labels":[],"label_agreement":null},{"id":"W2005328285","doi":"10.2165/00003088-200038010-00003","title":"Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":907,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Pharmacology; Drug interaction; Ritonavir; CYP3A4; Ketoconazole; Triazolam; Pharmacokinetics; Dextromethorphan; Medicine; Chemistry; Benzodiazepine; Cytochrome P450; Internal medicine","score_opus":0.2913135195647739,"score_gpt":0.5702358397399223,"score_spread":0.2789223201751484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005328285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009235396,0.9967535,0.00031696184,0.00034151322,0.00012427554,0.000006368896,0.000031584765,0.000009129462,0.0014930211],"genre_scores_gemma":[0.005165634,0.9926918,0.00034993247,0.00028818598,0.00017987292,0.000009081524,0.00005288113,0.0000025485251,0.0012600381],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99983335,0.000039629544,0.000019303621,0.00003077675,0.000064940985,0.00001193255],"domain_scores_gemma":[0.9997737,0.00011558168,0.000045419358,0.0000074085756,0.00004475598,0.000013077805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005369055,0.0007019108,0.0013975479,0.00081068627,0.00010624999,0.0006558798,0.00059747114,0.00066579145,0.0022756918],"category_scores_gemma":[0.0006437697,0.00015759999,0.0004038146,0.0009584287,0.00027129037,0.00051580573,0.00022487924,0.0010340061,0.0011676318],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035470494,0.000099972916,0.00037375453,0.004265027,0.000103324404,0.00046359946,0.000027132586,0.00040791594,0.0034439682,0.0010863654,0.009118813,0.9802555],"study_design_scores_gemma":[0.00028480662,0.0010400058,0.007894665,0.0022883483,0.0007026892,0.006921462,0.00010194469,0.0004744657,0.006458286,0.0039476096,0.9698343,0.000051437404],"about_ca_topic_score_codex":0.0006273223,"about_ca_topic_score_gemma":0.0014244865,"teacher_disagreement_score":0.0022756918,"about_ca_system_score_codex":0.00039883135,"about_ca_system_score_gemma":0.00057081436,"threshold_uncertainty_score":0.0076130033},"labels":[],"label_agreement":null},{"id":"W2007492343","doi":"10.2165/11531820-000000000-00000","title":"Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000 mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects","year":2010,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Sirtuins and Resveratrol in Medicine","field":"Medicine","cited_by":259,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Pharmacokinetics; Cmax; Resveratrol; Tolerability; Chemistry; Pharmacology; Medicine; Adverse effect","score_opus":0.04732261035777299,"score_gpt":0.3892470478806883,"score_spread":0.34192443752291535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007492343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748695,0.0008146251,0.00056001503,0.000033304157,0.000019782896,0.000058215966,0.0003162946,0.000058230737,0.00065253343],"genre_scores_gemma":[0.9966743,0.00029445408,0.0003679381,0.000095758754,0.000029435258,0.000071105285,0.0005528322,0.00002176358,0.0018922932],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997565,0.00009432656,0.000013263775,0.00006821044,0.000030337813,0.000037344522],"domain_scores_gemma":[0.9996693,0.000081810496,0.00007060029,0.000052543888,0.000044442197,0.00008133905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005371993,0.00052085106,0.00073975656,0.00024059402,0.00026331464,0.00047589763,0.0002322865,0.00057034584,0.0020434891],"category_scores_gemma":[0.0010068672,0.0004706005,0.0006391049,0.00024085841,0.00040467875,0.00070155103,0.0001503125,0.0007695712,0.00060133165],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5699995,0.0071306177,0.051516797,0.00025343683,0.0013563266,0.0006968972,0.0006442265,0.0025548525,0.28462183,0.0002706214,0.0016970542,0.07925782],"study_design_scores_gemma":[0.0141734965,0.25539586,0.6015724,0.000048234353,0.0029378778,0.0019394942,0.00077565736,0.011156873,0.10539758,0.000616526,0.005738076,0.00024798498],"about_ca_topic_score_codex":0.0023496277,"about_ca_topic_score_gemma":0.0019907732,"teacher_disagreement_score":0.0023496277,"about_ca_system_score_codex":0.00038875113,"about_ca_system_score_gemma":0.00033489996,"threshold_uncertainty_score":0.0068361163},"labels":[],"label_agreement":null},{"id":"W2008616614","doi":"10.2165/00003088-200342150-00004","title":"Stereoselectivity in the Pharmacodynamics and Pharmacokinetics of the Chiral Antimalarial Drugs","year":2003,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":108,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Stereoselectivity; Chemistry; Pharmacology; Pharmacokinetics; Enantiomer; Primaquine; Mefloquine; Plasmodium falciparum; Chloroquine; Stereochemistry; Medicine; Biochemistry; Malaria","score_opus":0.2544438096591189,"score_gpt":0.5451954329062285,"score_spread":0.2907516232471096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008616614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015161658,0.9943644,0.0012486964,0.00022739613,0.000092854,0.000008202472,0.000040707095,0.00001972153,0.002481932],"genre_scores_gemma":[0.008016915,0.98840094,0.0010748021,0.00021805258,0.00019447207,0.000009123937,0.00007769974,0.000004873107,0.0020031976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971145,0.00006240766,0.000034782563,0.00005756923,0.00011375143,0.000020081976],"domain_scores_gemma":[0.99959916,0.00018611635,0.00009515454,0.000017446162,0.00008206699,0.0000200256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000993839,0.0005922537,0.0014538448,0.0010434306,0.00014805698,0.0006676885,0.00082491,0.00057731674,0.00203646],"category_scores_gemma":[0.0006331384,0.0002804574,0.00036279354,0.0014236512,0.0005934929,0.00073490053,0.00037475541,0.0009507522,0.0013055879],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017345042,0.00005967564,0.0005815003,0.005283405,0.00006921722,0.0002986227,0.000041147592,0.00062667206,0.008718279,0.0037466667,0.0045480146,0.9758533],"study_design_scores_gemma":[0.00008979534,0.00050805375,0.006232726,0.0010997187,0.00031970724,0.007677889,0.00009099047,0.00060130283,0.019593263,0.006286225,0.957434,0.00006639138],"about_ca_topic_score_codex":0.0017267385,"about_ca_topic_score_gemma":0.002860292,"teacher_disagreement_score":0.00203646,"about_ca_system_score_codex":0.0006711304,"about_ca_system_score_gemma":0.0009348499,"threshold_uncertainty_score":0.006812632},"labels":[],"label_agreement":null},{"id":"W2009004874","doi":"10.1007/s40262-014-0178-6","title":"Population Pharmacokinetic Analysis of Abiraterone in Chemotherapy-Naïve and Docetaxel-Treated Patients with Metastatic Castration-Resistant Prostate Cancer","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Abiraterone acetate; Pharmacokinetics; Docetaxel; Medicine; Prostate cancer; Chemotherapy; Pharmacology; Abiraterone; Oncology; Population; Internal medicine; Cancer; Androgen deprivation therapy; Androgen receptor","score_opus":0.036582942117500156,"score_gpt":0.40118511546433133,"score_spread":0.3646021733468312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009004874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987029,0.00038453052,0.00034697773,0.000040074196,0.000005711506,0.000014640251,0.00014120276,0.000022704087,0.00034136348],"genre_scores_gemma":[0.99939394,0.00009933665,0.00011495011,0.000029005849,0.000009888377,0.000008582948,0.0002018188,0.0000074355908,0.0001349289],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989428,0.0004662376,0.00006741325,0.00019638996,0.00024314261,0.00008405124],"domain_scores_gemma":[0.99800974,0.0009516918,0.00043174266,0.0001972,0.00014329089,0.00026645762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097333186,0.0003310491,0.0008836465,0.00039634822,0.00031434625,0.0009264174,0.00036815033,0.00042472302,0.0009024922],"category_scores_gemma":[0.005413453,0.0003254774,0.00077249884,0.0006021004,0.000357142,0.0006447945,0.0003362938,0.0009818714,0.00017161376],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076468565,0.0013560973,0.83952606,0.00014893863,0.002917038,0.0009870449,0.0009190079,0.011142629,0.01709627,0.0005994682,0.0011663686,0.047672585],"study_design_scores_gemma":[0.0013371715,0.008323951,0.964439,0.000012602409,0.0010222497,0.0020835295,0.00040945495,0.01823797,0.0019173325,0.00067297637,0.0014548328,0.00008906034],"about_ca_topic_score_codex":0.0035942926,"about_ca_topic_score_gemma":0.0028876897,"teacher_disagreement_score":0.0035942926,"about_ca_system_score_codex":0.000958557,"about_ca_system_score_gemma":0.0009633908,"threshold_uncertainty_score":0.007146716},"labels":[],"label_agreement":null},{"id":"W2012456279","doi":"10.2165/00003088-200746060-00002","title":"A Systematic Review of Limited Sampling Strategies for Platinum Agents Used in Cancer Chemotherapy","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Carboplatin; Pharmacokinetics; Dosing; Nedaplatin; Pharmacology; Pharmacodynamics; Blood sampling; Cisplatin; Body surface area; Therapeutic drug monitoring; Drug; Oncology; Area under the curve; Intensive care medicine; Chemotherapy; Internal medicine","score_opus":0.34252929319881403,"score_gpt":0.5544087444008821,"score_spread":0.21187945120206803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012456279","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006717367,0.9986634,0.00017592161,0.00008591291,0.000045184024,0.00012895605,0.000086549175,0.0000057937236,0.00013658075],"genre_scores_gemma":[0.013371587,0.9846075,0.0013540192,0.00030306037,0.000038432,0.00015107257,0.00007866175,0.000004717739,0.000090900416],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9943281,0.0024397084,0.0019252419,0.00039579382,0.00080727966,0.00010385425],"domain_scores_gemma":[0.983041,0.011851693,0.0036388126,0.00023758832,0.0010670933,0.00016388427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008500779,0.0013851619,0.00851902,0.0043343366,0.0003539034,0.0018526228,0.0018814541,0.0013942025,0.0030619288],"category_scores_gemma":[0.026376965,0.000895047,0.006843765,0.0050530033,0.0006466971,0.0017048247,0.00109269,0.0009870614,0.00019496887],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005666199,0.000028956636,0.0004577684,0.8788534,0.011884365,0.00011310815,0.00012245197,0.00026074972,0.000272452,0.00025478913,0.0013789424,0.1058064],"study_design_scores_gemma":[0.0014561226,0.0014617576,0.007365048,0.6712995,0.2515011,0.0011135228,0.00035159788,0.0003712194,0.00076806144,0.0007877932,0.06342115,0.0001030782],"about_ca_topic_score_codex":0.0049975165,"about_ca_topic_score_gemma":0.017164027,"teacher_disagreement_score":0.00851902,"about_ca_system_score_codex":0.0022154672,"about_ca_system_score_gemma":0.0060140733,"threshold_uncertainty_score":0.044956982},"labels":[],"label_agreement":null},{"id":"W2013067955","doi":"10.2165/00003088-200645090-00004","title":"Lack of Effect of Sex and Disease State on the Pharmacokinetics of Porfimer Sodium","year":2006,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"QLT (Canada)","funders":"","keywords":"Medicine; Pharmacokinetics; Urology; Confidence interval; Surgery; Gastroenterology; Pharmacology; Anesthesia; Internal medicine","score_opus":0.059697676918916,"score_gpt":0.4408096437659001,"score_spread":0.3811119668469841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013067955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940094,0.001107092,0.0009072052,0.00017672671,0.000053575284,0.00004976978,0.00027419598,0.000041036994,0.0033810092],"genre_scores_gemma":[0.99680054,0.00026544687,0.00027345153,0.0000685198,0.000032549866,0.000022052336,0.00017257166,0.000034629033,0.0023300652],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99905497,0.00044874471,0.00007137499,0.00013067588,0.00019806637,0.000096175245],"domain_scores_gemma":[0.9910204,0.005368419,0.0006540945,0.0017807743,0.0004244841,0.0007518652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018237308,0.00029017634,0.00079388946,0.00031425126,0.000261091,0.00054534944,0.0004691614,0.0003084398,0.0053664693],"category_scores_gemma":[0.007129093,0.00033499833,0.00050041097,0.000366753,0.00078168185,0.0009910336,0.0003168511,0.0007189685,0.0006350169],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19963801,0.0046775546,0.29349583,0.00057468575,0.0011212302,0.0019799252,0.0019475865,0.0010208143,0.34271663,0.0016656622,0.001103031,0.1500591],"study_design_scores_gemma":[0.001068425,0.05852396,0.80834967,0.000056821635,0.0009286879,0.0038252305,0.0008256881,0.0028573074,0.11159429,0.0012120566,0.0106811235,0.00007675219],"about_ca_topic_score_codex":0.0012142614,"about_ca_topic_score_gemma":0.001293145,"teacher_disagreement_score":0.0053664693,"about_ca_system_score_codex":0.00032214154,"about_ca_system_score_gemma":0.000695764,"threshold_uncertainty_score":0.017952621},"labels":[],"label_agreement":null},{"id":"W2013783025","doi":"10.2165/00003088-200038050-00004","title":"Methods for Clinical Monitoring of Cyclosporin in Transplant Patients","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Therapeutic drug monitoring; Medicine; Therapeutic index; Intensive care medicine; Clinical Practice; Pharmacotherapy; Pharmacodynamics; Pharmacology; Drug; Pharmacokinetics; Internal medicine","score_opus":0.30568029841200633,"score_gpt":0.6088180192785816,"score_spread":0.30313772086657526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013783025","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014520787,0.998343,0.00062514446,0.00012581276,0.00010913001,0.000011901442,0.000023925199,0.00001602764,0.0005998503],"genre_scores_gemma":[0.0010841467,0.996157,0.0018139771,0.00023395637,0.00017191702,0.00002308397,0.00006879235,0.0000044749163,0.00044270046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930584,0.0001351488,0.00015508472,0.00011765179,0.00026261443,0.00002370435],"domain_scores_gemma":[0.99827516,0.00097232,0.00034245822,0.00006242888,0.0002805229,0.000067115674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016611037,0.0014396509,0.0031655622,0.0037058352,0.00024084393,0.0011325296,0.0015318394,0.001031511,0.0027891768],"category_scores_gemma":[0.002062559,0.00038104336,0.0010569652,0.0028027897,0.00081898796,0.0014942724,0.00063131953,0.0024047089,0.0020283253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120522884,0.0000869,0.00026565872,0.010441888,0.00012821362,0.0001279786,0.000024796158,0.00026699525,0.0013492652,0.0009761101,0.0064148745,0.9797967],"study_design_scores_gemma":[0.00019686062,0.00051185593,0.0056450726,0.010246995,0.0010779076,0.004758195,0.00009959413,0.00056830683,0.0035594152,0.0031984488,0.97003293,0.00010442304],"about_ca_topic_score_codex":0.0009880315,"about_ca_topic_score_gemma":0.0015539267,"teacher_disagreement_score":0.0037058352,"about_ca_system_score_codex":0.0006946325,"about_ca_system_score_gemma":0.0012816717,"threshold_uncertainty_score":0.00933069},"labels":[],"label_agreement":null},{"id":"W2021943338","doi":"10.2165/00003088-200342060-00004","title":"Pharmacokinetics of Rofecoxib","year":2003,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Rofecoxib; Pharmacology; Pharmacokinetics; Medicine; Volume of distribution; Drug interaction; Enterohepatic circulation; Bioavailability; Internal medicine; Chemistry; Cyclooxygenase; Metabolism; Enzyme; Biochemistry","score_opus":0.16322765445455747,"score_gpt":0.5030552790391593,"score_spread":0.3398276245846018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021943338","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008013854,0.9977348,0.00023181016,0.00019799129,0.00008490742,0.000008633104,0.00004562102,0.00001366162,0.0008810302],"genre_scores_gemma":[0.003838904,0.99435776,0.00031533244,0.00017992238,0.00013154153,0.000011451104,0.00007150364,0.0000028957704,0.001090703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979347,0.000042223994,0.000045163513,0.0000312888,0.00007429188,0.000013644984],"domain_scores_gemma":[0.99957734,0.00016086138,0.00014875912,0.000013281091,0.00008069964,0.000019186718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006027705,0.000875577,0.0021575605,0.0015581368,0.00013994986,0.0007981742,0.0005582976,0.0006586447,0.0029006356],"category_scores_gemma":[0.0010405469,0.000320738,0.00060207746,0.0015948685,0.00027978464,0.00087425025,0.0002615145,0.0010071765,0.0013396293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068692584,0.0001299793,0.00038389888,0.012988216,0.00025025816,0.0003852342,0.000041720876,0.00058474514,0.004421136,0.00055527233,0.013889589,0.965683],"study_design_scores_gemma":[0.00050025154,0.0014622643,0.005410758,0.003916749,0.0016151838,0.006698566,0.00008215563,0.0005926357,0.0058319354,0.0007616636,0.973069,0.000058886697],"about_ca_topic_score_codex":0.0012674194,"about_ca_topic_score_gemma":0.00242385,"teacher_disagreement_score":0.0029006356,"about_ca_system_score_codex":0.00057797524,"about_ca_system_score_gemma":0.00092778006,"threshold_uncertainty_score":0.009703577},"labels":[],"label_agreement":null},{"id":"W2025835403","doi":"10.2165/00003088-200443010-00001","title":"Treatment of the Metabolic Disturbances Caused by Antipsychotic Drugs","year":2004,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"","keywords":"Medicine; Antipsychotic; Drug; Pharmacodynamics; Pharmacotherapy; Pharmacology; Olanzapine; Population; Intensive care medicine; Schizophrenia (object-oriented programming); Pharmacokinetics; Psychiatry","score_opus":0.12697458387138072,"score_gpt":0.48007362954940447,"score_spread":0.35309904567802375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025835403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029950176,0.9987142,0.00017122267,0.000077709046,0.000066911736,0.0000065091917,0.00001996276,0.00001007898,0.00063390384],"genre_scores_gemma":[0.0013355428,0.99767226,0.00039964926,0.00010799306,0.000071521186,0.000007988278,0.000035853398,0.000002010333,0.00036720667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998154,0.00003688364,0.000042203104,0.000031861924,0.000057714184,0.000015938018],"domain_scores_gemma":[0.99971026,0.00013915703,0.000072948154,0.000012163628,0.0000470902,0.000018354816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000540593,0.0013310233,0.0024567964,0.002108343,0.0001986657,0.000712295,0.0011502386,0.00089333375,0.002763326],"category_scores_gemma":[0.00059577264,0.00027787036,0.0007634512,0.0019909618,0.00036746447,0.00077269395,0.00045216066,0.0012073658,0.0012195917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028475933,0.00013442742,0.00015907465,0.018901708,0.00023345518,0.0003703093,0.00003650081,0.00033070796,0.0027161404,0.00066996855,0.00667659,0.9694864],"study_design_scores_gemma":[0.00030176237,0.0007359872,0.003900813,0.007985852,0.0013241525,0.0058147805,0.00011762607,0.00028758714,0.0031571207,0.0014867479,0.974831,0.00005660913],"about_ca_topic_score_codex":0.0009999955,"about_ca_topic_score_gemma":0.002256696,"teacher_disagreement_score":0.002763326,"about_ca_system_score_codex":0.00036043575,"about_ca_system_score_gemma":0.0005499329,"threshold_uncertainty_score":0.009244263},"labels":[],"label_agreement":null},{"id":"W2038460944","doi":"10.2165/00003088-200544080-00001","title":"Sirolimus","year":2005,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Sirolimus; Therapeutic drug monitoring; Ciclosporin; Pharmacokinetics; Medicine; Pharmacology; Trough level; Transplantation; Immunosuppressive drug; Therapeutic index; Adverse effect; Trough Concentration; Drug; Internal medicine; Urology; Tacrolimus","score_opus":0.2698213307202227,"score_gpt":0.5539225902184918,"score_spread":0.2841012594982691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038460944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018270785,0.99803275,0.00015858909,0.0003175288,0.0001674613,0.000012964214,0.00003210201,0.000010333765,0.0010855353],"genre_scores_gemma":[0.0014207141,0.996599,0.00031686164,0.0004102102,0.0002044962,0.000018344324,0.00006124814,0.0000015715959,0.0009676618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99961853,0.000102446706,0.00010120142,0.000044862354,0.00011227548,0.000020751491],"domain_scores_gemma":[0.9993901,0.00026547007,0.00021043973,0.000016842236,0.000090702735,0.000026484227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008814188,0.00091662764,0.002195768,0.001886884,0.00015687193,0.00085105613,0.0005629486,0.00066658325,0.005122147],"category_scores_gemma":[0.0016381635,0.00030078721,0.000623225,0.0020916506,0.00031733507,0.0008529786,0.00057778874,0.0012471967,0.001767914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023793601,0.000067200664,0.00016458679,0.019282436,0.0002675439,0.00010220157,0.000020890508,0.00016171263,0.000985921,0.0007739794,0.026174664,0.95176095],"study_design_scores_gemma":[0.00040324367,0.0004245104,0.0026405877,0.010966084,0.0019494552,0.0023414777,0.00004414881,0.00023420158,0.0013667198,0.00110864,0.97849095,0.000029902307],"about_ca_topic_score_codex":0.00087840523,"about_ca_topic_score_gemma":0.00268584,"teacher_disagreement_score":0.005122147,"about_ca_system_score_codex":0.0004613193,"about_ca_system_score_gemma":0.0015719151,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2045786281","doi":"10.1007/s40262-013-0055-8","title":"A Review of the Pharmacokinetic Implications of Schistosomiasis","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Oxamniquine; Schistosomiasis; Pharmacokinetics; Praziquantel; Adverse effect; Internal medicine; Pharmacology; Intensive care medicine; Immunology","score_opus":0.1561153974858897,"score_gpt":0.4961730662207778,"score_spread":0.3400576687348881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045786281","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006447551,0.99869555,0.000103528284,0.00034787573,0.00033892406,0.0000030324422,0.000018039002,0.000004988807,0.0004236232],"genre_scores_gemma":[0.00036232764,0.99832064,0.00015065321,0.00025294328,0.0005517933,0.000003276905,0.000024154817,9.550117e-7,0.00033326796],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998048,0.000039775394,0.000039704297,0.00002996986,0.00006963465,0.000016161592],"domain_scores_gemma":[0.9995091,0.00022292734,0.000080639045,0.000010344414,0.00012319227,0.000053820153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000622044,0.00074127025,0.0013953083,0.0022913096,0.0002319899,0.0010043269,0.00068606646,0.0009325324,0.003347422],"category_scores_gemma":[0.0012008157,0.0002729896,0.0003981901,0.002456512,0.000429981,0.0012246881,0.0006827661,0.0014684147,0.0012474433],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093843875,0.00007160717,0.00020364406,0.015147504,0.00007933148,0.00025420016,0.00003819577,0.00026946032,0.0010689808,0.0016835063,0.07437118,0.90671855],"study_design_scores_gemma":[0.000026282076,0.00011632504,0.001077171,0.0045869374,0.00014639867,0.0020364625,0.000051282666,0.00014700531,0.00026410003,0.0014545512,0.9900675,0.000025924626],"about_ca_topic_score_codex":0.0012271887,"about_ca_topic_score_gemma":0.002835381,"teacher_disagreement_score":0.003347422,"about_ca_system_score_codex":0.0005640572,"about_ca_system_score_gemma":0.0013286043,"threshold_uncertainty_score":0.011198282},"labels":[],"label_agreement":null},{"id":"W2050422640","doi":"10.1007/s40262-015-0243-9","title":"A Review of Pharmacokinetic Drug–Drug Interactions with the Anthelmintic Medications Albendazole and Mebendazole","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Helminth infection and control","field":"Veterinary","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"World Health Organization","keywords":"Albendazole; Mebendazole; Pharmacology; Medicine; Pharmacokinetics; Anthelmintic; Carbamazepine; Surgery; Epilepsy; Biology","score_opus":0.1736120260924888,"score_gpt":0.5138472965560672,"score_spread":0.3402352704635784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050422640","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001972792,0.99910295,0.000103163,0.00012150623,0.00007368074,0.00000779596,0.000039554394,0.0000050456483,0.00034903703],"genre_scores_gemma":[0.001081038,0.9980246,0.00031104247,0.00015571187,0.00009238107,0.0000070907768,0.000046245255,0.0000011461157,0.00028083948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995963,0.00007402399,0.00011856966,0.000053854987,0.00013706592,0.000020268828],"domain_scores_gemma":[0.9990947,0.0004821281,0.00021812243,0.000014502474,0.00015982287,0.000030764197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007601532,0.00085882004,0.0018903508,0.0028281128,0.0001930075,0.0009795593,0.00082245335,0.00093985256,0.004149332],"category_scores_gemma":[0.0015614042,0.00034569422,0.0012959569,0.0023781136,0.00023909798,0.0010542023,0.0004854586,0.0010448557,0.00067569764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018647172,0.00015256071,0.0005123336,0.08232218,0.00067864795,0.0003274835,0.00006626445,0.0004917216,0.0022084338,0.0009406628,0.020069283,0.89204395],"study_design_scores_gemma":[0.00014373276,0.0005831584,0.0046350383,0.023739802,0.002679026,0.004151635,0.000117701566,0.00047221102,0.0014617642,0.0011597225,0.9607752,0.00008090629],"about_ca_topic_score_codex":0.0015869878,"about_ca_topic_score_gemma":0.0033333616,"teacher_disagreement_score":0.004149332,"about_ca_system_score_codex":0.00042520592,"about_ca_system_score_gemma":0.0012874624,"threshold_uncertainty_score":0.013880849},"labels":[],"label_agreement":null},{"id":"W2052170838","doi":"10.1007/s40262-014-0202-x","title":"Population Pharmacokinetic Analysis of Tesamorelin in HIV-Infected Patients and Healthy Subjects","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical; Theratechnologies (Canada); Université de Montréal","funders":"Fonds de recherche du Québec – Nature et technologies; Health Canada; Mitacs","keywords":"Pharmacokinetics; NONMEM; Volume of distribution; Population; Medicine; Pulsatile flow; Population pharmacokinetics; Covariate; Internal medicine; Pharmacology; Endocrinology; Mathematics; Statistics","score_opus":0.026222276686788455,"score_gpt":0.38063108022323616,"score_spread":0.3544088035364477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052170838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999159,0.0001703287,0.00017932501,0.000013009825,0.0000033028432,0.000007979823,0.0000897594,0.000008440396,0.00036882758],"genre_scores_gemma":[0.999503,0.000057827754,0.000090016394,0.000021270742,0.000006431976,0.000008867826,0.00014183653,0.0000028953002,0.00016771261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974376,0.000101366815,0.000018102022,0.000066334476,0.000038474685,0.000031897336],"domain_scores_gemma":[0.9995521,0.0002164134,0.00007178905,0.000048961207,0.00003593164,0.000074837706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034577004,0.00021506257,0.00036274188,0.0003147742,0.00023553723,0.0005053419,0.00012551298,0.00031654947,0.0012787367],"category_scores_gemma":[0.0014962843,0.00020784664,0.00022542666,0.00026738923,0.00024575862,0.00035256732,0.00019954315,0.0004526933,0.00017217216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0182807,0.00055811007,0.9301889,0.00006871247,0.0007535229,0.0010834744,0.0009439211,0.001118533,0.016999716,0.00034061365,0.0004518153,0.029212095],"study_design_scores_gemma":[0.00022821542,0.004252643,0.9880905,0.000005657895,0.00019250001,0.0020153315,0.0005248564,0.0025097511,0.0012157405,0.0002458422,0.0006950357,0.000023785286],"about_ca_topic_score_codex":0.0008630542,"about_ca_topic_score_gemma":0.00060620974,"teacher_disagreement_score":0.0012787367,"about_ca_system_score_codex":0.00022161703,"about_ca_system_score_gemma":0.00017073516,"threshold_uncertainty_score":0.0042777658},"labels":[],"label_agreement":null},{"id":"W2055116166","doi":"10.1007/s40262-013-0053-x","title":"Telaprevir: Clinical Pharmacokinetics, Pharmacodynamics, and Drug–Drug Interactions","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Drug; Medicine; Telaprevir; Pharmacology; Pharmacotherapy; Internal medicine","score_opus":0.24765078272731922,"score_gpt":0.5643196578562294,"score_spread":0.3166688751289102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055116166","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014990648,0.9990251,0.00011197909,0.00019611417,0.000052952517,0.000004941757,0.000019610883,0.000006343152,0.00043311753],"genre_scores_gemma":[0.0013257469,0.9977108,0.00025137686,0.00020343436,0.000120452045,0.000006583025,0.000033669796,0.0000012146891,0.00034664874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972063,0.00005403847,0.000047767488,0.000042001124,0.00011648435,0.000019112544],"domain_scores_gemma":[0.9995166,0.000255016,0.00010174868,0.000011861035,0.000086748856,0.00002806641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087606814,0.0011437873,0.0021796455,0.0019238474,0.00019806574,0.0009726542,0.00087512785,0.00089926814,0.0027012548],"category_scores_gemma":[0.00087011413,0.00030405563,0.0007495782,0.00195564,0.00043448657,0.0010826229,0.00054771936,0.0018829071,0.0010749256],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014318414,0.00009174811,0.00024357696,0.0140827885,0.00019395235,0.00011943567,0.000023338327,0.0003698246,0.0014536442,0.001120844,0.012089892,0.9700677],"study_design_scores_gemma":[0.00017004409,0.00040532573,0.00306189,0.0067635034,0.00087193813,0.0030455727,0.00008715237,0.00044119754,0.0015892977,0.0027858813,0.98072296,0.000055197706],"about_ca_topic_score_codex":0.0010163282,"about_ca_topic_score_gemma":0.0025876383,"teacher_disagreement_score":0.0027012548,"about_ca_system_score_codex":0.00054827903,"about_ca_system_score_gemma":0.0009700264,"threshold_uncertainty_score":0.009036601},"labels":[],"label_agreement":null},{"id":"W2056835200","doi":"10.2165/00003088-200443080-00003","title":"Pharmacokinetic Profile of Intramuscular Fulvestrant in Advanced Breast Cancer","year":2004,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":101,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"","keywords":"Fulvestrant; Medicine; Pharmacokinetics; Breast cancer; Cancer; Oncology; Pharmacotherapy; Pharmacology; Internal medicine; Tamoxifen","score_opus":0.013715583939819137,"score_gpt":0.3546423921816309,"score_spread":0.34092680824181176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056835200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951794,0.002109623,0.001009241,0.0001244025,0.000021638707,0.0000452916,0.0001762372,0.000077571625,0.0012565635],"genre_scores_gemma":[0.9978947,0.0005111632,0.00040722577,0.00005176011,0.000027970567,0.000022397888,0.00017367429,0.000020264411,0.0008909125],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9998578,0.00006877428,0.0000060450325,0.000016980233,0.00002482281,0.00002551506],"domain_scores_gemma":[0.9997174,0.0000980121,0.00006246907,0.00003127431,0.00002082756,0.00007002966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033310946,0.00028205826,0.00045967908,0.0002159346,0.00014445905,0.00033500887,0.00017447562,0.0003293897,0.0012916101],"category_scores_gemma":[0.0012617926,0.00016171287,0.00019088178,0.00023465476,0.00024534843,0.00031563875,0.00009447757,0.00081461266,0.00038480348],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13708021,0.0023429035,0.019363087,0.00029252394,0.00023428578,0.00083276705,0.00048268065,0.007015274,0.57796293,0.00079999556,0.0019791226,0.2516142],"study_design_scores_gemma":[0.010477327,0.24410188,0.2760394,0.00012729283,0.0008036834,0.008430106,0.0005328844,0.024208803,0.4100489,0.000883026,0.024215722,0.00013102205],"about_ca_topic_score_codex":0.0010874217,"about_ca_topic_score_gemma":0.0010567196,"teacher_disagreement_score":0.0012916101,"about_ca_system_score_codex":0.0004317383,"about_ca_system_score_gemma":0.00034616797,"threshold_uncertainty_score":0.00432086},"labels":[],"label_agreement":null},{"id":"W2056954418","doi":"10.1007/s40262-014-0152-3","title":"A Comprehensive Review on the Pharmacokinetics of Antibiotics in Interstitial Fluid Spaces in Humans: Implications on Dosing and Clinical Pharmacokinetic Monitoring","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"Pharmacokinetics; Piperacillin; Dosing; Pharmacology; Medicine; Antibiotics; Volume of distribution; Distribution (mathematics); Intensive care medicine; Internal medicine; Biology; Microbiology","score_opus":0.2205027227140201,"score_gpt":0.5156797864411059,"score_spread":0.2951770637270858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056954418","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000672319,0.9993461,0.00009265278,0.0001289079,0.00008368038,0.000005466058,0.00003152761,0.000003731173,0.00024072627],"genre_scores_gemma":[0.00034041365,0.99906224,0.00021207605,0.00013239411,0.000077449164,0.0000058646947,0.000028073242,8.9187137e-7,0.00014069349],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995345,0.00010224026,0.00011751453,0.00006380082,0.00015539947,0.000026610192],"domain_scores_gemma":[0.9990865,0.0005275246,0.00016909024,0.000016283431,0.00016767823,0.000032906584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010395502,0.0010333434,0.0025585468,0.0024869887,0.0002025929,0.0013439045,0.0008838767,0.0011255033,0.003273815],"category_scores_gemma":[0.0018056794,0.00037532605,0.0012341558,0.0025650982,0.00037050206,0.0014353059,0.0006899399,0.0015879899,0.0010674242],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018725886,0.00009269438,0.00022043685,0.08159081,0.00033433145,0.00019251577,0.00006548664,0.0004470851,0.0021691916,0.0016005526,0.027112555,0.88598704],"study_design_scores_gemma":[0.00006606249,0.00029085545,0.0016663556,0.020372678,0.0010416352,0.0015810846,0.00009659046,0.00019726055,0.00093701266,0.0014326337,0.9722577,0.000060236973],"about_ca_topic_score_codex":0.0014951505,"about_ca_topic_score_gemma":0.002527323,"teacher_disagreement_score":0.003273815,"about_ca_system_score_codex":0.000582845,"about_ca_system_score_gemma":0.0021193658,"threshold_uncertainty_score":0.010951996},"labels":[],"label_agreement":null},{"id":"W2057321814","doi":"10.1007/s40262-014-0160-3","title":"Physiologically Based Pharmacokinetic Modeling of Impaired Carboxylesterase-1 Activity: Effects on Oseltamivir Disposition","year":2014,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of General Medical Sciences","keywords":"Physiologically based pharmacokinetic modelling; Pharmacology; Oseltamivir; Active metabolite; Pharmacokinetics; Prodrug; Carboxylesterase; In vivo; Chemistry; Metabolite; Drug metabolism; Drug; Medicine; Enzyme; Biology; Biochemistry; Internal medicine; Genetics","score_opus":0.05865650321010264,"score_gpt":0.38554346208410956,"score_spread":0.3268869588740069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057321814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69623756,0.0026000272,0.28438312,0.0015739312,0.00012013085,0.0002154936,0.00090598146,0.00040375587,0.013560037],"genre_scores_gemma":[0.9891887,0.00060014974,0.006922611,0.00016838219,0.000025412433,0.00010228786,0.00018308262,0.000034008677,0.0027753646],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99978715,0.000093964656,0.0000101205205,0.000039098675,0.000040644907,0.000029044171],"domain_scores_gemma":[0.9994961,0.00031126617,0.00008774694,0.000017909517,0.0000705501,0.000016522357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005060896,0.0007109769,0.00075517135,0.00020382303,0.00019968857,0.0012179444,0.0007723777,0.0010752871,0.0009437087],"category_scores_gemma":[0.0017720254,0.00031321158,0.0007476599,0.00021148652,0.00029898257,0.00056098955,0.00032114706,0.000916195,0.00029348445],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003579833,0.0001263688,0.0014817534,0.00008367305,0.00007796344,0.00020696425,0.00005903405,0.97515976,0.013380133,0.002770242,0.00042295866,0.005873079],"study_design_scores_gemma":[0.00004233784,0.000110234454,0.0005477746,0.00000519003,0.000039862185,0.00007812955,0.00001162592,0.9954032,0.0024522922,0.0007715421,0.00052578736,0.0000121867515],"about_ca_topic_score_codex":0.0055940934,"about_ca_topic_score_gemma":0.0020523535,"teacher_disagreement_score":0.0055940934,"about_ca_system_score_codex":0.0006702777,"about_ca_system_score_gemma":0.0012287993,"threshold_uncertainty_score":0.011123061},"labels":[],"label_agreement":null},{"id":"W2057831073","doi":"10.1007/s40262-012-0026-5","title":"Pharmacokinetic Profile of Artemisinin Derivatives and Companion Drugs Used in Artemisinin-Based Combination Therapies for the Treatment of Plasmodium falciparum Malaria in Children","year":2013,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Malaria Research and Control","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Artemisinin; Medicine; Malaria; Amodiaquine; Mefloquine; Piperaquine; Lumefantrine; Plasmodium falciparum; Pharmacokinetics; Artesunate; Population; Pharmacology; Sulfadoxine; Intensive care medicine; Pyrimethamine; Environmental health; Immunology","score_opus":0.10039458079513733,"score_gpt":0.4317332631590931,"score_spread":0.3313386823639558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057831073","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032998677,0.99923694,0.00006516093,0.000051842388,0.000025218538,0.0000047805624,0.000025477972,0.0000033890863,0.0002572163],"genre_scores_gemma":[0.0018596537,0.9976597,0.00017306005,0.00005474914,0.00003718607,0.000004516688,0.00004289738,9.379412e-7,0.00016728682],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977666,0.00004500749,0.000049136226,0.000032762513,0.00008017555,0.000016323547],"domain_scores_gemma":[0.9995285,0.00023703698,0.000113663926,0.0000080880955,0.00009085598,0.00002174656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073326466,0.0007338183,0.0023638075,0.0017238568,0.0001410534,0.0007587933,0.0008270186,0.0006131039,0.0021416182],"category_scores_gemma":[0.0009519604,0.00029122204,0.0008895671,0.0021208297,0.00026187205,0.0007486188,0.0003465031,0.001109973,0.0005802966],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004444009,0.00012370956,0.00038382635,0.038258795,0.00050987635,0.0002057696,0.000055689856,0.00063154695,0.0025333725,0.0010270042,0.009397929,0.946428],"study_design_scores_gemma":[0.0003966678,0.0011351729,0.006423504,0.011939953,0.0031997138,0.004896183,0.00015288139,0.00078041776,0.0041504,0.0015494283,0.9652626,0.00011314631],"about_ca_topic_score_codex":0.0015555612,"about_ca_topic_score_gemma":0.002812253,"teacher_disagreement_score":0.0023638075,"about_ca_system_score_codex":0.00047564253,"about_ca_system_score_gemma":0.0008456442,"threshold_uncertainty_score":0.0071644187},"labels":[],"label_agreement":null},{"id":"W2060839842","doi":"10.1007/s40262-014-0170-1","title":"Review of Evidence for Measuring Drug Concentrations of First-Line Antitubercular Agents in Adults","year":2014,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Drug; Observational study; Tuberculosis; Dosing; Therapeutic drug monitoring; Intensive care medicine; Clinical trial; Pharmacotherapy; Pharmacology; First line; MEDLINE; Internal medicine; Pathology","score_opus":0.466190475329744,"score_gpt":0.544976112923545,"score_spread":0.07878563759380097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060839842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006833797,0.99966383,0.00003503338,0.000069510315,0.00003308818,0.000008240243,0.000035027897,0.0000017219071,0.00008515437],"genre_scores_gemma":[0.00088225654,0.9986387,0.00021436105,0.00014880706,0.00003707596,0.000011624908,0.00003240602,7.869539e-7,0.000033921016],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9982851,0.00039328105,0.0007090295,0.00018447201,0.00037954762,0.000048527545],"domain_scores_gemma":[0.9944758,0.0038186277,0.0011493302,0.000059494236,0.00042905557,0.00006770296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026534456,0.0013115985,0.0047416454,0.0044079134,0.00024398796,0.0016593862,0.001897747,0.0016229206,0.0036685888],"category_scores_gemma":[0.008237044,0.0006400138,0.0033617446,0.00429462,0.0005782213,0.0015069403,0.0008197645,0.0012410057,0.00052286783],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043664276,0.000057280857,0.00066210417,0.55096036,0.0035665813,0.0002190105,0.00007920492,0.00027490864,0.00057803176,0.00085230893,0.008013219,0.43430033],"study_design_scores_gemma":[0.0005558248,0.0006972057,0.008555225,0.4953286,0.038683973,0.003252075,0.0003228198,0.00035098585,0.0011748871,0.0020935,0.44885156,0.0001333378],"about_ca_topic_score_codex":0.0034422823,"about_ca_topic_score_gemma":0.006241167,"teacher_disagreement_score":0.0047416454,"about_ca_system_score_codex":0.0009975386,"about_ca_system_score_gemma":0.0031954767,"threshold_uncertainty_score":0.01403296},"labels":[],"label_agreement":null},{"id":"W2061459550","doi":"10.1007/s40262-013-0065-6","title":"The Integration of Allometry and Virtual Populations to Predict Clearance and Clearance Variability in Pediatric Populations over the Age of 6 Years","year":2013,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Blackberry (Canada); University of Waterloo","funders":"","keywords":"Allometry; Biology; Pharmacotherapy; Medicine; Demography; Ecology; Internal medicine","score_opus":0.16065767397032374,"score_gpt":0.47878067063202867,"score_spread":0.31812299666170496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061459550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585674,0.00087060523,0.03715361,0.00023106768,0.00007044304,0.000062089624,0.0011590912,0.00056859263,0.0013171856],"genre_scores_gemma":[0.9928349,0.00015581424,0.005958506,0.000058582667,0.000026533715,0.000034627355,0.0006691656,0.00007068334,0.00019125531],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976375,0.0012797121,0.00011909256,0.0005378076,0.00031157339,0.00011433332],"domain_scores_gemma":[0.98999363,0.005517458,0.0019346148,0.0013193161,0.00086575723,0.000369136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005549954,0.0007215075,0.0012936082,0.0016796412,0.00033976563,0.0018761838,0.0008648958,0.0008516533,0.0009999893],"category_scores_gemma":[0.02214505,0.00033503887,0.0010682275,0.0011809134,0.00039553238,0.0016947654,0.0010951802,0.0011632754,0.00049807824],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00124912,0.00019049666,0.90318024,0.00004864797,0.00077277736,0.00018196135,0.00026569644,0.024589023,0.0013223696,0.0009888144,0.0012373278,0.06597353],"study_design_scores_gemma":[0.000091217895,0.0017533726,0.43052396,0.000052082665,0.0005801783,0.0022423293,0.0003877561,0.5521409,0.0026044252,0.006912992,0.0026194416,0.00009142518],"about_ca_topic_score_codex":0.0030460216,"about_ca_topic_score_gemma":0.0019879208,"teacher_disagreement_score":0.005549954,"about_ca_system_score_codex":0.0005397098,"about_ca_system_score_gemma":0.000800286,"threshold_uncertainty_score":0.029351294},"labels":[],"label_agreement":null},{"id":"W2062889937","doi":"10.2165/00003088-200544020-00001","title":"Interactions Between Antiretrovirals and Antineoplastic Drug Therapy","year":2005,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; St. Michael's Hospital","funders":"","keywords":"Pharmacology; Drug interaction; Medicine; CYP2B6; Taxane; Docetaxel; Efavirenz; Drug; Ifosfamide; Pharmacokinetics; Reverse-transcriptase inhibitor; Abacavir; CYP3A4; Oncology; Cancer; Chemotherapy; Internal medicine; Cytochrome P450; Antiretroviral therapy; Immunology; Human immunodeficiency virus (HIV); Viral load; Breast cancer","score_opus":0.19453442601007181,"score_gpt":0.5078662005472501,"score_spread":0.31333177453717825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062889937","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001401382,0.9983006,0.0001451995,0.00012383475,0.00010293388,0.0000053791105,0.000013802577,0.000007339489,0.001160885],"genre_scores_gemma":[0.0010731001,0.99744946,0.00030499423,0.00016823845,0.00020283448,0.0000071531576,0.000030107134,0.0000012010657,0.0007629246],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996166,0.000089684545,0.000059763643,0.000046756762,0.00016429556,0.000022716842],"domain_scores_gemma":[0.99927145,0.00043302233,0.00015673917,0.000015763222,0.000094490526,0.000028524839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006969164,0.0009253514,0.001996615,0.0019157351,0.00023158856,0.000892921,0.0009794566,0.0010843725,0.0046240566],"category_scores_gemma":[0.0011582192,0.00032151132,0.00061848405,0.0020516387,0.00035856498,0.000840675,0.0004529743,0.001382571,0.0019727743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012508161,0.00008862673,0.0002176807,0.010716883,0.00013765186,0.00023759715,0.000025018255,0.0004105103,0.0011195255,0.0009997692,0.015653882,0.9702678],"study_design_scores_gemma":[0.000089580055,0.00022166985,0.0019021417,0.0038584198,0.0004996872,0.0031559167,0.000039269402,0.000265676,0.0008832608,0.001285384,0.98777443,0.000024630568],"about_ca_topic_score_codex":0.0011789224,"about_ca_topic_score_gemma":0.0026860635,"teacher_disagreement_score":0.0046240566,"about_ca_system_score_codex":0.0005325447,"about_ca_system_score_gemma":0.000870447,"threshold_uncertainty_score":0.015469074},"labels":[],"label_agreement":null},{"id":"W2063035659","doi":"10.2165/00003088-200140110-00001","title":"Pharmacogenetics","year":2001,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":120,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacogenetics; Medicine; Therapeutic drug monitoring; Drug; Pharmacology; CYP2D6; CYP2C19; Pharmacogenomics; Intensive care medicine; Bioinformatics; Internal medicine; Biology; Cytochrome P450; Genotype; Genetics","score_opus":0.5455348796245921,"score_gpt":0.6286190238947967,"score_spread":0.08308414427020461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063035659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00087586505,0.9202786,0.017068708,0.003663772,0.0021285682,0.00011874403,0.0003480266,0.00028593157,0.05523177],"genre_scores_gemma":[0.012320496,0.91159,0.0144041125,0.0056120036,0.0032085972,0.00016439098,0.0009348746,0.000058974027,0.051706523],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994362,0.0001769512,0.000055104054,0.00010686204,0.00018905845,0.000035780446],"domain_scores_gemma":[0.99953926,0.00020048792,0.000054999742,0.000058737012,0.0001147192,0.000031727424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009365946,0.0011096838,0.0012066225,0.0016188495,0.0002167058,0.0011307029,0.00081766746,0.0010011914,0.011201246],"category_scores_gemma":[0.0017683147,0.00024173563,0.00057451834,0.0017252194,0.0005606491,0.0007608732,0.00090625783,0.0017435157,0.007564515],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006560859,0.000068357345,0.0004314238,0.0016068574,0.0000546139,0.00035895986,0.000024870671,0.00026518496,0.0012693463,0.007218333,0.051657278,0.9369792],"study_design_scores_gemma":[0.000031769752,0.00006268146,0.00087158306,0.0010329735,0.00007679241,0.003792643,0.000018693418,0.00018071389,0.0010858831,0.005108869,0.98772556,0.000011911396],"about_ca_topic_score_codex":0.0009985361,"about_ca_topic_score_gemma":0.001224526,"teacher_disagreement_score":0.011201246,"about_ca_system_score_codex":0.0005391036,"about_ca_system_score_gemma":0.0012531142,"threshold_uncertainty_score":0.03747183},"labels":[],"label_agreement":null},{"id":"W2071991687","doi":"10.2165/00003088-200544050-00003","title":"Pharmacokinetic Profile of Ganciclovir After its Oral Administration and From its Prodrug, Valganciclovir, in Solid Organ Transplant Recipients","year":2005,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Valganciclovir; Ganciclovir; Pharmacokinetics; Medicine; Prodrug; NONMEM; Population; Dosing; Pharmacology; Internal medicine; Human cytomegalovirus; Immunology; Virus","score_opus":0.06633831168241856,"score_gpt":0.42403871865701737,"score_spread":0.3577004069745988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071991687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964461,0.0014729038,0.00040068306,0.000065597334,0.000022565931,0.000023503331,0.00018486801,0.000051921714,0.0013319221],"genre_scores_gemma":[0.9988158,0.00024123084,0.000107531436,0.000056583107,0.000027566966,0.000011016617,0.00016386362,0.000016900483,0.0005594729],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99974495,0.00010776643,0.000012652181,0.000041675245,0.000037974845,0.000054999466],"domain_scores_gemma":[0.9994584,0.00020392952,0.00010352815,0.000040428233,0.000034073215,0.00015965356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044268204,0.00036860403,0.00059066794,0.0002898611,0.0002362018,0.00085895584,0.00020169916,0.00043159694,0.0015099798],"category_scores_gemma":[0.0020861896,0.00026036336,0.00034661376,0.00027546866,0.00041875598,0.0005388884,0.00012801404,0.00090539735,0.00052842195],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30139887,0.0025722373,0.08327999,0.00037482925,0.00052264845,0.0033298493,0.0011996949,0.009437331,0.37825745,0.0014082511,0.003657553,0.2145613],"study_design_scores_gemma":[0.0078084245,0.13326035,0.5623351,0.000109586435,0.0014363315,0.0125969555,0.0010935661,0.029390747,0.2342654,0.0015990074,0.015785256,0.00031933247],"about_ca_topic_score_codex":0.0018379653,"about_ca_topic_score_gemma":0.0009747499,"teacher_disagreement_score":0.0018379653,"about_ca_system_score_codex":0.00074377836,"about_ca_system_score_gemma":0.0005296168,"threshold_uncertainty_score":0.0053964853},"labels":[],"label_agreement":null},{"id":"W2076217357","doi":"10.1007/bf03261928","title":"Fundamentals of Population Pharmacokinetic Modelling","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"Society for Academic Emergency Medicine","keywords":"Pharmacokinetics; Pharmacotherapy; Medicine; Population; Population pharmacokinetics; Intensive care medicine; Pharmacology; Internal medicine; Environmental health","score_opus":0.5505319429749933,"score_gpt":0.5812774078301474,"score_spread":0.03074546485515406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076217357","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006728818,0.5314177,0.44476742,0.0051759225,0.0017111677,0.00013359838,0.0007970657,0.0008391714,0.0144850975],"genre_scores_gemma":[0.025022253,0.82958144,0.13226192,0.002213427,0.0032555014,0.00040421254,0.00081158563,0.00015437577,0.0062952912],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868935,0.0005122305,0.00015058673,0.00018208107,0.00041207933,0.000053644322],"domain_scores_gemma":[0.99784136,0.0015349776,0.00018755542,0.00012660195,0.0002715527,0.000037889855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027540068,0.0021814613,0.0028747825,0.0017648167,0.00026491767,0.0028484846,0.0022675507,0.0022038387,0.0047384845],"category_scores_gemma":[0.005233462,0.0007111961,0.0020271277,0.0023222675,0.0013843873,0.0026594668,0.001226073,0.0036361683,0.00413791],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000626359,0.00009466491,0.000601578,0.006438605,0.00027404615,0.00028270954,0.00012740694,0.05229195,0.0010572722,0.14287373,0.034798514,0.7610968],"study_design_scores_gemma":[0.000059247846,0.00013846846,0.000926847,0.0033551953,0.00031341842,0.0012523246,0.000057806363,0.060867094,0.0014240653,0.3160278,0.615439,0.00013877465],"about_ca_topic_score_codex":0.0027783476,"about_ca_topic_score_gemma":0.0011585751,"teacher_disagreement_score":0.0047384845,"about_ca_system_score_codex":0.0013374793,"about_ca_system_score_gemma":0.0029778555,"threshold_uncertainty_score":0.015851796},"labels":[],"label_agreement":null},{"id":"W2081433798","doi":"10.2165/11531190-000000000-00000","title":"Rate and Extent of Drug Accumulation after Multiple Dosing Revisited","year":2010,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dosing; Pharmacokinetics; Drug; Pharmacology; Bolus (digestion); Medicine; Plasma concentration; Analyte; Intensive care medicine; Chemistry; Internal medicine","score_opus":0.3070457126826455,"score_gpt":0.5598952058502331,"score_spread":0.2528494931675876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081433798","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003986717,0.984571,0.0067560524,0.0009800722,0.0002088252,0.000013323852,0.00009617834,0.000054331595,0.003333428],"genre_scores_gemma":[0.03538413,0.95613015,0.003195029,0.0006580356,0.00070906046,0.0000288928,0.00008283,0.00003625179,0.0037756863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932003,0.00016583715,0.0000974989,0.00020004292,0.0001823572,0.000034235716],"domain_scores_gemma":[0.9982394,0.0009954381,0.00039543,0.00010237807,0.00023819262,0.000029093306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001749081,0.000980465,0.0021025974,0.0011838108,0.0001187249,0.0014964987,0.0011531744,0.0011712098,0.0024807707],"category_scores_gemma":[0.0026117293,0.00046401372,0.00088117784,0.0012910579,0.0009675495,0.0031480975,0.0006223055,0.0022437966,0.0017988965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005762812,0.00009329453,0.0016254442,0.0046548285,0.0001596982,0.00054390857,0.0000976181,0.0018322547,0.010266761,0.014879663,0.00541395,0.9598563],"study_design_scores_gemma":[0.00016608005,0.0022677667,0.020153789,0.0036824462,0.0012068411,0.042422842,0.0003669932,0.007800702,0.045079395,0.043188788,0.83347523,0.00018915563],"about_ca_topic_score_codex":0.00072741584,"about_ca_topic_score_gemma":0.0007108699,"teacher_disagreement_score":0.0024807707,"about_ca_system_score_codex":0.0008376022,"about_ca_system_score_gemma":0.0010045862,"threshold_uncertainty_score":0.009250164},"labels":[],"label_agreement":null},{"id":"W20820324","doi":"10.2165/00003088-200847100-00001","title":"Disposition of Drugs in Block Copolymer Micelle Delivery Systems","year":2008,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Bioavailability; Drug delivery; Pharmacology; Drug; Biodistribution; Micelle; Distribution (mathematics); Therapeutic index; Medicine; Chemistry; Nanotechnology; Materials science; Organic chemistry; In vitro; Aqueous solution","score_opus":0.06246443151503158,"score_gpt":0.37933505012734087,"score_spread":0.3168706186123093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W20820324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030213646,0.9908805,0.0036686847,0.00014767185,0.00015579059,0.000018651002,0.000033757082,0.00004445832,0.0020290914],"genre_scores_gemma":[0.009250806,0.98313725,0.0024323652,0.00017231012,0.00019080467,0.000028548775,0.00006443612,0.000009612034,0.0047138357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998172,0.000027823979,0.000018134284,0.00004081074,0.000080589554,0.000015531708],"domain_scores_gemma":[0.9998783,0.00005224226,0.000028720242,0.0000060648185,0.000029363719,0.000005362192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004987369,0.0006841844,0.0013912156,0.0008449201,0.00013829337,0.0007092438,0.0007282815,0.000753089,0.0010085425],"category_scores_gemma":[0.0004163325,0.0003609379,0.00038531114,0.0008416429,0.0002915921,0.0007735791,0.00030085977,0.0007448785,0.0013726981],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023246666,0.00014100446,0.000233014,0.0067600324,0.00007724669,0.0004894117,0.00005378969,0.0021555217,0.083165064,0.0028716645,0.0066976547,0.8971232],"study_design_scores_gemma":[0.000072150346,0.00074617803,0.0018405156,0.001111281,0.0002880042,0.0057540913,0.00004985988,0.0026925388,0.113045014,0.002007301,0.8723187,0.00007452133],"about_ca_topic_score_codex":0.00061685103,"about_ca_topic_score_gemma":0.00072790094,"teacher_disagreement_score":0.0013912156,"about_ca_system_score_codex":0.00053703267,"about_ca_system_score_gemma":0.0004084467,"threshold_uncertainty_score":0.0038964748},"labels":[],"label_agreement":null},{"id":"W2085312586","doi":"10.2165/00003088-200544060-00003","title":"Application and Impact of Population Pharmacokinetics in the Assessment of Antiretroviral Pharmacotherapy","year":2005,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Dosing; Population; Pharmacokinetics; Pharmacotherapy; Drug; Pharmacodynamics; Intensive care medicine; Pharmacology; Clinical trial; Therapeutic drug monitoring; Internal medicine; Environmental health","score_opus":0.09711398041052753,"score_gpt":0.533612792953196,"score_spread":0.4364988125426684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085312586","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025825365,0.9959777,0.0025237768,0.00021509893,0.0001022778,0.000010936675,0.000022152606,0.000015191384,0.0008746062],"genre_scores_gemma":[0.0037335868,0.9926709,0.002908476,0.00019207817,0.00018879306,0.0000150403785,0.000031853873,0.0000045900974,0.00025474463],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981641,0.0007403382,0.00016989317,0.0002209568,0.0006582362,0.000046426947],"domain_scores_gemma":[0.99498475,0.0036816082,0.00039401953,0.00013047653,0.0007315844,0.00007758412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004505744,0.0014583415,0.005615135,0.0033488858,0.00027554328,0.002817706,0.0021319936,0.0016579452,0.0018938682],"category_scores_gemma":[0.0055729556,0.0005751509,0.001510876,0.0041327826,0.0013020985,0.002022062,0.0008840354,0.0028272711,0.0011436407],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105599756,0.00009046331,0.00063049013,0.011579542,0.00040054458,0.00018357286,0.00006257462,0.003459994,0.0010731409,0.009272614,0.0046539465,0.96848744],"study_design_scores_gemma":[0.00017034904,0.00081429305,0.006685371,0.010978571,0.0016669222,0.006007835,0.00026881933,0.009024915,0.0036781484,0.03436197,0.92607296,0.00026978785],"about_ca_topic_score_codex":0.0029973339,"about_ca_topic_score_gemma":0.0025273087,"teacher_disagreement_score":0.005615135,"about_ca_system_score_codex":0.0014472482,"about_ca_system_score_gemma":0.0022110466,"threshold_uncertainty_score":0.023828924},"labels":[],"label_agreement":null},{"id":"W2088788142","doi":"10.2165/00003088-200241100-00005","title":"Enterohepatic Circulation","year":2002,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":655,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Enterohepatic circulation; Bioavailability; Reabsorption; Pharmacology; Pharmacokinetics; Chemistry; Efflux; Drug metabolism; Glucuronidation; Transporter; Internal medicine; Metabolism; Endocrinology; Biology; Drug; Biochemistry; Enzyme; Medicine; Kidney","score_opus":0.22230048817132525,"score_gpt":0.47425539050488663,"score_spread":0.2519549023335614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088788142","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00056925265,0.99425733,0.0010727525,0.00055220176,0.00041407553,0.000018066647,0.000035238165,0.000051092968,0.0030300699],"genre_scores_gemma":[0.0035814086,0.9902526,0.0010593481,0.00043791768,0.0005219097,0.000027311815,0.00007576883,0.000008085122,0.0040357052],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998084,0.000052417556,0.000028960812,0.000035007848,0.000057993955,0.000017178298],"domain_scores_gemma":[0.99971324,0.00010192401,0.000056954268,0.000017676233,0.00008565175,0.000024480292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057463744,0.001096891,0.0020666774,0.0015010142,0.00021264754,0.0012199855,0.00052605395,0.0008881298,0.0053965785],"category_scores_gemma":[0.0008715957,0.000286522,0.00033821183,0.0014682547,0.0004883978,0.0013994571,0.0007001394,0.0014201319,0.0038841958],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003556041,0.0000905315,0.00019083283,0.0050915526,0.000058586535,0.00047743303,0.000021045562,0.00014308293,0.0030584063,0.0011623029,0.016172674,0.97317797],"study_design_scores_gemma":[0.00017315231,0.00038531062,0.0015699359,0.0014585415,0.00030297792,0.0070449756,0.000042393243,0.00026722514,0.003954927,0.0016091444,0.983166,0.000025373089],"about_ca_topic_score_codex":0.0005233662,"about_ca_topic_score_gemma":0.0007112727,"teacher_disagreement_score":0.0053965785,"about_ca_system_score_codex":0.0005093859,"about_ca_system_score_gemma":0.0013632177,"threshold_uncertainty_score":0.018053353},"labels":[],"label_agreement":null},{"id":"W2089663335","doi":"10.2165/00003088-200140050-00002","title":"Comparative Pharmacokinetics and Pharmacodynamics of the Rifamycin Antibacterials","year":2001,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":335,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Rifabutin; Rifamycin; Rifapentine; Pharmacology; Rifampicin; Pharmacokinetics; CYP3A; Pharmacodynamics; Drug interaction; Antibiotics; Bioavailability; Antibacterial agent; Medicine; Mycobacterium tuberculosis; Microbiology; Biology; Latent tuberculosis; Internal medicine; Clarithromycin; Cytochrome P450; Tuberculosis; Metabolism","score_opus":0.2620719895744265,"score_gpt":0.5471323598162761,"score_spread":0.28506037024184955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089663335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019889211,0.9993718,0.00009921365,0.0000769922,0.000023630546,0.0000014701807,0.0000065451163,0.0000024381322,0.00021906737],"genre_scores_gemma":[0.0017162338,0.99765235,0.0002847111,0.00008387057,0.000078507604,0.0000034338882,0.000017342943,9.800506e-7,0.00016262362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993863,0.00015858367,0.00011295729,0.00010653121,0.00021228916,0.000023300187],"domain_scores_gemma":[0.9983917,0.0009824578,0.0002792676,0.000037139398,0.00026777192,0.000041650794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015569414,0.0008117607,0.002926949,0.0025875017,0.00015407089,0.0009765085,0.0008972389,0.0009694041,0.0014986015],"category_scores_gemma":[0.0026043432,0.00031270584,0.0007425712,0.0034861418,0.00047862198,0.0013192382,0.00035548926,0.0011555469,0.0006216751],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031845475,0.00007048776,0.00045796408,0.013412849,0.00019989336,0.00018229769,0.00003777557,0.0003047687,0.001908624,0.0008988976,0.0037138257,0.97849417],"study_design_scores_gemma":[0.00031571928,0.0016100117,0.015420565,0.010294597,0.0023029242,0.0118732825,0.00023196443,0.0006910275,0.0062141614,0.0038495346,0.94706595,0.00013026764],"about_ca_topic_score_codex":0.001073854,"about_ca_topic_score_gemma":0.0019062281,"teacher_disagreement_score":0.002926949,"about_ca_system_score_codex":0.0007846278,"about_ca_system_score_gemma":0.0012455733,"threshold_uncertainty_score":0.008234024},"labels":[],"label_agreement":null},{"id":"W2092225831","doi":"10.2165/00003088-200038040-00004","title":"Pharmacokinetic Drug Interactions Between Oral Contraceptives and Second-Generation Anticonvulsants","year":2000,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Oxcarbazepine; Lamotrigine; Felbamate; Zonisamide; Vigabatrin; Medicine; Anticonvulsant; Pharmacology; Topiramate; Tiagabine; Pharmacokinetics; Drug interaction; Carbamazepine; Epilepsy","score_opus":0.2758623970161912,"score_gpt":0.5270605067803867,"score_spread":0.25119810976419554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092225831","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000894671,0.9976363,0.0002188551,0.00006966536,0.000047831418,0.0000080973105,0.000029878092,0.000009780206,0.0010848691],"genre_scores_gemma":[0.003933697,0.9941199,0.00050145475,0.00011211393,0.00008543929,0.000013137863,0.000053971416,0.0000022412705,0.0011781226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997192,0.000060054772,0.000046492314,0.000039309754,0.000119767945,0.000015219657],"domain_scores_gemma":[0.9995995,0.0002042427,0.000117713644,0.000008007192,0.000056146284,0.000014356412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046270524,0.00076882134,0.001901119,0.0017039889,0.00017378789,0.00057620934,0.0006639387,0.00059861405,0.00282582],"category_scores_gemma":[0.0007468381,0.00020998679,0.00063045794,0.0020249218,0.00020756124,0.00053393043,0.00025578417,0.0005718022,0.0009880357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000324194,0.00012653133,0.0006225489,0.017419226,0.00030751323,0.0006288933,0.000040829993,0.00039980534,0.0042672306,0.0004902345,0.0064004986,0.9689725],"study_design_scores_gemma":[0.00026767375,0.0010857766,0.011592408,0.0050947648,0.0020269933,0.015288288,0.00014312683,0.0005566641,0.0069577997,0.0011082216,0.95581216,0.000066082765],"about_ca_topic_score_codex":0.0014167757,"about_ca_topic_score_gemma":0.0026877567,"teacher_disagreement_score":0.00282582,"about_ca_system_score_codex":0.000386267,"about_ca_system_score_gemma":0.0006099595,"threshold_uncertainty_score":0.009453356},"labels":[],"label_agreement":null},{"id":"W2097429326","doi":"10.2165/00003088-200342040-00001","title":"Maternal-Fetal Transport of Hypoglycaemic Drugs","year":2003,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":123,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Chlorpropamide; Medicine; Tolbutamide; Pregnancy; Placenta; Glibenclamide; Pharmacology; Fetus; Diabetes mellitus; Drug; Insulin; Pharmacodynamics; Pharmacokinetics; Internal medicine; Endocrinology; Biology","score_opus":0.13380008607052357,"score_gpt":0.4533784332183283,"score_spread":0.31957834714780475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097429326","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024465847,0.9992792,0.000056730154,0.0000617519,0.000031709948,0.000003509688,0.0000143603,0.0000027599633,0.00030538856],"genre_scores_gemma":[0.0009529504,0.99867743,0.00013158926,0.000052694944,0.000023003488,0.000004265855,0.000017553282,7.305245e-7,0.00013969037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969923,0.0000755808,0.000073657524,0.000045820652,0.00008798417,0.000017838285],"domain_scores_gemma":[0.9993106,0.00040868038,0.000150227,0.000017156912,0.000095077725,0.00001829293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009210101,0.00094159006,0.002429067,0.002232537,0.00017830802,0.0008945244,0.00089527346,0.0008324804,0.0025586013],"category_scores_gemma":[0.0014407453,0.00029563336,0.0008386057,0.0030138632,0.00034142213,0.0009239735,0.00042238244,0.0007837707,0.0007094983],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046719663,0.00010264396,0.0005179687,0.050454628,0.0006153988,0.0004960225,0.000065431595,0.00031179993,0.0018306635,0.0007921997,0.0065988,0.9377473],"study_design_scores_gemma":[0.00044625072,0.00092649786,0.007488765,0.025636114,0.004642781,0.0071915556,0.00025836297,0.00028744352,0.0042949743,0.0012677873,0.94747615,0.0000832718],"about_ca_topic_score_codex":0.0019078754,"about_ca_topic_score_gemma":0.0030747661,"teacher_disagreement_score":0.0025586013,"about_ca_system_score_codex":0.00061997835,"about_ca_system_score_gemma":0.0012990988,"threshold_uncertainty_score":0.008559346},"labels":[],"label_agreement":null},{"id":"W2142711346","doi":"10.2165/0003088-200847120-00006","title":"Pharmacokinetics of Sapropterin in Patients with Phenylketonuria","year":2008,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"BioMarin Pharmaceutical","keywords":"Phenylalanine; Medicine; Phenylalanine hydroxylase; Pharmacokinetics; Tetrahydrobiopterin; Phenylketonurias; Placebo; Population; Internal medicine; Hyperphenylalaninemia; Blood sampling; Pharmacotherapy; Pediatrics; Pharmacology; Amino acid; Chemistry; Biochemistry","score_opus":0.023051826954967675,"score_gpt":0.3165657192490158,"score_spread":0.2935138922940481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142711346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974255,0.00085477554,0.00030912427,0.00017567287,0.000021070202,0.000016032223,0.0001532455,0.000042317624,0.0010021727],"genre_scores_gemma":[0.99919015,0.000175268,0.00013439571,0.000116029165,0.000029416862,0.00001139805,0.00013677796,0.000009452939,0.00019703055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995968,0.00014478365,0.000044006603,0.00007702605,0.00008690644,0.00005055506],"domain_scores_gemma":[0.9981218,0.0008141876,0.00035377592,0.00010555253,0.000102758815,0.0005019342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045647883,0.0006564492,0.0013796397,0.0004625791,0.0005110635,0.0007425878,0.0002371276,0.00075555826,0.0010206073],"category_scores_gemma":[0.0034175098,0.00037379508,0.0005160858,0.0005011363,0.00044055673,0.00076088845,0.00024601226,0.0013680311,0.00022407215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05569334,0.0010217688,0.84235954,0.00023728125,0.0008911171,0.012569757,0.00090286124,0.0033351025,0.032759983,0.00040543798,0.0015550819,0.04826874],"study_design_scores_gemma":[0.0015245818,0.013044066,0.95723486,0.000032770404,0.00055345596,0.013284389,0.0003988035,0.0062014493,0.005667054,0.00060013286,0.001380725,0.00007773836],"about_ca_topic_score_codex":0.0013582238,"about_ca_topic_score_gemma":0.0012745284,"teacher_disagreement_score":0.0013796397,"about_ca_system_score_codex":0.0007624563,"about_ca_system_score_gemma":0.00045808163,"threshold_uncertainty_score":0.005532086},"labels":[],"label_agreement":null},{"id":"W2185569199","doi":"10.2165/11594550-000000000-00000","title":"Pharmacokinetics of Antimalarials in Pregnancy","year":2011,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Pharmacokinetics; Lumefantrine; Pregnancy; Proguanil; Sulfadoxine/pyrimethamine; Sulfadoxine; Malaria; Artemether/lumefantrine; Chloroquine; Pharmacology; MEDLINE; Artemisinin; Pyrimethamine; Plasmodium falciparum; Immunology","score_opus":0.30778625613371663,"score_gpt":0.5209147555254692,"score_spread":0.21312849939175255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185569199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014399864,0.99926907,0.000093592294,0.00008626485,0.00003465089,0.000004422688,0.000018117136,0.0000043937903,0.00034547807],"genre_scores_gemma":[0.00090311863,0.9985409,0.00019924594,0.000087096676,0.00004996664,0.0000055082287,0.000022946599,0.0000010191162,0.00019031683],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997398,0.00005746225,0.00006573852,0.000037242786,0.0000846676,0.000015071544],"domain_scores_gemma":[0.9992519,0.00042785218,0.00017629306,0.00001681277,0.000103967584,0.00002308544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008315912,0.00094735366,0.0023041198,0.0022290333,0.00016883972,0.0007790171,0.0008716571,0.0008401013,0.0026646128],"category_scores_gemma":[0.001439594,0.00037462826,0.00074753165,0.0024322695,0.0003683269,0.00090761716,0.00042897265,0.0013444896,0.0009859317],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028876239,0.00010289231,0.00026178977,0.038409468,0.000287714,0.00023324022,0.000046069592,0.00053685607,0.0019805585,0.00092616404,0.009739224,0.9471873],"study_design_scores_gemma":[0.00028342693,0.0006869101,0.0036776136,0.015290298,0.0019405895,0.0044971355,0.000106349886,0.0004623337,0.002533445,0.0018054316,0.96865016,0.00006629007],"about_ca_topic_score_codex":0.001483411,"about_ca_topic_score_gemma":0.0029838118,"teacher_disagreement_score":0.0026646128,"about_ca_system_score_codex":0.00051598717,"about_ca_system_score_gemma":0.00091151183,"threshold_uncertainty_score":0.008914053},"labels":[],"label_agreement":null},{"id":"W2269037162","doi":"10.1007/s40262-015-0352-5","title":"Development of a Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug–Drug Interaction Prediction","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Itraconazole; Physiologically based pharmacokinetic modelling; Pharmacokinetics; Pharmacology; Drug; Chemistry; Medicine; Antifungal","score_opus":0.327424888735298,"score_gpt":0.5071408996172214,"score_spread":0.1797160108819234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269037162","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025512163,0.00028713967,0.9680265,0.00034199245,0.00006494362,0.00011444535,0.00032263514,0.0011186851,0.004211412],"genre_scores_gemma":[0.77787673,0.00073631475,0.20813018,0.0002888677,0.00008753645,0.00071980356,0.00092797587,0.00023848761,0.010994075],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997849,0.00004630862,0.000016534414,0.000054841912,0.0000770773,0.000020309108],"domain_scores_gemma":[0.99963,0.00017363565,0.00003761751,0.00001979887,0.00012301191,0.00001597196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004464728,0.00066663243,0.00095219543,0.0003645013,0.00038784993,0.0009059358,0.0012325259,0.0012951184,0.0017973019],"category_scores_gemma":[0.0012601417,0.00057471875,0.0010049514,0.0003024193,0.00021061058,0.0007158158,0.00050767575,0.001279115,0.00089467026],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023995763,0.000042740452,0.0006884819,0.000042539614,0.00003824155,0.000096546464,0.000023623674,0.97416794,0.004357907,0.0020981668,0.00061434804,0.01780552],"study_design_scores_gemma":[0.000003256098,0.000011168532,0.00011541938,0.0000021763433,0.00000723881,0.000019429564,0.0000019173679,0.9984546,0.00048060672,0.00038735202,0.00051272684,0.000004179948],"about_ca_topic_score_codex":0.012145648,"about_ca_topic_score_gemma":0.007309276,"teacher_disagreement_score":0.012145648,"about_ca_system_score_codex":0.0007074977,"about_ca_system_score_gemma":0.0018909897,"threshold_uncertainty_score":0.024149895},"labels":[],"label_agreement":null},{"id":"W2402000540","doi":"10.1007/s40262-016-0408-1","title":"Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent–Metabolite Population Pharmacokinetic Model","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; American Foundation for Pharmaceutical Education; National Center for Advancing Translational Sciences; Howard Hughes Medical Institute","keywords":"Glucuronidation; Pharmacokinetics; Acetaminophen; Metabolite; Urine; Population; Sulfation; Pharmacology; NONMEM; Gestational age; Chemistry; Gestation; Medicine; Endocrinology; Pregnancy; Biochemistry; Microsome; Biology","score_opus":0.1707557073575224,"score_gpt":0.4667549812125988,"score_spread":0.2959992738550764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402000540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7892045,0.003192033,0.19997422,0.00037381548,0.00003522213,0.00013324563,0.0009050943,0.00016832215,0.0060136346],"genre_scores_gemma":[0.9832351,0.0020416523,0.010343518,0.000074333504,0.000010331642,0.00012740555,0.0004529217,0.00003601327,0.0036787612],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999853,0.000048099715,0.000009128519,0.00004888952,0.000023033903,0.000017759003],"domain_scores_gemma":[0.9997521,0.000101964426,0.00006828654,0.000015217806,0.000045137873,0.000017225115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045049182,0.0005044708,0.00041882004,0.00022561847,0.00011524362,0.0004524202,0.00045915006,0.0003155611,0.0010431907],"category_scores_gemma":[0.0010933846,0.00024108679,0.00069576205,0.00017183858,0.00022048292,0.00039983695,0.0002711603,0.0006249436,0.00026809634],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003491365,0.0005516823,0.07415116,0.0004507611,0.0007533947,0.0020754812,0.0007763884,0.4862198,0.24049181,0.050337,0.002325349,0.13837582],"study_design_scores_gemma":[0.00007824933,0.0013405535,0.030337853,0.000047120702,0.0004915482,0.001362222,0.00011653535,0.9134675,0.041549377,0.006069455,0.005066076,0.0000734762],"about_ca_topic_score_codex":0.0066464725,"about_ca_topic_score_gemma":0.0028092647,"teacher_disagreement_score":0.0066464725,"about_ca_system_score_codex":0.0006717146,"about_ca_system_score_gemma":0.00086037425,"threshold_uncertainty_score":0.013215601},"labels":[],"label_agreement":null},{"id":"W2474545910","doi":"10.1007/s40262-016-0425-0","title":"Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Janssen Research and Development","keywords":"Prostate cancer; Abiraterone; Medicine; Oncology; Abiraterone acetate; Prostate; Prostate-specific antigen; Castration; Internal medicine; Cancer; Urology; Hormone; Androgen deprivation therapy; Androgen receptor","score_opus":0.11871878469080704,"score_gpt":0.40642099729193215,"score_spread":0.2877022126011251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474545910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96351385,0.000895155,0.029523276,0.0013289332,0.00004128959,0.000069504604,0.00077481655,0.00017009856,0.0036830786],"genre_scores_gemma":[0.9954839,0.00021111926,0.0015263609,0.000094443414,0.000016153357,0.00002781359,0.00019651417,0.000016870536,0.0024269675],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996507,0.00014362577,0.000015443273,0.00007184697,0.00004292916,0.00007537113],"domain_scores_gemma":[0.9970816,0.002289821,0.0003366026,0.000053982913,0.000116948206,0.00012100129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010973425,0.00078093953,0.0009795186,0.0004093512,0.0003464362,0.0015219896,0.0009551243,0.0012892393,0.0015596999],"category_scores_gemma":[0.0053612106,0.00076712674,0.0010751976,0.00045327103,0.0004947249,0.0005769754,0.0005705351,0.001430553,0.0002625105],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002736193,0.00011828237,0.014537275,0.000028378403,0.00012378627,0.00019067981,0.000054368833,0.97996634,0.00065268466,0.0010854998,0.00030229878,0.0026667651],"study_design_scores_gemma":[0.00004892589,0.00009217707,0.002760493,0.000003987904,0.00005077672,0.00008685246,0.00002282805,0.9956726,0.00020238548,0.0007764657,0.00027095008,0.000011567169],"about_ca_topic_score_codex":0.04659787,"about_ca_topic_score_gemma":0.021084856,"teacher_disagreement_score":0.04659787,"about_ca_system_score_codex":0.0013766655,"about_ca_system_score_gemma":0.0021368088,"threshold_uncertainty_score":0.092653275},"labels":[],"label_agreement":null},{"id":"W2515414172","doi":"10.1007/s40262-016-0442-z","title":"Open Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical Bioequivalence","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"U.S. Food and Drug Administration","keywords":"Bioequivalence; Pharmacokinetics; Medicine; Pharmacology","score_opus":0.283421452958704,"score_gpt":0.5430172333162642,"score_spread":0.25959578035756015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515414172","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7274659,0.010849039,0.25487038,0.00044784156,0.00030774195,0.0019122034,0.00067390583,0.0004162409,0.0030567676],"genre_scores_gemma":[0.8835749,0.0014633427,0.11305966,0.00020228005,0.00013241581,0.00067968183,0.00013565968,0.000025386329,0.00072672457],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979845,0.0008632145,0.00008226656,0.00036162251,0.00063390535,0.00007453644],"domain_scores_gemma":[0.9978484,0.0012012237,0.000506609,0.00015029703,0.00023207814,0.00006142184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035076847,0.0004699409,0.00056326715,0.0006582688,0.00025293996,0.0005184171,0.00040047514,0.00069330545,0.0018653673],"category_scores_gemma":[0.0031961787,0.00021671756,0.0003050405,0.00032802028,0.00087312766,0.00061941997,0.00034254527,0.0009363666,0.0001981449],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021350558,0.0005320878,0.004404578,0.0003056479,0.000042988217,0.000051136456,0.00008456632,0.00070117606,0.94670886,0.000500737,0.00030163073,0.04423165],"study_design_scores_gemma":[0.0003425967,0.013726681,0.035593808,0.00006515076,0.00020021985,0.0012259334,0.00008374519,0.022233598,0.9212157,0.0006460859,0.0045855637,0.000080800215],"about_ca_topic_score_codex":0.0006576671,"about_ca_topic_score_gemma":0.0006212507,"teacher_disagreement_score":0.0035076847,"about_ca_system_score_codex":0.0005837551,"about_ca_system_score_gemma":0.00041159318,"threshold_uncertainty_score":0.018550634},"labels":[],"label_agreement":null},{"id":"W2555438271","doi":"10.1007/s40262-016-0487-z","title":"Erratum to: Open Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical Bioequivalence","year":2016,"lang":"en","type":"erratum","venue":"Clinical Pharmacokinetics","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bioequivalence; Medicine; Pharmacokinetics; Pharmacotherapy; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.23016181609948047,"score_gpt":0.5287070725347852,"score_spread":0.2985452564353047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555438271","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062376715,0.005114437,0.0012613162,0.04326782,0.9422886,0.00006353057,0.00061068585,0.00022885743,0.0065411148],"genre_scores_gemma":[0.01808615,0.033694707,0.014712483,0.12282691,0.2572806,0.0002942412,0.0029365898,0.0012882656,0.54888004],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99684554,0.0003144172,0.0007413704,0.0002366741,0.0016513986,0.00021054367],"domain_scores_gemma":[0.98941237,0.002863007,0.00096538843,0.0005336585,0.0057551414,0.0004704232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023178647,0.0020921992,0.0018710089,0.0027444828,0.0019446736,0.002646639,0.0018284102,0.0060265316,0.019831765],"category_scores_gemma":[0.019552223,0.0011287734,0.0014660674,0.0015343225,0.0015554596,0.0019317331,0.0010801979,0.0067058797,0.022003494],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010089542,0.00005234181,0.00017778699,0.00023775309,0.000015753016,0.0008875292,0.000025070034,0.0000837011,0.0003537096,0.00068255066,0.97582257,0.021560365],"study_design_scores_gemma":[0.00006173551,0.000115428214,0.0010947112,0.0004583383,0.00007887233,0.0015754328,0.00008072802,0.00045883624,0.001806055,0.000821624,0.99340194,0.000046332796],"about_ca_topic_score_codex":0.008565114,"about_ca_topic_score_gemma":0.011894257,"teacher_disagreement_score":0.019831765,"about_ca_system_score_codex":0.0024966851,"about_ca_system_score_gemma":0.004479379,"threshold_uncertainty_score":0.0663439},"labels":[],"label_agreement":null},{"id":"W2566808867","doi":"10.1007/s40262-016-0496-y","title":"A Phase I Pharmacokinetic Study of Trastuzumab Emtansine (T-DM1) in Patients with Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function","year":2016,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"F. Hoffmann-La Roche","keywords":"Trastuzumab emtansine; Medicine; Internal medicine; Pharmacokinetics; Metastatic breast cancer; Breast cancer; Gastroenterology; Endocrinology; Cancer","score_opus":0.08172419646481328,"score_gpt":0.4483246871888897,"score_spread":0.3666004907240764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566808867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774617,0.0005301784,0.00029603794,0.00016405933,0.000028449238,0.00026421316,0.0002559748,0.00004132658,0.000673563],"genre_scores_gemma":[0.9971053,0.00047771895,0.00050720305,0.00022549559,0.000049354916,0.00025291427,0.0005671759,0.000022123695,0.000792673],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996793,0.00012609885,0.0000122468,0.00007725201,0.000028792296,0.00007621865],"domain_scores_gemma":[0.99949706,0.000107379565,0.00007924403,0.00004924688,0.0000222912,0.0002448206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000753314,0.0012117629,0.0015475191,0.00034069494,0.00044728667,0.00083529565,0.00047144663,0.000770157,0.0019694918],"category_scores_gemma":[0.0012620679,0.00058415916,0.0009111584,0.00042784528,0.0008429013,0.00094744755,0.00026003862,0.0023609395,0.00052217353],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68942314,0.060714766,0.019558584,0.00036553468,0.00096439477,0.0008860302,0.0007470749,0.0069914544,0.099089555,0.0005122179,0.003192723,0.11755452],"study_design_scores_gemma":[0.34439203,0.57761467,0.05284909,0.000028649512,0.0007876641,0.0012346493,0.00019782572,0.0052852477,0.012253512,0.0003816152,0.0048739463,0.00010098834],"about_ca_topic_score_codex":0.0014157871,"about_ca_topic_score_gemma":0.002360951,"teacher_disagreement_score":0.0019694918,"about_ca_system_score_codex":0.0012131181,"about_ca_system_score_gemma":0.0013352133,"threshold_uncertainty_score":0.008801818},"labels":[],"label_agreement":null},{"id":"W2592879858","doi":"10.1007/s40262-017-0521-9","title":"Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia; Providence Health Care","funders":"","keywords":"Leflunomide; Medicine; Pharmacokinetics; Renal transplant; BK virus; Therapeutic drug monitoring; Pharmacotherapy; Pharmacology; Polyomavirus Infections; Metabolic clearance rate; Intensive care medicine; Kidney transplantation; Internal medicine; Transplantation; Rheumatoid arthritis","score_opus":0.1887635868518452,"score_gpt":0.5097140651357156,"score_spread":0.3209504782838704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592879858","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017665584,0.9994716,0.000054585056,0.0000963494,0.000030481022,0.000003415114,0.000015154052,0.000002177291,0.00014953373],"genre_scores_gemma":[0.002210181,0.9972025,0.00019825439,0.00019858174,0.000081990474,0.0000072356233,0.000028225086,0.0000010528166,0.00007202237],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995679,0.00010134338,0.0001499712,0.00006598333,0.000097339485,0.00001738158],"domain_scores_gemma":[0.9982287,0.0011479195,0.00037624172,0.000023019305,0.00018249208,0.000041509065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010530063,0.0006125546,0.002341609,0.0018616377,0.00017781429,0.0012263849,0.0008190411,0.00094077934,0.0019740625],"category_scores_gemma":[0.0027087028,0.00028069573,0.0012124903,0.0019596722,0.0003464139,0.0013948751,0.00048575093,0.0010602458,0.00033698816],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042454049,0.000089447974,0.0015098063,0.085019395,0.0009305107,0.00052451185,0.00009285467,0.00039419997,0.0016035098,0.00078408804,0.0105691105,0.898058],"study_design_scores_gemma":[0.0004596128,0.0010669826,0.012562283,0.08503439,0.008956539,0.016565489,0.00046468593,0.0009948276,0.00325121,0.002593102,0.8678523,0.00019858853],"about_ca_topic_score_codex":0.0009152074,"about_ca_topic_score_gemma":0.0017000644,"teacher_disagreement_score":0.002341609,"about_ca_system_score_codex":0.00043319765,"about_ca_system_score_gemma":0.0013100366,"threshold_uncertainty_score":0.006603956},"labels":[],"label_agreement":null},{"id":"W2596456348","doi":"10.1007/s40262-017-0526-4","title":"Population Pharmacokinetic Analysis of Ixazomib, an Oral Proteasome Inhibitor, Including Data from the Phase III TOURMALINE-MM1 Study to Inform Labelling","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Oncology","keywords":"Ixazomib; Pharmacology; Proteasome inhibitor; Pharmacokinetics; Population; Chemistry; Medicine; Proteasome; Biochemistry; Carfilzomib","score_opus":0.23345354210638997,"score_gpt":0.49510047905803145,"score_spread":0.2616469369516415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596456348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804125,0.0012367697,0.011351197,0.00012393242,0.000012389289,0.00033728444,0.0051279473,0.00015705598,0.0012409883],"genre_scores_gemma":[0.98227537,0.00040400878,0.005143207,0.00011508991,0.000016987844,0.0003460601,0.011036816,0.00004349178,0.00061897666],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9985815,0.0008634714,0.00006214458,0.00022769638,0.00019549372,0.000069729766],"domain_scores_gemma":[0.9984957,0.00080091046,0.00030137118,0.0001882874,0.00014956294,0.00006406712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044374564,0.0006086566,0.0012924408,0.00041099818,0.000129449,0.00071815844,0.00043373235,0.0004456734,0.0012742244],"category_scores_gemma":[0.003877934,0.00034524547,0.0015322143,0.0006444434,0.0002296039,0.0003099662,0.00038167904,0.0010064662,0.0002805376],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07175335,0.0028854548,0.32322505,0.0014174304,0.017312385,0.0012664729,0.0008588397,0.37888825,0.052687716,0.0020133003,0.011149862,0.13654193],"study_design_scores_gemma":[0.0063049053,0.03180251,0.53070664,0.00007339496,0.009585671,0.0024315296,0.00017401164,0.37739593,0.018209439,0.0023032075,0.020763205,0.00024959652],"about_ca_topic_score_codex":0.0027407242,"about_ca_topic_score_gemma":0.0021785963,"teacher_disagreement_score":0.0044374564,"about_ca_system_score_codex":0.0006614184,"about_ca_system_score_gemma":0.0011876865,"threshold_uncertainty_score":0.023467839},"labels":[],"label_agreement":null},{"id":"W2596528435","doi":"10.1007/s40262-017-0525-5","title":"Development of a Pediatric Physiologically-Based Pharmacokinetic Model of Clindamycin Using Opportunistic Pharmacokinetic Data","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Physiologically based pharmacokinetic modelling; Dosing; Pharmacokinetics; Medicine; Drug development; Clindamycin; Pharmacology; Drug; Antibiotics; Chemistry","score_opus":0.5641180925301839,"score_gpt":0.5241841764360174,"score_spread":0.03993391609416641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596528435","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07900798,0.0007731665,0.90316033,0.00067171565,0.00007379897,0.00016353899,0.001135386,0.0006252229,0.014388881],"genre_scores_gemma":[0.89884555,0.0011724228,0.08567074,0.00024732505,0.00006127869,0.0004922219,0.00084916735,0.00019407191,0.012467212],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998196,0.000048367427,0.000012245341,0.00004715099,0.000048284426,0.00002432617],"domain_scores_gemma":[0.99960417,0.00018599842,0.000057880345,0.000014998471,0.00011337567,0.000023609547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040629975,0.0005758371,0.000736986,0.00031738862,0.00034698058,0.000962373,0.0010400064,0.0009643284,0.0019982185],"category_scores_gemma":[0.0015183324,0.00051165157,0.0007423985,0.00040645103,0.00024966302,0.0007166481,0.0005436292,0.0010930883,0.0005480933],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025106543,0.00001941479,0.0012998456,0.00003642082,0.000020258198,0.00012519784,0.000041734027,0.9859947,0.0014933051,0.0037502751,0.0004734069,0.0067203795],"study_design_scores_gemma":[0.0000060339135,0.000012065981,0.00024496307,0.000004313593,0.00000932859,0.000037506838,0.0000071063328,0.9979017,0.00026230045,0.0006362571,0.00087350386,0.0000049267],"about_ca_topic_score_codex":0.026324116,"about_ca_topic_score_gemma":0.012639336,"teacher_disagreement_score":0.026324116,"about_ca_system_score_codex":0.00095061853,"about_ca_system_score_gemma":0.0022160164,"threshold_uncertainty_score":0.05234182},"labels":[],"label_agreement":null},{"id":"W2600807646","doi":"10.1007/s40262-017-0535-3","title":"Accounting for Pharmacokinetic Variability of Certolizumab Pegol in Patients with Crohn’s Disease","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Pharmacokinetics; Crohn's disease; Disease; Internal medicine; Adalimumab","score_opus":0.02272994562139833,"score_gpt":0.3501091740174944,"score_spread":0.32737922839609607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600807646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988897,0.0018428755,0.007124656,0.00030519543,0.00006203745,0.000025719854,0.00030698162,0.00009135514,0.0013441789],"genre_scores_gemma":[0.9987276,0.000084987696,0.00076971075,0.0000714808,0.000022882985,0.00000747105,0.00018600994,0.00002384156,0.00010608802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995706,0.0021018058,0.0004954898,0.0008734246,0.00056834525,0.00025505485],"domain_scores_gemma":[0.99045473,0.005490734,0.0016393991,0.0016457997,0.00048024324,0.00028914877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054019247,0.00043754542,0.0009794463,0.0005137214,0.00035725592,0.0017901667,0.00052820944,0.00062604883,0.0006203156],"category_scores_gemma":[0.015723843,0.00035595777,0.0011468377,0.0009583357,0.00032969413,0.0008578851,0.00044571122,0.0010904325,0.0002122813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036585953,0.00010294403,0.9492337,0.000056159188,0.0018085401,0.0004871437,0.00022650894,0.007333689,0.00415274,0.00044335614,0.0006855387,0.03181107],"study_design_scores_gemma":[0.0002138946,0.00151748,0.8983312,0.000042345782,0.0015928978,0.0032361946,0.00032572573,0.08202176,0.006630837,0.0021288127,0.0038917942,0.000066999],"about_ca_topic_score_codex":0.0017777425,"about_ca_topic_score_gemma":0.0013296107,"teacher_disagreement_score":0.0054019247,"about_ca_system_score_codex":0.0007801396,"about_ca_system_score_gemma":0.0008032913,"threshold_uncertainty_score":0.028568447},"labels":[],"label_agreement":null},{"id":"W2603265703","doi":"10.1007/s40262-017-0537-1","title":"Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Levetiracetam; Medicine; Tolerability; Epilepsy; Pharmacokinetics; Therapeutic drug monitoring; Pharmacotherapy; Antiepileptic drug; Drug; Adverse effect; MEDLINE; Pediatric epilepsy; Broad spectrum; Intensive care medicine; Pediatrics; Pharmacology; Internal medicine; Psychiatry","score_opus":0.3144511538562393,"score_gpt":0.5487371668921875,"score_spread":0.23428601303594826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2603265703","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020059622,0.9990563,0.000105712126,0.00017716386,0.000044233642,0.0000038534145,0.000015838585,0.0000068092645,0.00038947255],"genre_scores_gemma":[0.0026305288,0.99633324,0.0003638545,0.00031695244,0.00012325807,0.000008484586,0.00003653153,0.000002078928,0.00018512722],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965,0.000066992834,0.00011995981,0.00005606372,0.00008902209,0.000017941084],"domain_scores_gemma":[0.99894947,0.0006327028,0.0002522534,0.000016458873,0.00011608344,0.000033025142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077776687,0.0007912827,0.0020396826,0.0016324889,0.00012438632,0.0009557501,0.0008109423,0.00083550136,0.0020559318],"category_scores_gemma":[0.0022255778,0.00028360527,0.0009035789,0.0013830925,0.0003717955,0.0011770962,0.0005964217,0.0014287097,0.0005246116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001941655,0.00004946909,0.0007893736,0.019352729,0.00032393544,0.00026961224,0.000041819512,0.00024275367,0.00062803616,0.0006586657,0.008076297,0.969373],"study_design_scores_gemma":[0.0005326942,0.0006341394,0.012187622,0.038216393,0.0047911014,0.01154536,0.00024102545,0.0009220156,0.0024163076,0.0030931288,0.9252815,0.00013867034],"about_ca_topic_score_codex":0.00094344077,"about_ca_topic_score_gemma":0.0027635915,"teacher_disagreement_score":0.0020559318,"about_ca_system_score_codex":0.00046222095,"about_ca_system_score_gemma":0.0011490936,"threshold_uncertainty_score":0.0068778396},"labels":[],"label_agreement":null},{"id":"W2615999950","doi":"10.1007/s40262-017-0548-y","title":"Penetration of Vancomycin into the Cerebrospinal Fluid: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of Alberta; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Vancomycin; Ventriculitis; Medicine; Cerebrospinal fluid; Penetration (warfare); Meningitis; Internal medicine; Surgery; Staphylococcus aureus; Bacteria","score_opus":0.1640465031503143,"score_gpt":0.4801198568830462,"score_spread":0.31607335373273193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615999950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027190644,0.99943954,0.00004004013,0.00005263622,0.000034456134,0.00001826102,0.000073073905,0.0000020316684,0.000068039204],"genre_scores_gemma":[0.0020689638,0.9975223,0.000112649446,0.00016109657,0.0000303884,0.000016402117,0.000046793957,0.0000011909641,0.00004012589],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9987317,0.00023256484,0.0005317424,0.00018492065,0.00025125852,0.000067895766],"domain_scores_gemma":[0.99589986,0.0026873422,0.00095074053,0.000056736968,0.0003241173,0.00008127591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019563315,0.001385284,0.005562672,0.0043911836,0.00029306812,0.0021831973,0.0016169377,0.0016746784,0.0035307975],"category_scores_gemma":[0.0069963043,0.0006100185,0.004954895,0.0053869435,0.00057938084,0.0018673214,0.0011652452,0.0010783066,0.0003516675],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040021713,0.000044139557,0.00076479977,0.8639446,0.007407624,0.00023545152,0.00012523364,0.00023323474,0.0004834096,0.00029713503,0.0041157133,0.121948406],"study_design_scores_gemma":[0.00065679586,0.00066791556,0.009550743,0.7061033,0.14580515,0.002566976,0.00059701334,0.00024375327,0.0007237726,0.0009780426,0.13193302,0.0001735233],"about_ca_topic_score_codex":0.0045914245,"about_ca_topic_score_gemma":0.012222471,"teacher_disagreement_score":0.005562672,"about_ca_system_score_codex":0.0011594092,"about_ca_system_score_gemma":0.004612082,"threshold_uncertainty_score":0.011811733},"labels":[],"label_agreement":null},{"id":"W2616665343","doi":"10.1007/s40262-017-0544-2","title":"Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Morphine; Medicine; Pharmacokinetics; Glucuronidation; NONMEM; Population; Volume of distribution; Body mass index; Anesthesia; Pharmacology; Internal medicine; Chemistry","score_opus":0.06270001594124372,"score_gpt":0.3873581527800608,"score_spread":0.32465813683881706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2616665343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917847,0.00037459825,0.00028392204,0.000010758735,0.0000031320005,0.0000047035874,0.000038706396,0.000005047762,0.000100599165],"genre_scores_gemma":[0.9993192,0.00018026588,0.00027965455,0.000023763017,0.000005577991,0.0000042490315,0.000107093045,0.0000041287276,0.00007612386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997646,0.00009590903,0.000022518256,0.000034997403,0.00005518644,0.00002678775],"domain_scores_gemma":[0.999476,0.00016502822,0.00017211976,0.00006342309,0.00004054501,0.00008289929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039975767,0.0002819397,0.00047027852,0.00017871073,0.00012565691,0.0003944801,0.00006025581,0.0001577944,0.00042880134],"category_scores_gemma":[0.0010493885,0.00016681447,0.0003973881,0.00016818351,0.00023246842,0.00017945883,0.00020240966,0.00039852297,0.000081594146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03494125,0.0003816099,0.66793704,0.00018976032,0.0015658303,0.0012704412,0.00030645425,0.0036214322,0.24724294,0.0001938022,0.00020179721,0.042147655],"study_design_scores_gemma":[0.0001207875,0.0046871374,0.97442245,0.000008571551,0.00047172297,0.0013443846,0.000072613664,0.0050762226,0.013118045,0.00006997221,0.0005838794,0.000024270443],"about_ca_topic_score_codex":0.00094706623,"about_ca_topic_score_gemma":0.0010087057,"teacher_disagreement_score":0.00094706623,"about_ca_system_score_codex":0.00015068776,"about_ca_system_score_gemma":0.00019671611,"threshold_uncertainty_score":0.0021141171},"labels":[],"label_agreement":null},{"id":"W2742972753","doi":"10.1007/s40262-017-0576-7","title":"Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects","year":2017,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Center for Advancing Translational Sciences; National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; U.S. Food and Drug Administration; National Institutes of Health","keywords":"Ontogeny; Glycoprotein; Sigmoid function; Biology; Endocrinology; Physiology; Internal medicine; Medicine; Biochemistry; Computer science; Artificial intelligence","score_opus":0.0853104017071708,"score_gpt":0.44299663334826295,"score_spread":0.35768623164109214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2742972753","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973954,0.00045599346,0.0014070303,0.000038080336,0.000007853422,0.000026048972,0.000115790936,0.000026246593,0.00052755536],"genre_scores_gemma":[0.9981833,0.0001775853,0.0012574869,0.000034876626,0.0000058586575,0.000011656055,0.00013734496,0.000011725067,0.00018020338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872714,0.0007075935,0.000046163823,0.00020763313,0.00024712647,0.000064214786],"domain_scores_gemma":[0.99854124,0.00063012063,0.00027129933,0.00014385134,0.00026491817,0.00014857345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002279455,0.00043769498,0.0005520336,0.00024602728,0.00030423165,0.000553353,0.0002631407,0.00052593637,0.0005271032],"category_scores_gemma":[0.0053962865,0.00020218514,0.00020428376,0.0003458912,0.00028873718,0.00046763883,0.00029769383,0.0005948943,0.00016709369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011379558,0.00067050254,0.8944607,0.0001087095,0.00022535509,0.00023464774,0.0013337372,0.0023001297,0.032287724,0.0002970571,0.0006429398,0.05605897],"study_design_scores_gemma":[0.00012359134,0.015696274,0.94037336,0.00002382184,0.0003132327,0.001343078,0.00079710805,0.012291769,0.026750293,0.00018902865,0.0020621258,0.000036270456],"about_ca_topic_score_codex":0.0027892524,"about_ca_topic_score_gemma":0.0016302374,"teacher_disagreement_score":0.0027892524,"about_ca_system_score_codex":0.00039321743,"about_ca_system_score_gemma":0.0003861683,"threshold_uncertainty_score":0.012055099},"labels":[],"label_agreement":null},{"id":"W2752699676","doi":"10.1007/s40262-017-0593-6","title":"Population Pharmacokinetics of Mycophenolic Acid: An Update","year":2017,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Pharmacokinetics; Population; Pharmacology; Mycophenolic acid; Population pharmacokinetics; NONMEM; Medicine; Physiologically based pharmacokinetic modelling; Pharmacodynamics; Transplantation; Internal medicine","score_opus":0.3131514110980119,"score_gpt":0.5575333696247633,"score_spread":0.24438195852675137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752699676","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011180987,0.9992501,0.00013014814,0.00021207225,0.00008927685,0.0000034000373,0.00003471377,0.0000056270155,0.00016267184],"genre_scores_gemma":[0.00076923886,0.9982305,0.00030816704,0.00030479793,0.00023178759,0.00000640739,0.000053117685,0.0000021982157,0.00009379563],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938846,0.00013336625,0.00017947434,0.00010552352,0.00016384645,0.0000293953],"domain_scores_gemma":[0.99764293,0.0014965198,0.00039267552,0.00004814463,0.00035320784,0.000066500696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018278238,0.001059589,0.0033372417,0.0025298332,0.00016776132,0.002013701,0.0012653003,0.0014143419,0.0027569],"category_scores_gemma":[0.0035421131,0.0004737938,0.0019137703,0.0026653416,0.00045772412,0.0021529417,0.000748223,0.0021543815,0.0008030839],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030700665,0.00012284897,0.000972702,0.041431744,0.0010028483,0.00020152755,0.000045043143,0.0005223858,0.0006944381,0.001371445,0.023879554,0.9294485],"study_design_scores_gemma":[0.00036297375,0.00048394766,0.006592952,0.023741204,0.006124543,0.0048333653,0.00012375136,0.0008775529,0.0010042458,0.003544439,0.95217615,0.0001349652],"about_ca_topic_score_codex":0.0017019551,"about_ca_topic_score_gemma":0.0028542655,"teacher_disagreement_score":0.0033372417,"about_ca_system_score_codex":0.0008149127,"about_ca_system_score_gemma":0.0023666564,"threshold_uncertainty_score":0.009666562},"labels":[],"label_agreement":null},{"id":"W2785346493","doi":"10.1007/s40262-017-0624-3","title":"Daclatasvir: A Review of Preclinical and Clinical Pharmacokinetics","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arbutus Biopharma (Canada)","funders":"","keywords":"Daclatasvir; Pharmacokinetics; Pharmacology; Medicine; CYP3A4; Internal medicine; Cytochrome P450; Hepatitis C virus; Virology; Virus; Metabolism; Ribavirin","score_opus":0.38943379905223147,"score_gpt":0.6186080784491947,"score_spread":0.22917427939696328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785346493","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008879786,0.99920434,0.0000896898,0.00019733835,0.00008123395,0.0000074529776,0.000036022804,0.0000059225986,0.00028924597],"genre_scores_gemma":[0.00062468945,0.99854195,0.00023687891,0.00024547905,0.000119342716,0.000008401162,0.000044567267,0.000001625054,0.00017696123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953747,0.000085825566,0.00012791532,0.00006636698,0.00015181182,0.00003059338],"domain_scores_gemma":[0.99856746,0.00081933715,0.00023850346,0.00003487199,0.00027691753,0.00006291449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016930132,0.0011268589,0.0028401616,0.0031055638,0.00025823826,0.0016079465,0.001299826,0.0012642521,0.0040300884],"category_scores_gemma":[0.002674369,0.00047645342,0.0014216581,0.0029287504,0.0005809717,0.0019651328,0.0008187516,0.0022256898,0.0010878143],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031799366,0.00011906058,0.00028905892,0.04665363,0.0003301122,0.00014213026,0.000049500468,0.0004519325,0.0012640634,0.0016636692,0.022087444,0.9266314],"study_design_scores_gemma":[0.00016321622,0.00044321624,0.0014910608,0.015828468,0.0014575785,0.0016518355,0.000078264144,0.00035573047,0.0011196296,0.0020397846,0.97529775,0.0000733656],"about_ca_topic_score_codex":0.0011773064,"about_ca_topic_score_gemma":0.002402179,"teacher_disagreement_score":0.0040300884,"about_ca_system_score_codex":0.00071902404,"about_ca_system_score_gemma":0.002149756,"threshold_uncertainty_score":0.013481975},"labels":[],"label_agreement":null},{"id":"W2797029234","doi":"10.1007/s40262-018-0657-2","title":"Predicting Escitalopram Exposure to Breastfeeding Infants: Integrating Analytical and In Silico Techniques","year":2018,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Centre for Addiction and Mental Health; University of Waterloo; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Escitalopram; Breast milk; Breastfeeding; Pharmacokinetics; Physiologically based pharmacokinetic modelling; Population; Medicine; Pharmacology; Breast feeding; Physiology; Chemistry; Internal medicine; Pediatrics; Environmental health; Antidepressant","score_opus":0.045954309247078426,"score_gpt":0.42121145345235644,"score_spread":0.375257144205278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797029234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90687567,0.0047114957,0.0814806,0.0008944729,0.000059294933,0.0001506429,0.0024444796,0.0008105881,0.0025727344],"genre_scores_gemma":[0.975694,0.0018988391,0.020776762,0.00019576271,0.00003073083,0.000042907748,0.0009044128,0.00004090126,0.00041569435],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99928457,0.0003369203,0.000044139568,0.00011860663,0.00016798599,0.00004781003],"domain_scores_gemma":[0.998637,0.0009064769,0.00019287781,0.00007751105,0.00015150795,0.00003453231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013397748,0.0007218114,0.0011121666,0.0008830854,0.000253716,0.0014496517,0.0006249794,0.0008162965,0.00056235364],"category_scores_gemma":[0.003909437,0.0004495065,0.0008700109,0.0005927817,0.00019908552,0.00037597478,0.000370651,0.000560333,0.00026156238],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001638297,0.0012826541,0.5685159,0.0009811893,0.0025774413,0.0007392395,0.00026728606,0.21113959,0.061492354,0.0011009332,0.0021180888,0.148147],"study_design_scores_gemma":[0.00009852542,0.0011527664,0.07351877,0.00010292765,0.0011220383,0.0016603793,0.00021139816,0.8877457,0.028462837,0.0020774922,0.0037700483,0.00007713896],"about_ca_topic_score_codex":0.009036077,"about_ca_topic_score_gemma":0.0071993447,"teacher_disagreement_score":0.009036077,"about_ca_system_score_codex":0.000540936,"about_ca_system_score_gemma":0.0012613733,"threshold_uncertainty_score":0.017966926},"labels":[],"label_agreement":null},{"id":"W2806025779","doi":"10.1007/s40262-018-0681-2","title":"The Ontogeny of UDP-glucuronosyltransferase Enzymes, Recommendations for Future Profiling Studies and Application Through Physiologically Based Pharmacokinetic Modelling","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Pharmacokinetics; Pharmacology; Cytochrome P450; Drug; Drug development; Drug metabolism; Medicine; Physiologically based pharmacokinetic modelling; Pharmacotherapy; Glucuronosyltransferase; Bioinformatics; Computational biology; Enzyme; Biology; Metabolism; Internal medicine; Biochemistry; Microsome","score_opus":0.47038958596848207,"score_gpt":0.5852079668511639,"score_spread":0.11481838088268187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806025779","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011421811,0.99078923,0.004209402,0.0014250561,0.00025213632,0.000014081864,0.00010844424,0.000025616002,0.0020338874],"genre_scores_gemma":[0.0065457453,0.98713857,0.0038649004,0.0006226062,0.00023513826,0.000025852543,0.00015557483,0.000009861123,0.001401611],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974805,0.000059611993,0.00003835992,0.000074581185,0.000057157642,0.000022167274],"domain_scores_gemma":[0.9993142,0.00034327578,0.00011129807,0.000042340744,0.00015339094,0.00003549225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013806414,0.00092939695,0.0011641113,0.0016473046,0.00017518627,0.0020390956,0.00094832125,0.0011218159,0.002179514],"category_scores_gemma":[0.0015200018,0.0005137087,0.0007712072,0.0018200307,0.00094921753,0.002353625,0.00072371,0.0024683245,0.00120394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019972322,0.00008838373,0.0011728063,0.009110188,0.000093043134,0.00034053082,0.0000985971,0.0031524138,0.0062946593,0.026547063,0.008590936,0.9443116],"study_design_scores_gemma":[0.000026728634,0.00023965277,0.003795273,0.0038988118,0.00021161004,0.0020501767,0.00019837373,0.001935042,0.0055539524,0.024904292,0.9571127,0.00007316982],"about_ca_topic_score_codex":0.0024818552,"about_ca_topic_score_gemma":0.0023599255,"teacher_disagreement_score":0.0024818552,"about_ca_system_score_codex":0.0011031727,"about_ca_system_score_gemma":0.0023985247,"threshold_uncertainty_score":0.008004129},"labels":[],"label_agreement":null},{"id":"W2808895967","doi":"10.1007/s40262-018-0688-8","title":"Author’s Reply to Woillard et al.: “Population Pharmacokinetics of Mycophenolic Acid: an Update”","year":2018,"lang":"en","type":"letter","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Children's & Women's Health Centre of British Columbia; University of Alberta","funders":"","keywords":"Population pharmacokinetics; Mycophenolic acid; Pharmacokinetics; Medicine; Pharmacology; Pharmacotherapy; Internal medicine","score_opus":0.10171230293460967,"score_gpt":0.4614130572809739,"score_spread":0.3597007543463643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808895967","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014214203,0.0011948152,0.00007500651,0.9741974,0.023633936,0.000006133866,0.00008322132,0.00003640892,0.0006309641],"genre_scores_gemma":[0.001371316,0.0008735268,0.00015761096,0.9567544,0.03930253,0.00002246979,0.00003875322,0.000021653754,0.0014577181],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956709,0.0013293003,0.00087363995,0.0005495913,0.0011521572,0.00042444933],"domain_scores_gemma":[0.98149073,0.009859754,0.0016668534,0.0005046439,0.0049991827,0.0014789054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004563392,0.00091914064,0.0019798742,0.0010878755,0.0024838522,0.0033024943,0.0024151984,0.04227709,0.0065332893],"category_scores_gemma":[0.048879538,0.0008624923,0.0014240037,0.001194751,0.0021803654,0.0040744618,0.0016734663,0.037697602,0.009545495],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004606614,0.000016434193,0.00032844231,0.000050296305,0.000010450056,0.00069103396,0.000054790624,0.00003629194,0.000053329928,0.00042935068,0.9938538,0.004429766],"study_design_scores_gemma":[0.00022931807,0.00008455544,0.0014484574,0.00058007013,0.00005853159,0.004206174,0.00036208946,0.00049031415,0.00037892917,0.006330872,0.9857217,0.0001090676],"about_ca_topic_score_codex":0.004019419,"about_ca_topic_score_gemma":0.0053750607,"teacher_disagreement_score":0.04227709,"about_ca_system_score_codex":0.003223857,"about_ca_system_score_gemma":0.003786646,"threshold_uncertainty_score":0.024133801},"labels":[],"label_agreement":null},{"id":"W2886208449","doi":"10.1007/s40262-018-0705-y","title":"Clinical Pharmacokinetics and Pharmacodynamics of Ceftazidime–Avibactam Combination: A Model-Informed Strategy for its Clinical Development","year":2018,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Ceftazidime/avibactam; Avibactam; Ceftazidime; Population; Pharmacodynamics; Pharmacokinetics; Volume of distribution; Medicine; Pharmacology; Chemistry; Biology; Pseudomonas aeruginosa","score_opus":0.18508382199510282,"score_gpt":0.5016614182682003,"score_spread":0.3165775962730975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886208449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014938194,0.99819994,0.00044607656,0.00046431005,0.00013286903,0.00000784808,0.00003034288,0.0000091221045,0.00056001404],"genre_scores_gemma":[0.0017031564,0.9966499,0.0006793048,0.00034441845,0.00017882643,0.000016325332,0.000055442764,0.0000029873852,0.0003697191],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999741,0.00006744661,0.00003913022,0.000039440845,0.00009160403,0.000021317644],"domain_scores_gemma":[0.9992593,0.00041651048,0.00010094773,0.00002233641,0.00016263426,0.000038317005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012586399,0.0009025412,0.0017327318,0.001288326,0.00014151062,0.0013191855,0.0010699502,0.0013534081,0.002407268],"category_scores_gemma":[0.0017709074,0.00029475248,0.00063058257,0.0010061158,0.00052100274,0.0012344315,0.0005508736,0.0022868228,0.0010561409],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019832132,0.000115021074,0.00026306498,0.013248969,0.00011076438,0.00016184321,0.00003335123,0.00088221265,0.0023653712,0.00560172,0.024251847,0.9527676],"study_design_scores_gemma":[0.000096143725,0.00032817043,0.00086947257,0.004200489,0.00036172805,0.001406938,0.000050182498,0.0006287713,0.0017849294,0.0040760357,0.98615116,0.00004603854],"about_ca_topic_score_codex":0.001083259,"about_ca_topic_score_gemma":0.001831749,"teacher_disagreement_score":0.002407268,"about_ca_system_score_codex":0.0008151543,"about_ca_system_score_gemma":0.001777332,"threshold_uncertainty_score":0.008053184},"labels":[],"label_agreement":null},{"id":"W2904048219","doi":"10.1007/s40262-018-0722-x","title":"Correction to: Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children","year":2018,"lang":"en","type":"erratum","venue":"Clinical Pharmacokinetics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Posaconazole; Pharmacokinetics; Medicine; Pharmacotherapy; Medical physics; License; Intensive care medicine; Pediatrics; Pharmacology; Computer science; Internal medicine; Itraconazole; Antifungal; Dermatology","score_opus":0.14139106963709672,"score_gpt":0.5155674114102744,"score_spread":0.3741763417731777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904048219","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001164352,0.0016282878,0.00059639243,0.04703535,0.94649434,0.000025944106,0.0010786036,0.00022510673,0.0027995892],"genre_scores_gemma":[0.011330985,0.01871714,0.010422762,0.12877555,0.6287745,0.0002586043,0.0045395256,0.0017639023,0.19541691],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936318,0.0011683621,0.0015655509,0.00059836736,0.0025388873,0.0004971319],"domain_scores_gemma":[0.9537013,0.01286673,0.0025999614,0.0022694576,0.026792806,0.0017697187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004839332,0.0019727338,0.0017932848,0.0035355384,0.0018751937,0.0038459986,0.002781991,0.0059259715,0.03893263],"category_scores_gemma":[0.070729055,0.0011874682,0.001978594,0.0027561018,0.0016697453,0.0021148953,0.0014223122,0.013286072,0.030172182],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003371166,0.000007609116,0.000057873494,0.00011386435,0.000008232495,0.00009988293,0.000014105167,0.0000358066,0.000026881613,0.00037723582,0.99250364,0.006721125],"study_design_scores_gemma":[0.00004697247,0.000023514844,0.00062417187,0.0005056394,0.0000306587,0.00052003574,0.00004894291,0.0002043084,0.0002111554,0.0007740497,0.9969836,0.000026928115],"about_ca_topic_score_codex":0.014735231,"about_ca_topic_score_gemma":0.018064134,"teacher_disagreement_score":0.03893263,"about_ca_system_score_codex":0.0039701215,"about_ca_system_score_gemma":0.0055896495,"threshold_uncertainty_score":0.13024259},"labels":[],"label_agreement":null},{"id":"W2918993549","doi":"10.1007/s40262-019-00745-5","title":"Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"University of Illinois at Chicago; Ministry of Education, Culture, Sports, Science and Technology; University of Chicago","keywords":"Warfarin; Pharmacodynamics; CYP2C9; Medicine; VKORC1; Internal medicine; Dosing; Population; Pharmacokinetics; Cohort; Creatinine; Demography; Atrial fibrillation","score_opus":0.18952589734530464,"score_gpt":0.48143453915943135,"score_spread":0.2919086418141267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918993549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993285,0.000045371216,0.000102890415,0.00003240473,0.0000030531537,0.0000046893065,0.00006348944,0.0000021056144,0.0004174078],"genre_scores_gemma":[0.9996117,0.000021526133,0.00006547077,0.000026200612,0.000005058096,0.000004945065,0.000085068845,0.0000030797687,0.00017706992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994234,0.00019967552,0.000049885188,0.00013956706,0.00006767539,0.000119856915],"domain_scores_gemma":[0.9993525,0.00019239006,0.00018106532,0.00006354039,0.00008212988,0.00012835192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047428883,0.000272442,0.0003716959,0.00059540477,0.00073500985,0.000693458,0.00028597098,0.0005387412,0.0019790377],"category_scores_gemma":[0.0019290395,0.00018232054,0.0005504807,0.0006499447,0.0004361668,0.00037416286,0.00050529203,0.00060347863,0.0002695971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019328771,0.000255154,0.9880937,0.000007390459,0.00018393573,0.00018649851,0.0008519076,0.000090081805,0.003657139,0.0002681136,0.000101615675,0.004371597],"study_design_scores_gemma":[0.000028739241,0.00023190386,0.99804,0.0000026137786,0.00005629409,0.00022975249,0.0006529077,0.00026489203,0.0002190038,0.000118643315,0.00014891852,0.000006325715],"about_ca_topic_score_codex":0.0062681525,"about_ca_topic_score_gemma":0.004065874,"teacher_disagreement_score":0.0062681525,"about_ca_system_score_codex":0.00027963027,"about_ca_system_score_gemma":0.00020262013,"threshold_uncertainty_score":0.012463331},"labels":[],"label_agreement":null},{"id":"W2944551098","doi":"10.1007/s40262-019-00771-3","title":"Population Pharmacokinetics of Mycophenolic Acid Co-Administered with Tacrolimus in Corticosteroid-Free Adult Kidney Transplant Patients","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"Vancouver Coastal Health Research Institute; F. Hoffmann-La Roche","keywords":"Tacrolimus; Mycophenolic acid; Medicine; Population pharmacokinetics; Pharmacokinetics; Corticosteroid; Pharmacotherapy; Pharmacology; Kidney transplantation; Population; Kidney transplant; Urology; Kidney; Internal medicine; Transplantation","score_opus":0.03083618280051274,"score_gpt":0.36257030260954565,"score_spread":0.3317341198090329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2944551098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99914384,0.00023096189,0.00017733355,0.000032157033,0.000004528133,0.0000061467313,0.00007023802,0.0000095554815,0.0003251523],"genre_scores_gemma":[0.99959975,0.000055828175,0.000069244124,0.000036180525,0.000011529149,0.000004576293,0.00010550558,0.0000030309675,0.00011438234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995826,0.00012812682,0.0000333817,0.00010862311,0.0000746867,0.00007253768],"domain_scores_gemma":[0.99907243,0.0003082508,0.00029192146,0.0000943076,0.0000718002,0.00016131306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047406284,0.00021283742,0.0006238388,0.00022048355,0.00020305705,0.00071071443,0.00016484382,0.0004103831,0.00089703157],"category_scores_gemma":[0.002429024,0.000196163,0.00042074485,0.00031330055,0.00021394732,0.0006544583,0.000258287,0.0007316721,0.00016319091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014626461,0.00063078484,0.9476385,0.00005116871,0.00089130906,0.0010125474,0.00036570532,0.0015966696,0.010457717,0.00035846658,0.00068931014,0.021681368],"study_design_scores_gemma":[0.0001695677,0.0035333973,0.9889809,0.000007491102,0.00025509027,0.0014942951,0.00025347402,0.0033044259,0.0010958649,0.00026859192,0.0006095732,0.000027393058],"about_ca_topic_score_codex":0.0010427317,"about_ca_topic_score_gemma":0.0008411779,"teacher_disagreement_score":0.0010427317,"about_ca_system_score_codex":0.00034848446,"about_ca_system_score_gemma":0.00033681214,"threshold_uncertainty_score":0.0030008554},"labels":[],"label_agreement":null},{"id":"W2963706042","doi":"10.1007/s40262-019-00802-z","title":"Exposure-Toxicity Relationships of Mycophenolic Acid in Adult Kidney Transplant Patients","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Alberta","funders":"","keywords":"Mycophenolic acid; Toxicity; Adverse effect; Medicine; Mycophenolate; Therapeutic drug monitoring; Pharmacology; Transplantation; Internal medicine; Drug","score_opus":0.16312142743651983,"score_gpt":0.4367971145881044,"score_spread":0.2736756871515845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963706042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025376526,0.99951804,0.000041706215,0.000060652215,0.000016932667,0.0000024856615,0.00001482534,0.0000013593933,0.00009032251],"genre_scores_gemma":[0.003034233,0.99652916,0.00013667726,0.00014665947,0.00004996208,0.0000049171754,0.00002513543,6.297718e-7,0.00007262018],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99948525,0.00015608691,0.00014846778,0.00007133291,0.000118923715,0.0000199052],"domain_scores_gemma":[0.99818015,0.0012948693,0.00037305895,0.000018824467,0.00011028317,0.000022867474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011388806,0.00058401667,0.0020887693,0.0013288504,0.00011867498,0.000799781,0.0007569578,0.0008178069,0.0023924182],"category_scores_gemma":[0.0026380771,0.00023281132,0.0021514865,0.0018118627,0.00022941592,0.00061996747,0.00041111693,0.0010971115,0.00025030845],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006471099,0.00010736861,0.0016811852,0.10514282,0.0046430016,0.00014904734,0.00005232667,0.0007468425,0.0007214717,0.00094202784,0.005644777,0.8795221],"study_design_scores_gemma":[0.0014134845,0.0029287266,0.04887834,0.1485116,0.06268578,0.0077313664,0.00041608332,0.0021593221,0.0035944572,0.0074123293,0.7139975,0.00027111854],"about_ca_topic_score_codex":0.0015787903,"about_ca_topic_score_gemma":0.0030833858,"teacher_disagreement_score":0.0023924182,"about_ca_system_score_codex":0.00049382757,"about_ca_system_score_gemma":0.0010250112,"threshold_uncertainty_score":0.008003414},"labels":[],"label_agreement":null},{"id":"W2965773521","doi":"10.1007/s40262-019-00807-8","title":"Clinical Pharmacokinetic and Pharmacodynamic Considerations in Treating Non-Hodgkin Lymphoma","year":2019,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Lymphoma; Medicine; Pharmacodynamics; Pharmacokinetics; Rituximab; Concomitant; Hodgkin lymphoma; Monoclonal antibody; Oncology; Drug; Mantle cell lymphoma; Pharmacology; Internal medicine; Immunology; Antibody","score_opus":0.17407227704052403,"score_gpt":0.5115206867791848,"score_spread":0.3374484097386608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965773521","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000066076704,0.9991073,0.00008941293,0.00023163679,0.00009520109,0.0000042960714,0.000011246849,0.0000051614447,0.0003896167],"genre_scores_gemma":[0.0010016256,0.9977028,0.00024139672,0.0004967491,0.00019887548,0.0000093363415,0.000020638237,0.0000016329933,0.000327096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996526,0.00010067273,0.000083392515,0.000049347447,0.00008998849,0.00002396929],"domain_scores_gemma":[0.9990289,0.00056566915,0.00019749932,0.000017547358,0.00014633534,0.000044007327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010869018,0.0010198258,0.0025388289,0.001961064,0.00018783574,0.0014361748,0.00087091204,0.0013282703,0.0042975447],"category_scores_gemma":[0.0018993304,0.0004102681,0.0008506257,0.0018905777,0.00048624453,0.0014119382,0.0006728336,0.0032172257,0.0011681158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027110032,0.000117354146,0.00016182104,0.03400174,0.00031418153,0.00018148262,0.000047632773,0.0007393176,0.00091640675,0.0018360951,0.02426306,0.9371498],"study_design_scores_gemma":[0.00036923974,0.0005660237,0.0015645066,0.019649254,0.0019056246,0.002177903,0.000085127045,0.00062323146,0.00082114333,0.002942128,0.96923214,0.00006356912],"about_ca_topic_score_codex":0.0010505168,"about_ca_topic_score_gemma":0.0030880282,"teacher_disagreement_score":0.0042975447,"about_ca_system_score_codex":0.00076349557,"about_ca_system_score_gemma":0.0012829859,"threshold_uncertainty_score":0.0143767595},"labels":[],"label_agreement":null},{"id":"W2969690755","doi":"10.1007/s40262-019-00809-6","title":"Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; University of Waterloo","funders":"","keywords":"Covariate; Medicine; Population; Bayesian probability; Pharmacokinetics; NONMEM; Statistics; Oncology; Internal medicine; Mathematics","score_opus":0.10386284929754308,"score_gpt":0.4192405470228734,"score_spread":0.3153776977253303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969690755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53698635,0.004914096,0.3886566,0.0025816313,0.0011656856,0.02084994,0.03217668,0.0030756847,0.009593269],"genre_scores_gemma":[0.817582,0.0022070773,0.12546311,0.0018352284,0.00044150074,0.015430411,0.030248528,0.0012347278,0.0055573457],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9914153,0.006027907,0.00042520463,0.00082967116,0.0010570466,0.00024485303],"domain_scores_gemma":[0.9905821,0.005391778,0.0008487627,0.001441933,0.0015172852,0.00021811776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03585883,0.001829373,0.0027904212,0.0004581884,0.00035783934,0.00229378,0.0025075364,0.0012694539,0.0022688436],"category_scores_gemma":[0.03137319,0.0009436674,0.00538888,0.00042078216,0.00034590668,0.0010168053,0.0010800111,0.00231805,0.0012076636],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12356877,0.004123945,0.09162544,0.0035524496,0.056698777,0.00049507705,0.000540314,0.36007702,0.012877782,0.0044449177,0.049724586,0.2922709],"study_design_scores_gemma":[0.033673942,0.016103469,0.051048797,0.00044506558,0.028631432,0.0006295347,0.000203126,0.7949419,0.023081226,0.006000601,0.04488946,0.00035143815],"about_ca_topic_score_codex":0.005711391,"about_ca_topic_score_gemma":0.0021763172,"teacher_disagreement_score":0.03585883,"about_ca_system_score_codex":0.001611132,"about_ca_system_score_gemma":0.006394592,"threshold_uncertainty_score":0.18964183},"labels":[],"label_agreement":null},{"id":"W2972004072","doi":"10.1007/s40262-019-00817-6","title":"Vancomycin Population Pharmacokinetics in Critically Ill Adults During Sustained Low-Efficiency Dialysis","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ottawa Hospital","funders":"Kidney Foundation of Canada","keywords":"Vancomycin; Dosing; Medicine; Pharmacokinetics; Population; Dialysis; Therapeutic drug monitoring; Pharmacodynamics; Context (archaeology); Renal replacement therapy; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.017857962478946623,"score_gpt":0.36064554506753793,"score_spread":0.3427875825885913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972004072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998938,0.00046442586,0.0002541943,0.000035338344,0.0000042802053,0.000008765451,0.000068896574,0.000010124161,0.0002159649],"genre_scores_gemma":[0.99961436,0.00009782505,0.000095364296,0.00003787412,0.000008489065,0.000006492866,0.00006797852,0.0000026116497,0.00006897821],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99969053,0.000093813214,0.00003068257,0.00006089697,0.00007456039,0.000049491944],"domain_scores_gemma":[0.9990164,0.00033529534,0.00030809685,0.00005350409,0.00010195053,0.00018476497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034901977,0.00021510976,0.0007476955,0.000191974,0.0001804912,0.00084137666,0.00010923523,0.0003417235,0.00041474862],"category_scores_gemma":[0.0029262768,0.00014054362,0.00022330393,0.0002076632,0.00016007746,0.0004254125,0.00022115119,0.0006309325,0.00009235013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02688194,0.00057719206,0.8855122,0.00016016807,0.00046796346,0.0015410316,0.0013875224,0.0028691916,0.035861444,0.0004199348,0.0009373672,0.043384094],"study_design_scores_gemma":[0.00016609409,0.008652517,0.9786824,0.00003393922,0.00016132972,0.0020949647,0.00049678574,0.0045640976,0.003737233,0.00016637644,0.0012132962,0.000030880215],"about_ca_topic_score_codex":0.0013045657,"about_ca_topic_score_gemma":0.0009550123,"teacher_disagreement_score":0.0013045657,"about_ca_system_score_codex":0.00044128258,"about_ca_system_score_gemma":0.0003805611,"threshold_uncertainty_score":0.003201723},"labels":[],"label_agreement":null},{"id":"W2990779432","doi":"10.1007/s40262-019-00832-7","title":"Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Bayer","keywords":"Pharmacokinetics; Medicine; Population; Bay; Volume of distribution; Pharmacology","score_opus":0.14523148684190526,"score_gpt":0.4073626813025908,"score_spread":0.26213119446068556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990779432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84858996,0.0010407888,0.14712287,0.00017694446,0.000009007507,0.00013522612,0.0011498787,0.0004299962,0.0013453236],"genre_scores_gemma":[0.98313683,0.00041217566,0.015432206,0.000044839086,0.000009783389,0.00008535907,0.00055440323,0.000032408654,0.00029204285],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99962986,0.0001416593,0.000016544183,0.00008571815,0.00009996316,0.000026213009],"domain_scores_gemma":[0.9993073,0.0003501135,0.00018153223,0.000074347234,0.0000596371,0.000027048985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010629583,0.00030609217,0.0005718632,0.00023055026,0.00009024863,0.00052982505,0.00024570143,0.00025031297,0.0012816228],"category_scores_gemma":[0.0021782285,0.00018866357,0.0003055924,0.00021927786,0.00019333424,0.00030508352,0.00019802099,0.0006011597,0.00046258242],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036932742,0.0006647497,0.12783132,0.00036422463,0.0006739988,0.00048982206,0.0003251267,0.12659293,0.5582127,0.0025691998,0.0020728873,0.17650981],"study_design_scores_gemma":[0.0005631792,0.0074862936,0.24232931,0.00004713702,0.0008069286,0.0038557625,0.00014836756,0.4808699,0.24414524,0.0036318025,0.016008615,0.000107438624],"about_ca_topic_score_codex":0.00087842694,"about_ca_topic_score_gemma":0.0007727613,"teacher_disagreement_score":0.0012816228,"about_ca_system_score_codex":0.00030181243,"about_ca_system_score_gemma":0.0005417823,"threshold_uncertainty_score":0.0056215525},"labels":[],"label_agreement":null},{"id":"W3004945196","doi":"10.1007/s40262-020-00866-2","title":"An Update on Population Pharmacokinetic Analyses of Vancomycin, Part I: In Adults","year":2020,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Vancomycin; Pharmacokinetics; Dosing; Population; Medicine; Volume of distribution; Intensive care medicine; Pharmacology; Biology","score_opus":0.18300050021748707,"score_gpt":0.5292915664520057,"score_spread":0.34629106623451866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004945196","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000101622085,0.9986368,0.00017939342,0.00032822412,0.00027877864,0.0000065761897,0.00011753715,0.00001234504,0.0003387335],"genre_scores_gemma":[0.00055500236,0.9976895,0.00043779594,0.0005866816,0.0003485484,0.000012220651,0.00016043756,0.0000055580713,0.00020422894],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999081,0.00020623482,0.0003166137,0.00011047411,0.00024998194,0.00003576104],"domain_scores_gemma":[0.99634886,0.0021198785,0.00060699054,0.00006626462,0.0007466824,0.00011129264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021189032,0.0011159489,0.0027454738,0.0028918406,0.00015822245,0.0014821895,0.0012226362,0.0013022238,0.0033361935],"category_scores_gemma":[0.0059213894,0.00040204765,0.0021343671,0.0032335417,0.0003874534,0.0015512819,0.0006109876,0.0021154336,0.0013650599],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024109759,0.000071124574,0.00046607925,0.040496502,0.00054239255,0.00012572593,0.000041384563,0.00031802265,0.0009590373,0.00084708876,0.07030285,0.8855887],"study_design_scores_gemma":[0.00019755431,0.00035567812,0.0039974586,0.026359826,0.002530204,0.0017079611,0.000060463695,0.00029427843,0.0006799001,0.0010777225,0.9626662,0.00007271305],"about_ca_topic_score_codex":0.0027863998,"about_ca_topic_score_gemma":0.004762768,"teacher_disagreement_score":0.0033361935,"about_ca_system_score_codex":0.0008342342,"about_ca_system_score_gemma":0.002530949,"threshold_uncertainty_score":0.011205971},"labels":[],"label_agreement":null},{"id":"W3016616745","doi":"10.1007/s40262-020-00888-w","title":"Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor","year":2020,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Astellas Pharma","keywords":"Pharmacokinetics; Pharmacology; Chemistry; Medicine","score_opus":0.11511771043150763,"score_gpt":0.4183749330103149,"score_spread":0.3032572225788073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016616745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915902,0.004511319,0.0024185078,0.00019175674,0.000020859181,0.00006198357,0.0002457422,0.00014090432,0.00081884157],"genre_scores_gemma":[0.99701524,0.0008533873,0.001164596,0.00007909756,0.000035369758,0.000022810835,0.0003386014,0.000012659316,0.00047821295],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99983454,0.00004589885,0.000011184992,0.000037702397,0.00005476284,0.00001589241],"domain_scores_gemma":[0.99985456,0.000026783362,0.00006475128,0.0000075949906,0.000019483194,0.00002687768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031842216,0.00021858694,0.0004380579,0.00017429852,0.00014600715,0.00029605164,0.00011318644,0.0002526589,0.00092457054],"category_scores_gemma":[0.00041846244,0.00007274728,0.00024284194,0.00014121893,0.0001484572,0.00021153271,0.00009758876,0.00031395568,0.00027055008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012040799,0.0007347498,0.030272814,0.00055753894,0.00037870568,0.0011136284,0.00020475971,0.0038586867,0.79373807,0.00013455302,0.0019535767,0.15501215],"study_design_scores_gemma":[0.0034684187,0.06701865,0.38311005,0.000089154506,0.0016085145,0.026261888,0.00015055465,0.025269534,0.45765588,0.00025922773,0.034981396,0.00012679363],"about_ca_topic_score_codex":0.0006065449,"about_ca_topic_score_gemma":0.0008402967,"teacher_disagreement_score":0.00092457054,"about_ca_system_score_codex":0.00043400718,"about_ca_system_score_gemma":0.00031161838,"threshold_uncertainty_score":0.003148973},"labels":[],"label_agreement":null},{"id":"W3027472977","doi":"10.1007/s40262-020-00905-y","title":"Comment on: “An Extension of Janmahasatian’s Fat-Free Mass Model for Universal Application Across Populations of Different Ethnicities”","year":2020,"lang":"en","type":"letter","venue":"Clinical Pharmacokinetics","topic":"Body Composition Measurement Techniques","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Extension (predicate logic); Fat free mass; Ethnic group; Mathematics; Computer science; Sociology; Fat mass; Medicine; Anthropology; Body mass index; Programming language; Internal medicine","score_opus":0.23582571544418485,"score_gpt":0.45361702611239585,"score_spread":0.217791310668211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027472977","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004103806,0.00045737514,0.00021837873,0.9805551,0.017017575,0.000021562973,0.00019335332,0.00003130929,0.001094962],"genre_scores_gemma":[0.0009723626,0.00015605285,0.00015548612,0.9875236,0.008787732,0.000041023522,0.000024571511,0.000014447601,0.0023246917],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9912958,0.0023231232,0.0013647028,0.0014993369,0.001984657,0.0015323785],"domain_scores_gemma":[0.9763365,0.0153800445,0.0016632997,0.00058043207,0.0036578164,0.0023819192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011908944,0.0016817669,0.00284755,0.0011577421,0.007191687,0.004951997,0.004128587,0.10477324,0.0066385847],"category_scores_gemma":[0.05244646,0.0019476884,0.0034425918,0.0013647239,0.0045635807,0.004164664,0.003375626,0.07818624,0.007932375],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010038082,0.000028724584,0.00095079816,0.00004600277,0.000036119283,0.00069538434,0.0002231436,0.00014114431,0.00011247148,0.0029701479,0.9911028,0.003592925],"study_design_scores_gemma":[0.0003618348,0.00014208518,0.0048454003,0.0008001829,0.00018142616,0.0012291607,0.0010043029,0.0019314813,0.0005546009,0.016326074,0.97236294,0.00026062084],"about_ca_topic_score_codex":0.052463274,"about_ca_topic_score_gemma":0.066262215,"teacher_disagreement_score":0.10477324,"about_ca_system_score_codex":0.008112917,"about_ca_system_score_gemma":0.010525197,"threshold_uncertainty_score":0.10431576},"labels":[],"label_agreement":null},{"id":"W3028663891","doi":"10.1007/s40262-020-00898-8","title":"Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors: An Updated Review","year":2020,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Dolutegravir; Raltegravir; Pharmacology; Elvitegravir; Pharmacokinetics; Pharmacodynamics; Integrase; Integrase inhibitor; Medicine; Virology; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy","score_opus":0.15606513772846373,"score_gpt":0.4919753380905803,"score_spread":0.3359102003621166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028663891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019832182,0.99880874,0.00012983261,0.00022078912,0.0001387907,0.000007788174,0.000041213938,0.000006720546,0.00044787],"genre_scores_gemma":[0.0010971915,0.99773896,0.00026008056,0.0002821802,0.00020286198,0.000012719543,0.000092816415,0.0000032079386,0.00031002043],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995715,0.00009081466,0.00010629215,0.00007527005,0.00013318995,0.00002287063],"domain_scores_gemma":[0.9988263,0.00065182074,0.00017734247,0.000023751976,0.00028202473,0.000038767546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012915843,0.00076860335,0.0021079327,0.0021732326,0.0001576586,0.001406294,0.0010086697,0.0010336787,0.0036804632],"category_scores_gemma":[0.0019410149,0.00035328363,0.0012960489,0.0023607844,0.0003205063,0.0014308364,0.00041655306,0.0014938526,0.0012422026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026593223,0.00009586589,0.00030139936,0.026206404,0.00032584067,0.00011880087,0.000045232307,0.00028990905,0.001079922,0.0011718384,0.023939418,0.9461594],"study_design_scores_gemma":[0.00018913543,0.00052416004,0.002957185,0.014939174,0.0018354945,0.0022909408,0.00009549853,0.00038930133,0.0010694996,0.0016076734,0.97402984,0.00007225614],"about_ca_topic_score_codex":0.0011117492,"about_ca_topic_score_gemma":0.0013234674,"teacher_disagreement_score":0.0036804632,"about_ca_system_score_codex":0.0005712362,"about_ca_system_score_gemma":0.0013030022,"threshold_uncertainty_score":0.012312412},"labels":[],"label_agreement":null},{"id":"W3124028658","doi":"10.1007/s40262-020-00970-3","title":"Antibiotics in Adult Cystic Fibrosis Patients: A Review of Population Pharmacokinetic Analyses","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Université de Montréal","keywords":"Pharmacokinetics; Medicine; Cystic fibrosis; Antibiotics; Volume of distribution; Population; Linezolid; Internal medicine; Therapeutic drug monitoring; Pharmacology; Vancomycin; Biology; Microbiology","score_opus":0.14510540710034442,"score_gpt":0.5453029225007553,"score_spread":0.4001975154004109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3124028658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008266847,0.999564,0.00010653145,0.00011366362,0.00003080519,0.0000033027452,0.000022799051,0.0000033684032,0.000072785726],"genre_scores_gemma":[0.0007288657,0.9986314,0.00031443575,0.00015932352,0.00009068601,0.000007090921,0.000027450995,0.0000015703288,0.00003896386],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9990588,0.00020743266,0.0003094554,0.00017535845,0.00021946542,0.000029545272],"domain_scores_gemma":[0.9952043,0.0034133643,0.0007480857,0.00007329411,0.00047940164,0.00008152233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023497462,0.0011272158,0.004319394,0.0030089824,0.0001843091,0.0013670472,0.0011994222,0.0011849835,0.0018099749],"category_scores_gemma":[0.00545511,0.0005126462,0.0024591452,0.003171564,0.00048637867,0.0017517271,0.00069728243,0.0019513534,0.00041762835],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042191244,0.0001023681,0.0012085827,0.058976024,0.001372973,0.00014496809,0.00005290627,0.00064935966,0.0006464078,0.0010998598,0.009570377,0.9257543],"study_design_scores_gemma":[0.00072618475,0.0017591345,0.020908676,0.106714614,0.018272284,0.007068597,0.00028013423,0.002142669,0.0023239995,0.0069985385,0.83246034,0.0003448693],"about_ca_topic_score_codex":0.0014616742,"about_ca_topic_score_gemma":0.0029315017,"teacher_disagreement_score":0.004319394,"about_ca_system_score_codex":0.0007029913,"about_ca_system_score_gemma":0.002071829,"threshold_uncertainty_score":0.012426794},"labels":[],"label_agreement":null},{"id":"W3132426811","doi":"10.1007/s40262-020-00956-1","title":"Evaluation of the Pharmacokinetics and Exposure–Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; University of British Columbia","funders":"Universitair Medisch Centrum Groningen; Novo Nordisk Fonden; AstraZeneca","keywords":"Dapagliflozin; Renal function; Medicine; Kidney disease; Diabetes mellitus; Urology; Pharmacokinetics; Confidence interval; Internal medicine; Type 2 diabetes; Proteinuria; Creatinine; Volume of distribution; Endocrinology; Kidney","score_opus":0.052089754498444794,"score_gpt":0.36596830066246133,"score_spread":0.31387854616401656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132426811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975744,0.00074848114,0.0011245728,0.000051032603,0.0000062167182,0.000047026086,0.00016441729,0.000010848137,0.0002730262],"genre_scores_gemma":[0.9990275,0.000108125634,0.0005138644,0.00004175621,0.000008925428,0.00003436109,0.00019080548,0.0000025877307,0.00007201655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975775,0.0013787661,0.00021016166,0.00045241747,0.0002641438,0.00011706687],"domain_scores_gemma":[0.9930025,0.0050694793,0.0010595358,0.00041184147,0.00020182927,0.0002547568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049379524,0.0003640453,0.0015023607,0.00031460138,0.00016578741,0.00062092097,0.00030845538,0.000644222,0.00086390995],"category_scores_gemma":[0.011858758,0.00033633306,0.0012475752,0.00043739445,0.00026833007,0.0006216348,0.00035005846,0.0006861358,0.00010913767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10445583,0.0015672719,0.8329727,0.00039161736,0.003979288,0.0003976312,0.00042859497,0.009589742,0.0068943193,0.00024813358,0.00037993345,0.038694948],"study_design_scores_gemma":[0.0038757718,0.025732862,0.90911436,0.000039602488,0.0022142034,0.0009831475,0.00016307301,0.05368804,0.0022749691,0.0005914887,0.0012639423,0.000058555255],"about_ca_topic_score_codex":0.0009943444,"about_ca_topic_score_gemma":0.000717973,"teacher_disagreement_score":0.0049379524,"about_ca_system_score_codex":0.00057425996,"about_ca_system_score_gemma":0.00047936922,"threshold_uncertainty_score":0.026114643},"labels":[],"label_agreement":null},{"id":"W3133740787","doi":"10.1007/s40262-020-00983-y","title":"The Effect of Renal Impairment on the Pharmacokinetics and Safety of Talazoparib in Patients with Advanced Solid Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McGill University; Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; Pfizer","keywords":"Medicine; Tolerability; Renal function; Pharmacokinetics; Cmax; Urology; Dosing; Adverse effect; Internal medicine; Kidney disease","score_opus":0.01753290672712802,"score_gpt":0.3691539646569015,"score_spread":0.35162105792977344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133740787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970402,0.0020400363,0.00019623907,0.000081119404,0.0000070500987,0.000023195838,0.000052364838,0.000005794471,0.00055398775],"genre_scores_gemma":[0.99912626,0.000493493,0.00010697061,0.000077975295,0.000016855782,0.000008113689,0.00004579745,9.784555e-7,0.00012349873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995994,0.00018665534,0.000035256715,0.000035104626,0.0000836743,0.000059968257],"domain_scores_gemma":[0.9991697,0.00031256716,0.00030259302,0.00003178273,0.00004736435,0.00013598776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086351525,0.00023891545,0.00065075234,0.00014149417,0.00018884409,0.0003644575,0.00010800939,0.00017664625,0.0008326811],"category_scores_gemma":[0.0012559772,0.00009080829,0.00039767608,0.000210451,0.00027870375,0.00027091068,0.00021700331,0.00047934474,0.00010696322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07898168,0.0030981482,0.6173544,0.0008427709,0.0011736326,0.0018565146,0.00032372941,0.005905996,0.109566845,0.00033884955,0.0012100145,0.17934743],"study_design_scores_gemma":[0.0020566708,0.052457646,0.92381686,0.000042729174,0.00052953203,0.0023276568,0.00011189979,0.0030853667,0.011693829,0.00019456241,0.0036549997,0.000028290107],"about_ca_topic_score_codex":0.0004993553,"about_ca_topic_score_gemma":0.0010026696,"teacher_disagreement_score":0.00086351525,"about_ca_system_score_codex":0.0003105039,"about_ca_system_score_gemma":0.0003348677,"threshold_uncertainty_score":0.0045667887},"labels":[],"label_agreement":null},{"id":"W3152798658","doi":"10.1007/s40262-021-01013-1","title":"Piperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Université de Montréal","keywords":"Piperacillin; Piperacillin/tazobactam; Medicine; Tazobactam; Volume of distribution; Population; Intensive care unit; Dosing; Intensive care medicine; Pharmacokinetics; Intensive care; Pharmacology; Biology","score_opus":0.34170525116520595,"score_gpt":0.5795854406689658,"score_spread":0.23788018950375983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3152798658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007362442,0.9996654,0.000076252916,0.0000751673,0.000022916467,0.000005659655,0.000018927454,0.0000023543348,0.00005967116],"genre_scores_gemma":[0.0006984993,0.99880767,0.00026596917,0.00011735082,0.000044798184,0.000009484785,0.000022639331,0.0000013231784,0.00003214195],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99868804,0.0003317556,0.00043848748,0.00020573771,0.00029508054,0.000040890103],"domain_scores_gemma":[0.99532014,0.0032473195,0.0008024593,0.00007029394,0.00048799295,0.00007177379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032754103,0.0012982201,0.0050984467,0.0037701423,0.00019951518,0.0017467794,0.0016362063,0.0013951575,0.0027480442],"category_scores_gemma":[0.0066024167,0.00065162615,0.0031205174,0.004106408,0.0005124442,0.0019445784,0.00088283845,0.0018862034,0.0004591378],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045675048,0.00011561011,0.0006135609,0.16457342,0.0024639443,0.00015339635,0.0000681076,0.0007434374,0.00081476656,0.0012952388,0.0078977235,0.82080394],"study_design_scores_gemma":[0.0009943545,0.0020056346,0.014429007,0.22459169,0.032699984,0.0052159764,0.00033178405,0.0019899583,0.0021848904,0.0052088704,0.710007,0.0003408153],"about_ca_topic_score_codex":0.0018458008,"about_ca_topic_score_gemma":0.0038644553,"teacher_disagreement_score":0.0050984467,"about_ca_system_score_codex":0.0009038816,"about_ca_system_score_gemma":0.002865195,"threshold_uncertainty_score":0.017322242},"labels":[],"label_agreement":null},{"id":"W3157642871","doi":"10.1007/s40262-021-01016-y","title":"Pharmacokinetics of Selinexor: The First-in-Class Selective Inhibitor of Nuclear Export","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Nuclear Structure and Function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pharmacokinetics; Nuclear export signal; Pharmacology; Population; Concomitant; Cancer research; Volume of distribution; Biology; Medicine; Internal medicine; Cytoplasm; Cell nucleus; Cell biology","score_opus":0.04763893100028567,"score_gpt":0.38458304286342015,"score_spread":0.3369441118631345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157642871","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006947117,0.996082,0.00064821687,0.0006794395,0.00019588544,0.000015341808,0.000112564376,0.00003412433,0.001537741],"genre_scores_gemma":[0.0043149753,0.9921686,0.0006964183,0.00069901894,0.0002169595,0.00003142707,0.0002149886,0.000010815023,0.0016467196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998764,0.000031088715,0.000016036971,0.000021499824,0.000041344294,0.000013559912],"domain_scores_gemma":[0.99971455,0.00014316246,0.000051888343,0.0000073360256,0.000049464015,0.000033659737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062367326,0.0009754866,0.0017518931,0.0007252593,0.00012908292,0.00089936284,0.00083458994,0.00076435757,0.002667599],"category_scores_gemma":[0.000777685,0.00024121923,0.00056188187,0.0008203631,0.00036181073,0.00078714476,0.00031529108,0.002604976,0.0017045408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069939706,0.00018268125,0.00022828471,0.0058959746,0.00018235177,0.00019140814,0.000030417907,0.0010981989,0.0035095864,0.0024649096,0.034882043,0.9506347],"study_design_scores_gemma":[0.0007823868,0.0012628529,0.0019572761,0.0021253193,0.00044923852,0.0026764646,0.000038411064,0.00074898195,0.0031477194,0.002345121,0.9844109,0.000055432647],"about_ca_topic_score_codex":0.00064888416,"about_ca_topic_score_gemma":0.0015552271,"teacher_disagreement_score":0.002667599,"about_ca_system_score_codex":0.00066341145,"about_ca_system_score_gemma":0.0006188284,"threshold_uncertainty_score":0.008924007},"labels":[],"label_agreement":null},{"id":"W3161390137","doi":"10.1007/s40262-021-01027-9","title":"Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Dosing; Vancomycin; Observational study; Population; Renal function; Creatinine; MEDLINE; Pharmacokinetics; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.09495922480879287,"score_gpt":0.4483391402349466,"score_spread":0.3533799154261537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161390137","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007227083,0.9981188,0.0005453154,0.00010579609,0.000037978145,0.00006859085,0.00027644832,0.000011130884,0.0001131869],"genre_scores_gemma":[0.014125429,0.98408014,0.0011617716,0.00018273127,0.00004099119,0.00011584618,0.00021793492,0.000007238964,0.00006795272],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965869,0.0016181082,0.0009096817,0.00035729568,0.00046013022,0.000067885645],"domain_scores_gemma":[0.9807941,0.016022211,0.0021474964,0.00024948685,0.00068027596,0.00010648762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005876437,0.0021258288,0.009032773,0.0038490142,0.00020801554,0.0024103285,0.0025397337,0.0018211978,0.005115401],"category_scores_gemma":[0.02437681,0.0012216775,0.013554312,0.0044703977,0.0003759307,0.0019428781,0.00087406405,0.0019149245,0.00057795015],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008968788,0.000080921025,0.0024999706,0.7759823,0.09532568,0.00023397215,0.00015419773,0.0041978173,0.00021003414,0.0012340295,0.0037049549,0.115479216],"study_design_scores_gemma":[0.0016471122,0.0007917399,0.011474778,0.3463056,0.5838719,0.0010247655,0.00028102027,0.0036846905,0.00029547504,0.003715386,0.04671221,0.0001952413],"about_ca_topic_score_codex":0.007360733,"about_ca_topic_score_gemma":0.014691081,"teacher_disagreement_score":0.009032773,"about_ca_system_score_codex":0.0019136646,"about_ca_system_score_gemma":0.004808534,"threshold_uncertainty_score":0.031077921},"labels":[],"label_agreement":null},{"id":"W3164015288","doi":"10.1007/s40262-021-01034-w","title":"Thoroughly Validated Bayesian Estimator and Limited Sampling Strategy for Dose Individualization of Ganciclovir and Valganciclovir in Pediatric Transplant Recipients","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Valganciclovir; Ganciclovir; Statistics; Standard deviation; Estimator; Medicine; Mean squared error; Sampling (signal processing); Bayesian probability; Standard error; Internal medicine; Mathematics; Computer science","score_opus":0.1594833193919147,"score_gpt":0.45629053761875865,"score_spread":0.29680721822684397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164015288","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036550008,0.00040276907,0.96142024,0.00023750734,0.000023223094,0.00016044333,0.00018929453,0.00022895225,0.00078758283],"genre_scores_gemma":[0.5501285,0.00049508794,0.44528154,0.00034724784,0.00007103294,0.0005436578,0.0009748015,0.00012513946,0.0020330832],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99472964,0.0040989625,0.00017056362,0.00043603822,0.00040810124,0.00015669121],"domain_scores_gemma":[0.97704417,0.01935191,0.0009117267,0.0011447672,0.0012650153,0.00028238507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013198176,0.0005863355,0.0013295156,0.00069251924,0.0004062312,0.00095395156,0.0015386583,0.0011431708,0.0020779625],"category_scores_gemma":[0.045710195,0.0006861685,0.00097492436,0.0005457966,0.00062999123,0.0011378033,0.0010719064,0.0016891476,0.00035950897],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014442644,0.00031139262,0.015342442,0.00030744416,0.00057637267,0.00026646853,0.00024347268,0.7318755,0.005391076,0.043850064,0.0027184987,0.197673],"study_design_scores_gemma":[0.00010605251,0.00011838857,0.0022713798,0.000040619223,0.00007768741,0.00010582549,0.000016809268,0.9858004,0.0013735024,0.009163876,0.0009039915,0.000021540347],"about_ca_topic_score_codex":0.004853581,"about_ca_topic_score_gemma":0.0039659548,"teacher_disagreement_score":0.013198176,"about_ca_system_score_codex":0.00076738745,"about_ca_system_score_gemma":0.0026816118,"threshold_uncertainty_score":0.06979948},"labels":[],"label_agreement":null},{"id":"W3171593200","doi":"10.1007/s40262-021-01047-5","title":"Exposures of Phenylacetic Acid and Phenylacetylglutamine Across Different Subpopulations and Correlation with Adverse Events","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Phenylacetic acid; Medicine; Adverse effect; Urea cycle; Internal medicine; Hepatic encephalopathy; Gastroenterology; Pharmacokinetics; Encephalopathy; Pharmacology; Renal function; Hyperammonemia; Fractional excretion of sodium; Endocrinology; Cirrhosis; Chemistry; Arginine","score_opus":0.03546143010461324,"score_gpt":0.3685889158129184,"score_spread":0.3331274857083052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171593200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971938,0.0013551657,0.00048078256,0.000022836603,0.0000027062054,0.00002977753,0.00035990737,0.000008256928,0.0005466529],"genre_scores_gemma":[0.99918526,0.00020208418,0.00018417531,0.000015747288,0.000004087589,0.00001696407,0.00032139436,0.000002067871,0.0000682173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927336,0.00022141129,0.000119742734,0.00017183757,0.0001580785,0.000055567347],"domain_scores_gemma":[0.99546117,0.0014285283,0.0021774606,0.00024117799,0.0004916339,0.00019997523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017186882,0.00018006818,0.00037337324,0.000519755,0.00012967114,0.00040815945,0.0001672051,0.00021555301,0.00076252344],"category_scores_gemma":[0.0033328908,0.00009506082,0.0005145317,0.00054905744,0.00019050103,0.00024508563,0.0002605474,0.0002692321,0.00008533332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018436825,0.000034624576,0.985458,0.00006082008,0.00049634493,0.00018815229,0.000049164344,0.00035950783,0.004474058,0.000030820414,0.0000627284,0.0069420612],"study_design_scores_gemma":[0.00001768548,0.0010573493,0.9957306,0.0000070765022,0.00022301186,0.0007427744,0.00005687944,0.00034857405,0.0014082396,0.000049974013,0.0003527719,0.000005051395],"about_ca_topic_score_codex":0.00045098143,"about_ca_topic_score_gemma":0.00046827045,"teacher_disagreement_score":0.0017186882,"about_ca_system_score_codex":0.00021903694,"about_ca_system_score_gemma":0.00019927145,"threshold_uncertainty_score":0.00908941},"labels":[],"label_agreement":null},{"id":"W3174954811","doi":"10.1007/s40262-021-01046-6","title":"Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Minority Health and Health Disparities; National Institute of Allergy and Infectious Diseases; National Institute on Alcohol Abuse and Alcoholism; U.S. Food and Drug Administration; National Institute of General Medical Sciences; American Foundation for Pharmaceutical Education","keywords":"Meropenem; Physiologically based pharmacokinetic modelling; Dosing; Pharmacokinetics; Medicine; Population; Pharmacology; Antibiotics; Biology; Microbiology","score_opus":0.08503266443552253,"score_gpt":0.4117128196927645,"score_spread":0.326680155257242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174954811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7852936,0.0067112083,0.18873794,0.0016624131,0.000116374606,0.00015005715,0.00093534554,0.00029881045,0.016094232],"genre_scores_gemma":[0.989627,0.001566159,0.0042529944,0.00013354566,0.00003369117,0.00011330059,0.00019204203,0.000032664382,0.004048448],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999835,0.000065456305,0.0000074584646,0.000027475719,0.000037316368,0.000027227241],"domain_scores_gemma":[0.9996544,0.00023111362,0.000044327586,0.000008037899,0.000046092562,0.00001594684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040354792,0.0004164758,0.0007645349,0.00021771126,0.00019941533,0.0008740599,0.00070452987,0.0009674739,0.00078939943],"category_scores_gemma":[0.0016025527,0.0002724215,0.0007275458,0.00020859948,0.00024541252,0.00039169006,0.0003379459,0.00068552373,0.000245538],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027533693,0.000065838554,0.0023090416,0.00009959517,0.0000616368,0.00035991418,0.00008773097,0.97590077,0.007907867,0.0035706253,0.00051014073,0.008851422],"study_design_scores_gemma":[0.000021576045,0.00011583874,0.0012296323,0.000010057878,0.000025876643,0.00014494723,0.000023606877,0.9957787,0.001050436,0.0009599684,0.000627064,0.0000122193205],"about_ca_topic_score_codex":0.008951701,"about_ca_topic_score_gemma":0.0026033795,"teacher_disagreement_score":0.008951701,"about_ca_system_score_codex":0.0007035596,"about_ca_system_score_gemma":0.0010904886,"threshold_uncertainty_score":0.017799199},"labels":[],"label_agreement":null},{"id":"W3203265145","doi":"10.1007/s40262-021-01072-4","title":"Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic Modeling","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Institute of Child Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development; University of North Carolina at Chapel Hill; Duke Clinical Research Institute; National Institute of General Medical Sciences; Penn State College of Medicine; Wichita Medical Research and Education Foundation; Texas Christian University; American Foundation for Pharmaceutical Education; Pennsylvania State University; University of Louisville; Health Science Center, University of North Texas; University of Pennsylvania; Children's Hospital of Philadelphia","keywords":"Pharmacokinetics; Population; Dosing; Clindamycin; Medicine; Obesity; Volume of distribution; Trimethoprim; Pharmacology; Sulfamethoxazole; Internal medicine; Antibiotics; Chemistry; Environmental health","score_opus":0.12479444056124293,"score_gpt":0.4197282748783461,"score_spread":0.2949338343171031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203265145","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7457374,0.00013749853,0.2455842,0.0004951356,0.00007885303,0.0012854604,0.0017256058,0.00071001716,0.004245816],"genre_scores_gemma":[0.83830494,0.00015430641,0.15711746,0.0001578017,0.00002160629,0.001430876,0.0020339738,0.00005629443,0.00072279526],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988469,0.0006875073,0.00006413772,0.0001581802,0.00017328301,0.000070015805],"domain_scores_gemma":[0.99566,0.0025892504,0.00044652494,0.0003132318,0.00076079374,0.00023017853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037844595,0.0005695473,0.0005464536,0.0006014666,0.00041822437,0.0008169058,0.0012763081,0.00063074613,0.0018788904],"category_scores_gemma":[0.01011557,0.00038455613,0.0010060248,0.0003486448,0.0004195165,0.000675667,0.0011779924,0.0008883702,0.00029895292],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010222929,0.0011742603,0.093054555,0.00017535264,0.00028132577,0.00043313898,0.00045010733,0.82358366,0.004383227,0.00586297,0.0026515706,0.066927634],"study_design_scores_gemma":[0.00020836685,0.0010166878,0.009584495,0.000038134556,0.00007358386,0.00018805946,0.00020485079,0.9813602,0.0023890992,0.0018085235,0.0030939174,0.000034199933],"about_ca_topic_score_codex":0.008547821,"about_ca_topic_score_gemma":0.005920179,"teacher_disagreement_score":0.008547821,"about_ca_system_score_codex":0.0011781702,"about_ca_system_score_gemma":0.0023530438,"threshold_uncertainty_score":0.020014405},"labels":[],"label_agreement":null},{"id":"W3205056750","doi":"10.1007/s40262-021-01050-w","title":"An Update on Population Pharmacokinetic Analyses of Vancomycin, Part II: In Pediatric Patients","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada","keywords":"Vancomycin; Pharmacokinetics; Medicine; Population; Volume of distribution; Therapeutic drug monitoring; Renal function; Interquartile range; Intensive care medicine; Internal medicine; Biology","score_opus":0.1711546406325141,"score_gpt":0.520506627416482,"score_spread":0.34935198678396795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205056750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014906799,0.9985863,0.0001998543,0.00034790667,0.00024249993,0.000006785406,0.00011644398,0.000012266237,0.0003388644],"genre_scores_gemma":[0.00072102284,0.9975038,0.0005425022,0.0005503726,0.00030694553,0.000012804628,0.00016354946,0.000006040684,0.00019291083],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99913067,0.0002009817,0.00028695964,0.00010864299,0.00023525774,0.000037521924],"domain_scores_gemma":[0.9963354,0.002092099,0.0006032446,0.00006809439,0.0007904412,0.00011074504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019276307,0.0010342692,0.0025216942,0.0027422626,0.00015208624,0.0014347156,0.0011512598,0.001188751,0.0024446284],"category_scores_gemma":[0.005244217,0.00038899653,0.0019173586,0.0030392262,0.00036433936,0.0014421475,0.0005726031,0.0021016642,0.001089687],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020813938,0.00007949211,0.0006620247,0.034814853,0.00048806675,0.00014574951,0.000047110632,0.00037359333,0.0010612891,0.0008157846,0.057232108,0.904072],"study_design_scores_gemma":[0.0001713614,0.00041940386,0.005556313,0.026954435,0.0023955284,0.002369067,0.00007611437,0.00034786784,0.0010477011,0.0010163076,0.959568,0.00007792903],"about_ca_topic_score_codex":0.0023810237,"about_ca_topic_score_gemma":0.0040492867,"teacher_disagreement_score":0.0027422626,"about_ca_system_score_codex":0.0007608428,"about_ca_system_score_gemma":0.0025379332,"threshold_uncertainty_score":0.010194421},"labels":[],"label_agreement":null},{"id":"W3213170615","doi":"10.1007/s40262-021-01075-1","title":"Population Pharmacokinetic Analysis to Assist Dose Selection of the l-Ornithine Salt of Phenylacetic Acid","year":2021,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Phenylacetic acid; Hepatic encephalopathy; Population; Medicine; Pharmacokinetics; Cirrhosis; Pharmacology; Gastroenterology; Internal medicine; Endocrinology; Chemistry; Biochemistry","score_opus":0.022781168796576056,"score_gpt":0.36372316424518,"score_spread":0.34094199544860393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213170615","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24426167,0.00049647305,0.7476847,0.00085415423,0.000037386777,0.00047581934,0.0010036696,0.0012395161,0.00394661],"genre_scores_gemma":[0.9013526,0.00026477367,0.09470262,0.00028310495,0.000021835873,0.00044836084,0.000768193,0.00010701926,0.0020515067],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9992692,0.00050459296,0.000025202138,0.00009236688,0.00007218788,0.000036400677],"domain_scores_gemma":[0.9977418,0.0016479624,0.00024943292,0.00010505158,0.00020334002,0.00005240698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020968146,0.0005584704,0.0008733752,0.00040333273,0.00019518424,0.0007031511,0.00069785985,0.0005597904,0.0027571581],"category_scores_gemma":[0.0054002833,0.00041386217,0.0009471046,0.00032175754,0.00015350764,0.0004146755,0.0003873367,0.000831697,0.00037885038],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005587001,0.00013635297,0.0133705335,0.00006316575,0.00033291234,0.00014467764,0.000061509934,0.95180106,0.002357629,0.002074048,0.0011620827,0.027937325],"study_design_scores_gemma":[0.00007284241,0.00024664582,0.0024540287,0.000009701276,0.0000733739,0.000059663762,0.00001012143,0.9939814,0.00064590556,0.00130534,0.0011281413,0.000012829693],"about_ca_topic_score_codex":0.005986374,"about_ca_topic_score_gemma":0.0038676285,"teacher_disagreement_score":0.005986374,"about_ca_system_score_codex":0.0008462786,"about_ca_system_score_gemma":0.0018789816,"threshold_uncertainty_score":0.011903048},"labels":[],"label_agreement":null},{"id":"W3214830958","doi":"10.1007/s40262-021-01085-z","title":"Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development","keywords":"Pharmacokinetics; Renal replacement therapy; Medicine; Current (fluid); Intensive care medicine; Pharmacology; Engineering","score_opus":0.09726544620092836,"score_gpt":0.47280531129273345,"score_spread":0.3755398650918051,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214830958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006351443,0.9990095,0.000034422035,0.000052748568,0.000022602891,0.00002297375,0.00016241134,0.0000020441744,0.00005811076],"genre_scores_gemma":[0.007216444,0.9921245,0.0002927177,0.00018229816,0.000030608797,0.000036380403,0.00009197043,0.0000014897839,0.000023520024],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969598,0.00056022825,0.0014894779,0.00035271715,0.0005425214,0.00009527636],"domain_scores_gemma":[0.98691726,0.008932078,0.0032454072,0.00011273054,0.00065102684,0.00014147238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028552264,0.0009853758,0.0056150793,0.005746319,0.00031439777,0.001897062,0.0011859067,0.0014239373,0.0028581617],"category_scores_gemma":[0.013635796,0.0006989817,0.0067576137,0.007238248,0.0005949904,0.0015486866,0.0009856556,0.0011981055,0.00016317662],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034820134,0.00003444781,0.0029869326,0.92294985,0.01279019,0.00014519233,0.00017533558,0.0001523509,0.000229393,0.0001767605,0.0016117918,0.058399502],"study_design_scores_gemma":[0.0004905963,0.00035963615,0.025269413,0.7705599,0.16072623,0.0014655184,0.000525914,0.00019320726,0.0003186154,0.00037784342,0.03960275,0.00011034402],"about_ca_topic_score_codex":0.0077884956,"about_ca_topic_score_gemma":0.02374123,"teacher_disagreement_score":0.0077884956,"about_ca_system_score_codex":0.0015551836,"about_ca_system_score_gemma":0.004887075,"threshold_uncertainty_score":0.01548636},"labels":[],"label_agreement":null},{"id":"W325467568","doi":"10.2165/00003088-200039040-00007","title":"The Authors?? Reply","year":2000,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Case Reports on Hematomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacotherapy; Intensive care medicine; Medicine; Internal medicine","score_opus":0.06736476604610528,"score_gpt":0.4457189541299193,"score_spread":0.37835418808381405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W325467568","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034303786,0.0012445669,0.00008506124,0.9541148,0.042814918,0.000011271594,0.000032511685,0.000022438166,0.0013314823],"genre_scores_gemma":[0.0033546553,0.0007058197,0.00014373155,0.95788705,0.032257244,0.000028345505,0.000015730257,0.000017438195,0.005590007],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969825,0.0007169064,0.0005012724,0.0005620723,0.0007954464,0.00044168587],"domain_scores_gemma":[0.98412585,0.0064640823,0.0014084022,0.00090215873,0.0050168494,0.0020827076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037794327,0.00071451336,0.0015680948,0.0012202977,0.003053016,0.0037294484,0.0030742032,0.0574472,0.012362818],"category_scores_gemma":[0.03538354,0.0009221683,0.0012462527,0.00084059656,0.0033239613,0.004487341,0.0024296006,0.045978397,0.007827179],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052406387,0.000023748942,0.001067821,0.00006535604,0.000034003217,0.0021583545,0.00018304156,0.00003504494,0.00013326401,0.001921203,0.98972255,0.0046032574],"study_design_scores_gemma":[0.00008467072,0.000051642503,0.0014894658,0.0002738574,0.00006497882,0.003320082,0.0012927296,0.00021035435,0.00032129703,0.004282684,0.9884862,0.000122025995],"about_ca_topic_score_codex":0.0034303162,"about_ca_topic_score_gemma":0.0045210198,"teacher_disagreement_score":0.0574472,"about_ca_system_score_codex":0.0025653082,"about_ca_system_score_gemma":0.002923622,"threshold_uncertainty_score":0.041357696},"labels":[],"label_agreement":null},{"id":"W4210255115","doi":"10.1007/s40262-022-01107-4","title":"A Scoping Review of the Clinical Pharmacokinetics of Bedaquiline","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Bedaquiline; Medicine; Tuberculosis; Dosing; Pharmacokinetics; Drug; Intensive care medicine; Pharmacology; Pharmacotherapy; Mycobacterium tuberculosis; Drug resistance; Demographics; Internal medicine; Pathology; Biology","score_opus":0.4066103404580077,"score_gpt":0.6118421131518271,"score_spread":0.20523177269381943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210255115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059186998,0.9995055,0.000046604575,0.00013084608,0.000064290514,0.00001908945,0.00003859843,0.0000022605004,0.00013361065],"genre_scores_gemma":[0.0005244966,0.99899966,0.00014275915,0.00017316248,0.00003979904,0.000023760902,0.000036256453,0.0000010473428,0.000058983424],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99711275,0.00075605314,0.0011590709,0.00026071773,0.0006041121,0.000107340624],"domain_scores_gemma":[0.98977214,0.0075441604,0.0014830143,0.00014014763,0.00093366427,0.00012689618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005156812,0.0014336087,0.0056473333,0.007837547,0.00056924636,0.0027656185,0.0017623286,0.0022398322,0.004088938],"category_scores_gemma":[0.015200992,0.0008546444,0.004181672,0.009224589,0.0008010967,0.0021629971,0.001442219,0.0018524764,0.0005765527],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017467012,0.00003975359,0.00024892695,0.67913467,0.0019174669,0.00013712865,0.00014232943,0.00020795412,0.00036178823,0.0010019385,0.008259933,0.30837342],"study_design_scores_gemma":[0.000095120726,0.00017909007,0.0017527125,0.80747336,0.013489697,0.00071868894,0.00017521378,0.00012439219,0.00027507014,0.0009945278,0.17467697,0.00004515678],"about_ca_topic_score_codex":0.008354926,"about_ca_topic_score_gemma":0.01625807,"teacher_disagreement_score":0.008354926,"about_ca_system_score_codex":0.0026426103,"about_ca_system_score_gemma":0.009067779,"threshold_uncertainty_score":0.027272165},"labels":[],"label_agreement":null},{"id":"W4220788072","doi":"10.1007/s40262-022-01118-1","title":"Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Dosing; Piperacillin; Medicine; Nomogram; Population; Pharmacokinetics; Intensive care medicine; Intensive care; Piperacillin/tazobactam; Pharmacodynamics; Pharmacology; Internal medicine","score_opus":0.12337187482512263,"score_gpt":0.4499413502026235,"score_spread":0.32656947537750086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220788072","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23756161,0.0018275344,0.7460854,0.0017162088,0.0001685397,0.00059213385,0.0022229587,0.0018508383,0.007974793],"genre_scores_gemma":[0.90293497,0.0008100002,0.09022441,0.0008339087,0.00006645625,0.00046967214,0.0013569498,0.00015552751,0.0031480931],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989687,0.0005445423,0.00006566082,0.00017130029,0.00019290269,0.000056858633],"domain_scores_gemma":[0.9974043,0.0016025432,0.00032276436,0.00007858275,0.0005390475,0.000052620286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022129756,0.00070448354,0.0013375852,0.0003860349,0.00028869256,0.0019090136,0.00088432746,0.0014077304,0.001339778],"category_scores_gemma":[0.008557736,0.0004896627,0.0011568476,0.00040824446,0.00016505727,0.00060515996,0.00029617813,0.0014834928,0.00055865163],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037919986,0.0002058128,0.008943751,0.00013919738,0.00035485515,0.00029337194,0.000092134236,0.94397175,0.0027089664,0.0016837864,0.0030705996,0.03815651],"study_design_scores_gemma":[0.000068826004,0.00017316657,0.0021699655,0.000027862612,0.00012560455,0.00014307302,0.000016329644,0.9942405,0.0007449492,0.00072837254,0.0015385268,0.000022797432],"about_ca_topic_score_codex":0.01346117,"about_ca_topic_score_gemma":0.008035415,"teacher_disagreement_score":0.01346117,"about_ca_system_score_codex":0.0013084823,"about_ca_system_score_gemma":0.0036346035,"threshold_uncertainty_score":0.026765645},"labels":[],"label_agreement":null},{"id":"W4225824162","doi":"10.1007/s40262-021-01092-0","title":"Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19","year":2021,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Mount Sinai Hospital; Public Health Ontario; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Tocilizumab; Dosing; Medicine; Pharmacodynamics; Pharmacokinetics; Pharmacology; Coronavirus disease 2019 (COVID-19); Intensive care medicine; Internal medicine; Disease","score_opus":0.2582153043745333,"score_gpt":0.5585727688912274,"score_spread":0.3003574645166941,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225824162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022616214,0.9986993,0.00019420461,0.00023486414,0.000076503275,0.000009847785,0.000032067957,0.0000072336,0.00051971915],"genre_scores_gemma":[0.0024524247,0.9959484,0.0005209345,0.00037709266,0.00013769128,0.000022852737,0.00006873573,0.000003620614,0.00046829236],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996861,0.000091627655,0.000052060743,0.000047796777,0.00009267821,0.000029662357],"domain_scores_gemma":[0.9993635,0.0003912611,0.00012202466,0.0000116414685,0.00008869114,0.000022956854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015060209,0.00096342753,0.0023434723,0.0013632891,0.00015786033,0.0014443988,0.0012239028,0.0012046404,0.0042993263],"category_scores_gemma":[0.0018849929,0.00036778182,0.001503225,0.0012959735,0.00037088885,0.0012177216,0.00046266662,0.0028177812,0.0010839795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006094545,0.00011589799,0.00013873422,0.019156847,0.00042009892,0.00012795368,0.00004042863,0.0008522058,0.0014826378,0.0025766678,0.01564171,0.95883733],"study_design_scores_gemma":[0.0009811446,0.0012032895,0.0021971168,0.014954713,0.0026336804,0.0019158057,0.00008961629,0.0011300596,0.0018404437,0.0037852041,0.96918756,0.00008124899],"about_ca_topic_score_codex":0.0015469297,"about_ca_topic_score_gemma":0.002850213,"teacher_disagreement_score":0.0042993263,"about_ca_system_score_codex":0.00089572824,"about_ca_system_score_gemma":0.0011568685,"threshold_uncertainty_score":0.01438266},"labels":[],"label_agreement":null},{"id":"W4229020407","doi":"10.1007/s40262-022-01121-6","title":"Determining the Effects of Chronic Kidney Disease on Organic Anion Transporter1/3 Activity Through Physiologically Based Pharmacokinetic Modeling","year":2022,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Probenecid; Kidney disease; Organic anion transporter 1; Pharmacokinetics; Renal function; Pharmacology; Renal physiology; Medicine; Kidney; Renal blood flow; Furosemide; Internal medicine; Chemistry; Transporter; Biochemistry","score_opus":0.04074870510808417,"score_gpt":0.3466240286725328,"score_spread":0.30587532356444863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229020407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84568584,0.0035198233,0.14456981,0.00093719095,0.00005032301,0.00013560275,0.00083259156,0.0003472205,0.003921579],"genre_scores_gemma":[0.9902644,0.00085133594,0.007985216,0.00017337762,0.000011239473,0.00006364219,0.00017519027,0.000026036236,0.00044966274],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99966145,0.00017133165,0.000014502372,0.000055106804,0.0000662759,0.000031374246],"domain_scores_gemma":[0.999368,0.00047284947,0.00007859366,0.000030266332,0.000036842503,0.000013456757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008415005,0.00040222192,0.000678601,0.00016387421,0.0001486891,0.0010963249,0.0003457013,0.0005861561,0.0006513284],"category_scores_gemma":[0.0021021352,0.00021458573,0.00065870024,0.00019976341,0.00028192814,0.00042193776,0.0002551791,0.000762643,0.00019263042],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039206506,0.00067903753,0.05438005,0.00071729725,0.00097577774,0.00063217577,0.00033906754,0.6268688,0.22609992,0.0084019685,0.0021785037,0.07480686],"study_design_scores_gemma":[0.0001588988,0.0014308348,0.016891042,0.000030407251,0.00037284338,0.0006175287,0.00008895717,0.923909,0.049391143,0.0036214583,0.0034318622,0.00005606249],"about_ca_topic_score_codex":0.0035581177,"about_ca_topic_score_gemma":0.0020159197,"teacher_disagreement_score":0.0035581177,"about_ca_system_score_codex":0.0006578533,"about_ca_system_score_gemma":0.0009475044,"threshold_uncertainty_score":0.007074833},"labels":[],"label_agreement":null},{"id":"W4236581453","doi":"10.2165/11634200-000000000-00000","title":"Fundamentals of Population Pharmacokinetic Modelling","year":2012,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Pharmacokinetics; Population pharmacokinetics; Computer science; Medicine; Pharmacology","score_opus":0.37905310127943986,"score_gpt":0.5525052629288641,"score_spread":0.17345216164942429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236581453","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037321128,0.0012078554,0.9930146,0.00040366195,0.00010884725,0.000022352211,0.00018545229,0.00019641238,0.0044874493],"genre_scores_gemma":[0.15721923,0.013225756,0.8038101,0.0007740733,0.0015921881,0.0006758773,0.0010191345,0.0004899313,0.02119375],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99851626,0.0006564088,0.00009645994,0.00024760832,0.0004150216,0.00006823329],"domain_scores_gemma":[0.9973959,0.0018434427,0.00013907593,0.00021890672,0.00035840285,0.000044311957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026238232,0.0013406082,0.0016939008,0.0011091654,0.0004475052,0.002442485,0.0022527794,0.0017926617,0.0056536216],"category_scores_gemma":[0.0077295452,0.0008884823,0.0020369843,0.0015058883,0.00095961255,0.0016492333,0.0013892786,0.0029741433,0.0035594313],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014976095,0.000030096002,0.000687979,0.0002274806,0.0001258997,0.00014997055,0.00014058917,0.41029668,0.00064215006,0.49299657,0.0076642265,0.08702329],"study_design_scores_gemma":[0.000009339218,0.0000152283965,0.00020869738,0.000060199956,0.000036281526,0.00013826467,0.0000129454875,0.653639,0.00028933867,0.32186952,0.02369274,0.000028394636],"about_ca_topic_score_codex":0.005769703,"about_ca_topic_score_gemma":0.0023281523,"teacher_disagreement_score":0.005769703,"about_ca_system_score_codex":0.0010424356,"about_ca_system_score_gemma":0.0015546792,"threshold_uncertainty_score":0.018913269},"labels":[],"label_agreement":null},{"id":"W4245167824","doi":"10.1007/s40262-019-00839-0","title":"Acknowledgement to Referees","year":2019,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Université de Lausanne; Université Paris Diderot; Università degli Studi di Udine; Radboud Universiteit; Università degli Studi di Pavia; Universiteit Utrecht; Rijksuniversiteit Groningen; University of Otago; Universiteit Leiden; Universität Heidelberg; University of Waterloo; Karolinska Institutet; University of South Carolina; King's College London; University of Alberta; University of Washington; Helsingin Yliopisto; East Tennessee State University; University of Southern California","keywords":"Pharmacotherapy; Acknowledgement; Medicine; Internal medicine; Computer science","score_opus":0.2598516706215862,"score_gpt":0.5568679580104303,"score_spread":0.2970162873888441,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245167824","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016961994,0.0197713,0.016812004,0.30678093,0.57075214,0.0007284542,0.02362353,0.005134528,0.054700963],"genre_scores_gemma":[0.03900958,0.009487725,0.022254746,0.10682238,0.16393475,0.0016814154,0.016361315,0.0064177783,0.63403034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98240745,0.006142989,0.0020272222,0.0019394556,0.0067417496,0.0007411866],"domain_scores_gemma":[0.7580422,0.03629258,0.0070073307,0.011638869,0.17873119,0.008287839],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009774452,0.0017968648,0.0028338241,0.009223582,0.0031995089,0.004773856,0.0034297083,0.0029393772,0.26781267],"category_scores_gemma":[0.1799845,0.0007377336,0.0019421764,0.005230501,0.0013485843,0.003575809,0.0063948105,0.005797624,0.12809323],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003834793,0.0000117344725,0.00013867188,0.0001801006,0.000013995082,0.00018632387,0.00021584118,0.000098911514,0.00031175,0.0017989461,0.98750174,0.009503587],"study_design_scores_gemma":[0.00002330088,0.000010961387,0.000912859,0.0003069336,0.000037818605,0.00035148836,0.0004572418,0.0003355037,0.00027554942,0.003479501,0.9937629,0.00004591553],"about_ca_topic_score_codex":0.027221432,"about_ca_topic_score_gemma":0.024320394,"teacher_disagreement_score":0.73218733,"about_ca_system_score_codex":0.0074326913,"about_ca_system_score_gemma":0.0075274627,"threshold_uncertainty_score":0.89592266},"labels":[],"label_agreement":null},{"id":"W4247852028","doi":"10.2165/11634080-000000000-00000","title":"Fundamentals of Population Pharmacokinetic Modelling","year":2012,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Computer science; Usability; Population; Software; Context (archaeology); Variety (cybernetics); Data science; Risk analysis (engineering); Artificial intelligence; Medicine; Human–computer interaction; Biology","score_opus":0.9077627310124843,"score_gpt":0.7051695231200288,"score_spread":0.2025932078924555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4247852028","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004795368,0.75613385,0.2272802,0.004407716,0.0015177533,0.00007796718,0.00030923155,0.00034103854,0.00945274],"genre_scores_gemma":[0.015272933,0.900967,0.07453708,0.0016235051,0.0028878504,0.00025188964,0.0003163139,0.00006799013,0.00407549],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99866056,0.0006190038,0.00014509803,0.00013891497,0.00039074456,0.000045669098],"domain_scores_gemma":[0.9972619,0.002122577,0.00021519355,0.00012832208,0.00023407384,0.000037958784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002625537,0.0018130065,0.0027838952,0.0020164023,0.00025696994,0.002317783,0.0016595285,0.0020830391,0.0044777887],"category_scores_gemma":[0.0050635333,0.0005793753,0.0015238153,0.0026411642,0.0019942883,0.0023027873,0.0011021837,0.0037197096,0.0032592923],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004874067,0.00008584541,0.000309906,0.00908873,0.00018573384,0.00017077805,0.00013140743,0.02502118,0.0007575654,0.19112793,0.032630354,0.74044186],"study_design_scores_gemma":[0.00004340126,0.00012364482,0.0007796987,0.004193763,0.00019488194,0.00093046506,0.00005326109,0.02187174,0.0009397772,0.35731602,0.61345965,0.00009376335],"about_ca_topic_score_codex":0.001729002,"about_ca_topic_score_gemma":0.00087117724,"teacher_disagreement_score":0.0044777887,"about_ca_system_score_codex":0.0011406118,"about_ca_system_score_gemma":0.002875127,"threshold_uncertainty_score":0.01497972},"labels":[],"label_agreement":null},{"id":"W4293561164","doi":"10.1007/s40262-022-01171-w","title":"Clinical Pharmacokinetic Monitoring of Free Valproic Acid Levels: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Valproic Acid; Therapeutic drug monitoring; Internal medicine; Observational study; Clinical trial; Phenytoin; Pharmacology; Randomized controlled trial; Therapeutic index; Pharmacokinetics; Drug; Epilepsy; Psychiatry","score_opus":0.3780545239990777,"score_gpt":0.5462363506908153,"score_spread":0.16818182669173765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293561164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000453273,0.9990928,0.00008165842,0.00005865028,0.00004016244,0.000054004227,0.00011241095,0.0000039396314,0.00010310196],"genre_scores_gemma":[0.006368494,0.9927296,0.00033174682,0.00029272365,0.00004005691,0.00007223892,0.00009522352,0.0000025000854,0.00006743671],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99817026,0.00049040926,0.0007263328,0.00022486346,0.0003238398,0.000064287226],"domain_scores_gemma":[0.9926554,0.0053623375,0.0013562095,0.00010087797,0.00043585536,0.00008941333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032230495,0.0012197149,0.0069572832,0.0032371231,0.00027294506,0.0018261229,0.001543525,0.0015297877,0.004830744],"category_scores_gemma":[0.011350462,0.0006597998,0.0075002587,0.0045009,0.0005860743,0.0014387956,0.0009782256,0.0011799268,0.00035361992],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064333424,0.000039058355,0.0006565383,0.89415205,0.024506517,0.00009827045,0.00007543277,0.0001964237,0.0002580951,0.00022034564,0.0019881595,0.07716575],"study_design_scores_gemma":[0.0018103191,0.0006439257,0.008680235,0.60625356,0.337316,0.0007344673,0.00025114743,0.00026148008,0.00040853303,0.00068408775,0.04283916,0.000117103285],"about_ca_topic_score_codex":0.004694122,"about_ca_topic_score_gemma":0.013388068,"teacher_disagreement_score":0.0069572832,"about_ca_system_score_codex":0.0012906828,"about_ca_system_score_gemma":0.0038016797,"threshold_uncertainty_score":0.01704532},"labels":[],"label_agreement":null},{"id":"W4318946156","doi":"10.1007/s40262-023-01213-x","title":"Pharmacokinetic Alterations Associated with Critical Illness","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Pharmacokinetics; Intensive care medicine; Pharmacotherapy; Pharmacology; Drug; Polypharmacy; Dosing; Therapeutic drug monitoring; Renal replacement therapy; Drug metabolism; Amiodarone; Internal medicine; Atrial fibrillation","score_opus":0.2557920563187516,"score_gpt":0.5341036489901199,"score_spread":0.27831159267136824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318946156","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008720269,0.9992625,0.0000755823,0.00010398912,0.00007335426,0.0000049671835,0.00001565641,0.000004126931,0.00037248066],"genre_scores_gemma":[0.0009381164,0.99833846,0.00016638677,0.00018161845,0.00013307361,0.000007885852,0.00002319284,0.0000011977339,0.00021003732],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966204,0.00008219607,0.00008260746,0.000052547468,0.000096333584,0.000024304203],"domain_scores_gemma":[0.9992281,0.00041740068,0.00020233507,0.000016392041,0.00010759275,0.000028091239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073672476,0.001094387,0.0021503067,0.0019103814,0.00015872942,0.0011386393,0.0006413079,0.00090310164,0.0041163573],"category_scores_gemma":[0.0019713496,0.00031562432,0.00091282243,0.0018305192,0.0004253616,0.00096361164,0.0007031186,0.0018222479,0.0010401035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029326486,0.000099035955,0.00029660776,0.049062815,0.00039931134,0.00019377802,0.00003665676,0.0003745167,0.00097232376,0.0012792648,0.015514213,0.93147814],"study_design_scores_gemma":[0.00033475008,0.0006214774,0.004566718,0.031994864,0.0029627164,0.0038267884,0.00012127556,0.000506238,0.001689701,0.0029800741,0.9503066,0.00008869173],"about_ca_topic_score_codex":0.0011801409,"about_ca_topic_score_gemma":0.0022618629,"teacher_disagreement_score":0.0041163573,"about_ca_system_score_codex":0.00058868004,"about_ca_system_score_gemma":0.001312127,"threshold_uncertainty_score":0.01377058},"labels":[],"label_agreement":null},{"id":"W4322493875","doi":"10.1007/s40262-023-01212-y","title":"Clinical Evidence on the Purported Pharmacokinetic Interactions between Corticosteroids and Mycophenolic Acid","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pharmacokinetics; Prednisone; Prednisolone; Pharmacology; Mycophenolic acid; Adverse effect; Corticosteroid; Immunosuppression; Drug; Expert opinion; Pharmacotherapy; Intensive care medicine; Internal medicine; Transplantation","score_opus":0.31071969442141706,"score_gpt":0.5126108093168591,"score_spread":0.20189111489544204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322493875","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43879765,0.48839214,0.0046682297,0.020808544,0.00062375393,0.00016596162,0.0006556449,0.00004960017,0.045838486],"genre_scores_gemma":[0.92722076,0.06462686,0.0011731231,0.0041049807,0.0017540745,0.00003611267,0.00025513928,0.000013782061,0.000815155],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99611676,0.002175762,0.0004499691,0.00030639156,0.00080536416,0.00014579347],"domain_scores_gemma":[0.903947,0.07942075,0.010145336,0.0023384274,0.0033097703,0.0008387745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061231237,0.0004892577,0.00086908956,0.0007501023,0.00045590612,0.0016592955,0.0007954816,0.0016518726,0.007302228],"category_scores_gemma":[0.03395729,0.0002999213,0.00060658023,0.0012865517,0.0018666835,0.0009007354,0.0006106191,0.0019015527,0.00066582795],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03771758,0.0025378014,0.35607502,0.010709746,0.005476146,0.004500029,0.0008645661,0.0027475748,0.029984994,0.0148528395,0.00599701,0.5285368],"study_design_scores_gemma":[0.0034583276,0.020517442,0.7703383,0.006104806,0.0063293297,0.022833358,0.0014383366,0.0030709337,0.026175002,0.017421149,0.1221577,0.00015529903],"about_ca_topic_score_codex":0.0006979835,"about_ca_topic_score_gemma":0.0009067536,"teacher_disagreement_score":0.007302228,"about_ca_system_score_codex":0.000846982,"about_ca_system_score_gemma":0.0015339953,"threshold_uncertainty_score":0.032382548},"labels":[],"label_agreement":null},{"id":"W4362506207","doi":"10.1007/s40262-023-01233-7","title":"External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Polytechnique Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Confusion; Dosing; Computer science; Population; Risk analysis (engineering); Management science; Medicine; Pharmacology; Engineering; Psychology; Environmental health","score_opus":0.23623025221709973,"score_gpt":0.5167920882786811,"score_spread":0.28056183606158136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362506207","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036178317,0.043127153,0.8836215,0.00755217,0.0011834736,0.0014057113,0.004502508,0.0031880646,0.019241132],"genre_scores_gemma":[0.66020703,0.033969134,0.27912772,0.008322609,0.0018166915,0.002230504,0.008864344,0.0029034,0.0025584896],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.87415683,0.09823133,0.004510639,0.0067671523,0.015620347,0.0007137959],"domain_scores_gemma":[0.7029782,0.23406042,0.0142596485,0.025629101,0.02198775,0.0010849063],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13843918,0.002164253,0.0059084473,0.0013629834,0.00047250165,0.010935291,0.0048745363,0.0025444562,0.0046532415],"category_scores_gemma":[0.3400243,0.0010160151,0.0031353068,0.002478348,0.0020611628,0.0036725912,0.0030457666,0.004370556,0.0025457563],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003228532,0.00095966394,0.045533404,0.007505126,0.007989698,0.00015017024,0.0006942583,0.13736469,0.0016374515,0.034985825,0.026889408,0.73306173],"study_design_scores_gemma":[0.0014592675,0.0040375427,0.028780533,0.012763044,0.0050464952,0.000952507,0.0005416653,0.6399001,0.010156621,0.1329869,0.16295446,0.00042083874],"about_ca_topic_score_codex":0.0047247102,"about_ca_topic_score_gemma":0.001825957,"teacher_disagreement_score":0.8615608,"about_ca_system_score_codex":0.0029301753,"about_ca_system_score_gemma":0.0091755595,"threshold_uncertainty_score":0.7321451},"labels":[],"label_agreement":null},{"id":"W4380201598","doi":"10.1007/s40262-023-01264-0","title":"Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation","year":2023,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"National Health and Medical Research Council; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Medical Research Council; University of Queensland","keywords":"Dosing; Extracorporeal membrane oxygenation; Medicine; Critically ill; Intensive care medicine; Antifungal; Population; Drug; Antifungal drugs; Extracorporeal; Antifungal drug; Pharmacokinetics; Therapeutic drug monitoring; Critical illness; Volume of distribution; Pharmacology; Anesthesia; Internal medicine","score_opus":0.18065330493342838,"score_gpt":0.48318815209861776,"score_spread":0.3025348471651894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380201598","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018829934,0.99928397,0.000057283647,0.000115432005,0.00005203831,0.000003807511,0.000008638803,0.0000028112872,0.00028770333],"genre_scores_gemma":[0.0018296076,0.9976477,0.00016865924,0.0001224419,0.000078227284,0.0000068499626,0.000017865268,9.0563583e-7,0.00012767094],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995983,0.00011517182,0.00010565163,0.000046595702,0.000116366624,0.000017811326],"domain_scores_gemma":[0.9994498,0.00031874533,0.00012371558,0.000009244256,0.00008255149,0.000015944823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070583867,0.0006378903,0.0015051779,0.0014987313,0.00016084399,0.00080689247,0.00070955546,0.000920653,0.0017084839],"category_scores_gemma":[0.001625179,0.00020980046,0.000797404,0.001211412,0.0002766995,0.00070925895,0.0004012463,0.0010991435,0.00063571514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020076898,0.00006910358,0.00044491602,0.03714846,0.00024530373,0.00019362604,0.000059854257,0.00029458772,0.0008752707,0.0008881623,0.008680134,0.9508997],"study_design_scores_gemma":[0.00024060938,0.00069038215,0.010476484,0.050711624,0.0019255794,0.0078619765,0.00022293642,0.00071572606,0.0022803012,0.0032094961,0.9215866,0.00007824953],"about_ca_topic_score_codex":0.0009184364,"about_ca_topic_score_gemma":0.0014626712,"teacher_disagreement_score":0.0017084839,"about_ca_system_score_codex":0.00038605861,"about_ca_system_score_gemma":0.0008197848,"threshold_uncertainty_score":0.00571543},"labels":[],"label_agreement":null},{"id":"W4381714962","doi":"10.1007/s40262-023-01272-0","title":"Authors’ Reply to Lv et al.: “External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps”","year":2023,"lang":"en","type":"letter","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Dosing; Pharmacokinetics; Current (fluid); Medicine; Population; Intensive care medicine; Pharmacology; Physics","score_opus":0.24955563005409886,"score_gpt":0.5216436640067018,"score_spread":0.27208803395260295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381714962","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017134521,0.00075263734,0.000121701516,0.98122793,0.016912544,0.00001096273,0.000106399995,0.000030475652,0.0006659888],"genre_scores_gemma":[0.0011635543,0.0003734013,0.00018302152,0.97951686,0.017598728,0.000031678053,0.0000275877,0.00001901694,0.0010860853],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99188906,0.0030536482,0.0015117686,0.00095220195,0.0019111639,0.00068224757],"domain_scores_gemma":[0.9543563,0.030806538,0.0023575386,0.0009825143,0.00917269,0.0023243972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010987736,0.0008791504,0.0018815455,0.0009781655,0.0031217071,0.0037736704,0.0026595402,0.060189765,0.006242543],"category_scores_gemma":[0.07960614,0.001107943,0.0018495515,0.0011498732,0.0031713573,0.0036587408,0.0017464311,0.04721849,0.007997201],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071531525,0.000017119628,0.00041503337,0.000057298996,0.000016470318,0.0005802528,0.00009820888,0.00005212498,0.00007415685,0.0009285793,0.9938997,0.0037894472],"study_design_scores_gemma":[0.0003060747,0.00010033914,0.0016976503,0.0007191279,0.00008731944,0.0023331842,0.00051230774,0.00075917924,0.00058477564,0.011288983,0.98145664,0.00015432866],"about_ca_topic_score_codex":0.007305862,"about_ca_topic_score_gemma":0.008542477,"teacher_disagreement_score":0.060189765,"about_ca_system_score_codex":0.004183535,"about_ca_system_score_gemma":0.0067737475,"threshold_uncertainty_score":0.058109462},"labels":[],"label_agreement":null},{"id":"W4385264387","doi":"10.1007/s40262-023-01280-0","title":"Significant Effects of Renal Function on Mycophenolic Acid Total Clearance in Pediatric Kidney Transplant Recipients with Population Pharmacokinetic Modeling","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Mycophenolic acid; Population; Renal function; Pharmacokinetics; Kidney transplantation; Transplantation; Covariate; Urology; Internal medicine; Statistics; Mathematics","score_opus":0.04037206805120482,"score_gpt":0.35286892244369455,"score_spread":0.31249685439248975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385264387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869344,0.00033144257,0.011747377,0.00013373354,0.000010170259,0.000020408164,0.00019940574,0.00009078789,0.0005322618],"genre_scores_gemma":[0.9977763,0.00011878471,0.0017876291,0.000029403493,0.000004907878,0.000014030397,0.00011212812,0.000020896281,0.00013582637],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989791,0.0006864124,0.000036171095,0.00013877651,0.0000853962,0.00007412044],"domain_scores_gemma":[0.99524695,0.0037951395,0.00044734436,0.00030323642,0.00012952765,0.000077784614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029680792,0.0005199463,0.0006902885,0.00022373398,0.00020316392,0.0010757518,0.00048216467,0.0003880896,0.0010335393],"category_scores_gemma":[0.007964666,0.00022979792,0.0012614292,0.000276244,0.0002713592,0.00062267605,0.0005176258,0.00083210604,0.00013621702],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076251887,0.00065791747,0.7660818,0.00016945993,0.0043003545,0.0009562857,0.0005062035,0.15960464,0.006010226,0.0032931673,0.0011827638,0.04961196],"study_design_scores_gemma":[0.0002103226,0.0027422828,0.23422909,0.00004823788,0.0027952592,0.0012363032,0.00043709052,0.7459213,0.0062087877,0.003935248,0.0021647622,0.0000712807],"about_ca_topic_score_codex":0.0047162063,"about_ca_topic_score_gemma":0.002343973,"teacher_disagreement_score":0.0047162063,"about_ca_system_score_codex":0.00044603617,"about_ca_system_score_gemma":0.0013458559,"threshold_uncertainty_score":0.015696883},"labels":[],"label_agreement":null},{"id":"W4386916058","doi":"10.1007/s40262-023-01307-6","title":"Cannabidiol Exposure Through Maternal Marijuana Use: Predictions in Breastfed Infants","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Waterloo; Hospital for Sick Children","funders":"National Center for Advancing Translational Sciences; University of Waterloo; Canadian Institutes of Health Research; University of California, San Diego; National Institutes of Health; Gerber Foundation","keywords":"Breastfeeding; Medicine; Cannabidiol; Breast milk; Infant formula; Pediatrics; Pharmacokinetics; Breast feeding; Cannabis; Internal medicine","score_opus":0.09265376675567326,"score_gpt":0.43400183017477656,"score_spread":0.3413480634191033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386916058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808735,0.0003737079,0.0004622279,0.000048488553,0.000005416555,0.000009038459,0.00032268738,0.0000145053955,0.0006765853],"genre_scores_gemma":[0.9984251,0.00042284562,0.00044452737,0.000026909043,0.000003798449,0.000010941709,0.00028648993,0.0000058471483,0.0003734738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997359,0.000090902824,0.000018512996,0.000051120704,0.000066363624,0.000037217924],"domain_scores_gemma":[0.99851054,0.00080317573,0.0003286402,0.00010035202,0.00015103305,0.00010622106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007405324,0.00041892845,0.00035095698,0.0003240822,0.00020640674,0.000763289,0.0002991354,0.0005185375,0.001182224],"category_scores_gemma":[0.0050000586,0.0002655962,0.00032159776,0.00031557799,0.00023604395,0.00039213768,0.00033263818,0.000672349,0.0004308661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010314438,0.000079087804,0.9880058,0.000018314651,0.00004641605,0.00021023309,0.00014742595,0.0005563161,0.0011216576,0.000102748476,0.000164321,0.008516199],"study_design_scores_gemma":[0.000018215573,0.00066169404,0.9841559,0.00002919804,0.00008069499,0.0009304466,0.00039467742,0.010465688,0.0024143108,0.00024028639,0.00059448037,0.000014495463],"about_ca_topic_score_codex":0.011475091,"about_ca_topic_score_gemma":0.0056803375,"teacher_disagreement_score":0.011475091,"about_ca_system_score_codex":0.00060510717,"about_ca_system_score_gemma":0.0004864432,"threshold_uncertainty_score":0.022816598},"labels":[],"label_agreement":null},{"id":"W4388627262","doi":"10.1007/s40262-023-01319-2","title":"Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"Vir Biotechnology","keywords":"Medicine; Tolerability; Placebo; Pharmacokinetics; Confidence interval; Adverse effect; Anesthesia; Internal medicine","score_opus":0.0855138984506186,"score_gpt":0.4492437812063357,"score_spread":0.36372988275571705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388627262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856466,0.00070542656,0.00011508981,0.000029206662,0.000010366187,0.000114593786,0.00013555294,0.000006385155,0.00031867938],"genre_scores_gemma":[0.9982419,0.00042516706,0.0003001815,0.00016316788,0.000026434329,0.00019661391,0.00021286582,0.0000046762443,0.00042900606],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99972063,0.00010223287,0.000021275291,0.00007780873,0.00004111446,0.000036810223],"domain_scores_gemma":[0.99965703,0.00004752857,0.00013165492,0.000026135765,0.000039848102,0.00009783175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008406194,0.0003813797,0.00056673225,0.000119639866,0.0002633219,0.00036928148,0.0001749846,0.00051211193,0.0013369031],"category_scores_gemma":[0.0007988007,0.00025205524,0.0003803034,0.0001480073,0.00040621782,0.00032559474,0.00013447437,0.00042575368,0.00026369197],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46505216,0.015890393,0.1141819,0.0021290379,0.001986554,0.00051839236,0.0021588127,0.0011764308,0.28095156,0.00021672755,0.0030553604,0.112682745],"study_design_scores_gemma":[0.047487617,0.35112965,0.5766567,0.000113133894,0.0025283664,0.001252665,0.00067451847,0.0020287,0.012508907,0.00018479972,0.0053189592,0.00011598257],"about_ca_topic_score_codex":0.0011029772,"about_ca_topic_score_gemma":0.0016007426,"teacher_disagreement_score":0.0013369031,"about_ca_system_score_codex":0.0002799418,"about_ca_system_score_gemma":0.0005006555,"threshold_uncertainty_score":0.004472375},"labels":[],"label_agreement":null},{"id":"W4390060918","doi":"10.1007/s40262-023-01329-0","title":"Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step","year":2023,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Medicine; Dosing; Vancomycin; Nomogram; Population; NONMEM; Oncology; Renal function; Internal medicine; Intensive care medicine; Staphylococcus aureus","score_opus":0.0982444757694802,"score_gpt":0.42612978322872697,"score_spread":0.32788530745924677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390060918","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036806874,0.0016458586,0.94946694,0.004015889,0.00010600596,0.00017662479,0.00058174814,0.0013920779,0.005807839],"genre_scores_gemma":[0.688397,0.0018963948,0.30394787,0.0018051685,0.00016654383,0.0003568971,0.00086576043,0.0003222947,0.0022420501],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989942,0.0005130485,0.00004244489,0.000119589466,0.00026881855,0.00006201132],"domain_scores_gemma":[0.9975133,0.0014254192,0.0003352794,0.00021974913,0.00040412307,0.00010210983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019026515,0.0007453439,0.0019539823,0.00036117868,0.00027207704,0.0029188888,0.0014891657,0.0010837963,0.0023338655],"category_scores_gemma":[0.007016794,0.00067166914,0.0008644542,0.00032057718,0.0004161401,0.0016725957,0.00090356776,0.0025259086,0.00060788007],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025264753,0.00019908468,0.0018984412,0.00012238506,0.00014744882,0.00006824479,0.000047643316,0.9500731,0.0038102518,0.0094087375,0.0029170085,0.031055052],"study_design_scores_gemma":[0.00004666572,0.00014225543,0.00034799066,0.000031303807,0.00003219712,0.000034660436,0.000020360432,0.9856793,0.00094039453,0.010482108,0.0022243676,0.000018355566],"about_ca_topic_score_codex":0.008003172,"about_ca_topic_score_gemma":0.007932352,"teacher_disagreement_score":0.008003172,"about_ca_system_score_codex":0.0013990959,"about_ca_system_score_gemma":0.004808671,"threshold_uncertainty_score":0.015913188},"labels":[],"label_agreement":null},{"id":"W4391251185","doi":"10.1007/s40262-023-01345-0","title":"Maternal Ezetimibe Concentrations Measured in Breast Milk and Its Use in Breastfeeding Infant Exposure Predictions","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Toronto; Université de Montréal; University of Manitoba; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Ezetimibe; Breast milk; Breastfeeding; Pharmacokinetics; Physiologically based pharmacokinetic modelling; Infant formula; Breast feeding; Medicine; Active metabolite; Chemistry; Chromatography; Pharmacology; Food science; Internal medicine; Cholesterol; Biochemistry; Pediatrics","score_opus":0.07768222101468013,"score_gpt":0.3914468204472543,"score_spread":0.3137645994325742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391251185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751437,0.008396632,0.008095704,0.00093185424,0.000076289776,0.00003129234,0.0018641014,0.00011851598,0.0053420183],"genre_scores_gemma":[0.99612266,0.0012806387,0.0013992424,0.00007995531,0.000014252577,0.00001561311,0.0004773164,0.000013905338,0.00059646915],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9992567,0.0003204798,0.00006342617,0.00009240466,0.00022084726,0.000046158577],"domain_scores_gemma":[0.99735034,0.001920655,0.00038685772,0.00010935086,0.00017032759,0.000062360814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011904989,0.00040733113,0.00042956093,0.00034474325,0.00011666264,0.00092443667,0.00027562815,0.00048818675,0.0012299458],"category_scores_gemma":[0.008997495,0.00021920574,0.00036896334,0.00037899488,0.00017395683,0.00039184262,0.00026009468,0.00075571885,0.0003702777],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044067446,0.0001444895,0.9084623,0.00020091934,0.0005538152,0.0006807549,0.00030920436,0.006595382,0.0073142485,0.00093551143,0.0013076323,0.06908906],"study_design_scores_gemma":[0.0001256632,0.0023712104,0.86817294,0.00034125763,0.0011920772,0.0041448176,0.0007069222,0.069894895,0.03773243,0.002199829,0.013061448,0.00005644601],"about_ca_topic_score_codex":0.0029250125,"about_ca_topic_score_gemma":0.0017092086,"teacher_disagreement_score":0.0029250125,"about_ca_system_score_codex":0.00046372612,"about_ca_system_score_gemma":0.00054591964,"threshold_uncertainty_score":0.0062960386},"labels":[],"label_agreement":null},{"id":"W4392880216","doi":"10.1007/s40262-024-01362-7","title":"Optimization of Ganciclovir and Valganciclovir Starting Dose in Children by Machine Learning","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Ganciclovir; Valganciclovir; Pharmacokinetics; Algorithm; Test set; Confidence interval; Medicine; Receiver operating characteristic; Population; Mathematics; Set (abstract data type); Computer science; Machine learning; Artificial intelligence; Statistics; Pharmacology","score_opus":0.038260621678176045,"score_gpt":0.39887686622556584,"score_spread":0.3606162445473898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392880216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8241364,0.006652168,0.16301754,0.0006986177,0.000057843114,0.00018657905,0.00046072135,0.0008624054,0.003927872],"genre_scores_gemma":[0.9605852,0.00083108275,0.03766246,0.000098679164,0.0000148418,0.0000748048,0.00019488472,0.00005782909,0.000480178],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99973685,0.0001284613,0.0000202561,0.000046496818,0.000040638406,0.000027309912],"domain_scores_gemma":[0.9994567,0.00037872788,0.00008415882,0.0000130399385,0.000039234128,0.000028274755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048173737,0.00039446072,0.0007175916,0.00032451042,0.00010856916,0.00049831666,0.00022198903,0.00029608695,0.0007525392],"category_scores_gemma":[0.0019914138,0.00023181479,0.0004606937,0.00023436632,0.0001374866,0.0002484548,0.00016730509,0.00068060076,0.0001276586],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068301023,0.00060007477,0.06864265,0.00028677232,0.00043391157,0.00034412713,0.0001033948,0.3963344,0.027332358,0.0010325809,0.0024643042,0.49559534],"study_design_scores_gemma":[0.0003595439,0.002176111,0.03745253,0.00008117231,0.00029161078,0.00064456614,0.000080559366,0.928755,0.025632706,0.001103385,0.0033672208,0.00005560295],"about_ca_topic_score_codex":0.0041782064,"about_ca_topic_score_gemma":0.0036755584,"teacher_disagreement_score":0.0041782064,"about_ca_system_score_codex":0.000700044,"about_ca_system_score_gemma":0.0012130112,"threshold_uncertainty_score":0.008307755},"labels":[],"label_agreement":null},{"id":"W4399172435","doi":"10.1007/s40262-024-01367-2","title":"Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric Population","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; Duke Clinical Research Institute; National Institute of Child Health and Human Development; National Institutes of Health","keywords":"Levetiracetam; Pharmacokinetics; Medicine; Obesity; Disposition; Pediatrics; Population; Age groups; Pharmacology; Epilepsy; Internal medicine; Demography; Psychology; Psychiatry; Environmental health","score_opus":0.06324273030691942,"score_gpt":0.3990396598029761,"score_spread":0.3357969294960567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399172435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7349728,0.0013966976,0.25841284,0.0007288272,0.000042950454,0.00013641662,0.0008265904,0.00035170568,0.003131178],"genre_scores_gemma":[0.9750997,0.00086350925,0.022914557,0.00012017995,0.00002052659,0.00009052896,0.00031639807,0.000040930725,0.0005336642],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99979836,0.000108862085,0.00001156942,0.000030961906,0.000033146836,0.000017128461],"domain_scores_gemma":[0.99939024,0.00041111946,0.000095746014,0.000031851225,0.000053290027,0.000017691464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007269644,0.00047163115,0.00056003855,0.00029504515,0.00017985574,0.00067407294,0.00035860413,0.00043531196,0.00051282265],"category_scores_gemma":[0.0031836377,0.00019430318,0.0006580035,0.00029506514,0.00011476374,0.00029667834,0.0002548455,0.00068585435,0.00013522054],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009976171,0.0005539709,0.1046117,0.00012830361,0.00061427185,0.0007350865,0.00029426828,0.7859787,0.01318963,0.0044864947,0.0014500432,0.08696004],"study_design_scores_gemma":[0.000042602813,0.0004260243,0.014207196,0.000011358252,0.00012094182,0.0005116993,0.00006228877,0.9799018,0.002101805,0.0014170505,0.0011739915,0.000023337449],"about_ca_topic_score_codex":0.009459732,"about_ca_topic_score_gemma":0.004707103,"teacher_disagreement_score":0.009459732,"about_ca_system_score_codex":0.00043844935,"about_ca_system_score_gemma":0.0013030873,"threshold_uncertainty_score":0.018809319},"labels":[],"label_agreement":null},{"id":"W4402634804","doi":"10.1007/s40262-024-01418-8","title":"Physiologically-Based Pharmacokinetic Modeling of Total and Unbound Valproic Acid to Evaluate Dosing in Children With and Without Hypoalbuminemia","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health; National Institute of Child Health and Human Development; GlaxoSmithKline","keywords":"Hypoalbuminemia; Dosing; Valproic Acid; Pharmacokinetics; Pharmacology; Medicine; Chemistry; Internal medicine; Epilepsy; Psychiatry","score_opus":0.06425689875237436,"score_gpt":0.4134818528070195,"score_spread":0.34922495405464515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402634804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79006827,0.0019024025,0.20297545,0.00035638933,0.00003105157,0.00013548613,0.00048253726,0.0003514682,0.003696964],"genre_scores_gemma":[0.98884904,0.00053029635,0.009668158,0.00006831198,0.0000074209647,0.00007521789,0.000157113,0.00002767534,0.00061671674],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99984086,0.00007563016,0.000008957339,0.000022481005,0.00003478531,0.000017309298],"domain_scores_gemma":[0.99970883,0.00019363636,0.000044292978,0.000010698986,0.00003098867,0.000011464487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037050346,0.0004223426,0.0006214603,0.00017913658,0.00014128952,0.0007087083,0.00039764878,0.0004817877,0.0004892565],"category_scores_gemma":[0.0014400232,0.0002007881,0.000599295,0.00017806794,0.00018840273,0.00024482756,0.0001965948,0.0004994853,0.00013617391],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005157344,0.00012035367,0.01026856,0.00008595458,0.00013199494,0.00019313776,0.00009663139,0.95817626,0.012208184,0.0018005623,0.00043630347,0.01596629],"study_design_scores_gemma":[0.000045298275,0.0002849119,0.0027456735,0.000007858323,0.000040028688,0.0001950518,0.000023447601,0.9927684,0.002743875,0.00053876126,0.0005952634,0.000011425727],"about_ca_topic_score_codex":0.00910413,"about_ca_topic_score_gemma":0.0036313704,"teacher_disagreement_score":0.00910413,"about_ca_system_score_codex":0.0006284689,"about_ca_system_score_gemma":0.0012275483,"threshold_uncertainty_score":0.018102288},"labels":[],"label_agreement":null},{"id":"W4402925791","doi":"10.1007/s40262-024-01424-w","title":"Physiologically Based Pharmacokinetic Modelling in Critically Ill Children Receiving Anakinra While on Extracorporeal Life Support","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"University of Waterloo; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Foundation for the National Institutes of Health","keywords":"Critically ill; Anakinra; Extracorporeal; Life support; Medicine; Intensive care medicine; Pharmacokinetics; Extracorporeal membrane oxygenation; Anesthesia; Pharmacology; Internal medicine; Disease","score_opus":0.09297391029454456,"score_gpt":0.3993955792869996,"score_spread":0.30642166899245504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402925791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92164284,0.001547143,0.070700556,0.00072731334,0.00006169432,0.00009566154,0.00061544473,0.00017720963,0.0044321194],"genre_scores_gemma":[0.9943001,0.0005551628,0.003507101,0.00007005668,0.000014512087,0.000060300383,0.000206837,0.000019740504,0.0012662372],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998266,0.00007428804,0.000009974516,0.00002953509,0.000026569705,0.000033025408],"domain_scores_gemma":[0.9991271,0.0006810039,0.00008118058,0.000014216899,0.00006865085,0.000027811933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029951837,0.00043000377,0.000752854,0.00019055845,0.00023371562,0.0011334199,0.0005031197,0.0010359302,0.0009803757],"category_scores_gemma":[0.0018270888,0.00025116524,0.0007628956,0.00022154521,0.00026812087,0.00034075536,0.00033534085,0.0009304331,0.00019505605],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024183736,0.00006114448,0.0056627523,0.000068785484,0.0000638531,0.00025174845,0.00009530575,0.98507845,0.0023317658,0.0009223913,0.00031990372,0.0049020736],"study_design_scores_gemma":[0.00002951091,0.00019814946,0.0037128746,0.00001641643,0.000036701396,0.00018117442,0.000056493118,0.99365294,0.000952276,0.00045955786,0.00068207685,0.000021889065],"about_ca_topic_score_codex":0.020179942,"about_ca_topic_score_gemma":0.006831515,"teacher_disagreement_score":0.020179942,"about_ca_system_score_codex":0.0007128892,"about_ca_system_score_gemma":0.0012943915,"threshold_uncertainty_score":0.040124953},"labels":[],"label_agreement":null},{"id":"W4404706680","doi":"10.1007/s40262-024-01447-3","title":"Coupling Pre- and Postnatal Infant Exposures with Physiologically Based Pharmacokinetic Modeling to Predict Cumulative Maternal Levetiracetam Exposure During Breastfeeding","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Breastfeeding Practices and Influences","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children; University of Waterloo","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Physiologically based pharmacokinetic modelling; Breastfeeding; Breast milk; Medicine; Infant formula; Population; Pharmacokinetics; Breast feeding; NONMEM; Physiology; Obstetrics; Pediatrics; Environmental health; Pharmacology; Chemistry","score_opus":0.04698075393296283,"score_gpt":0.37706661241123657,"score_spread":0.33008585847827376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404706680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84225076,0.0009411342,0.15390128,0.0002640424,0.0000339774,0.000061398394,0.00038100654,0.00040868434,0.0017578143],"genre_scores_gemma":[0.9917459,0.00023432804,0.007385966,0.000044027172,0.000008127177,0.00004287194,0.00014050747,0.000022536064,0.00037570298],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997831,0.00009200099,0.000014818075,0.00004438414,0.000047353715,0.0000184297],"domain_scores_gemma":[0.99926263,0.00053064333,0.000084954925,0.000029650808,0.00006884539,0.00002330419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048783503,0.00043552136,0.00059022586,0.00018966479,0.0001367128,0.000639918,0.00037262848,0.0004095622,0.0005365082],"category_scores_gemma":[0.0030159974,0.00027190457,0.00046609994,0.00019081372,0.00011569671,0.0003086663,0.00028763898,0.0006368367,0.00020863925],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080875953,0.00040171912,0.104436554,0.00011569416,0.0005492444,0.00030454967,0.00019720163,0.81626624,0.010191638,0.0010199245,0.0006037392,0.06510483],"study_design_scores_gemma":[0.0000129188375,0.00019415819,0.010577648,0.000006924313,0.000063250474,0.000098179655,0.000022129716,0.9869223,0.0014832293,0.00035241965,0.00025592197,0.000010901767],"about_ca_topic_score_codex":0.009572754,"about_ca_topic_score_gemma":0.005027054,"teacher_disagreement_score":0.009572754,"about_ca_system_score_codex":0.0004103272,"about_ca_system_score_gemma":0.0010315719,"threshold_uncertainty_score":0.019034028},"labels":[],"label_agreement":null},{"id":"W4405775005","doi":"10.1007/s40262-024-01460-6","title":"A Pooled Pharmacokinetic Analysis for Piperacillin/Tazobactam Across Different Patient Populations: From Premature Infants to the Elderly","year":2024,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"China Scholarship Council","keywords":"Dosing; Pharmacokinetics; Medicine; Pharmacodynamics; Piperacillin; Piperacillin/tazobactam; Population; Tazobactam; Pharmacology; Covariate; Internal medicine; Biology; Statistics; Mathematics; Genetics","score_opus":0.0778859544124117,"score_gpt":0.44332378971303554,"score_spread":0.36543783530062385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405775005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95070034,0.0047786455,0.040633846,0.000285149,0.000041787283,0.00019653462,0.0024635815,0.00015113028,0.0007488597],"genre_scores_gemma":[0.9887589,0.0012425917,0.0076295114,0.00010743545,0.00002920124,0.00014974186,0.001675819,0.000026558331,0.00038020278],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9988254,0.0006908503,0.00009420878,0.00024780526,0.00008519013,0.000056702876],"domain_scores_gemma":[0.99600756,0.0025951848,0.0004529638,0.00038702096,0.00044469527,0.00011254127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051383483,0.0010209996,0.002103228,0.00075586897,0.00018843595,0.00085677,0.00056497083,0.0006911522,0.0011277647],"category_scores_gemma":[0.010449992,0.000372275,0.0050954893,0.00050484244,0.00015061896,0.00047212074,0.00075552333,0.00060487597,0.00019384982],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012837271,0.00051523984,0.327532,0.0015514673,0.03959343,0.0034458367,0.0006116743,0.4620387,0.010186063,0.0013911548,0.0030582927,0.13723898],"study_design_scores_gemma":[0.0011709764,0.011773468,0.22401838,0.00025365452,0.032783788,0.0021730866,0.00059859897,0.71384346,0.004656415,0.0028260082,0.0057147588,0.0001874163],"about_ca_topic_score_codex":0.005953741,"about_ca_topic_score_gemma":0.002665391,"teacher_disagreement_score":0.005953741,"about_ca_system_score_codex":0.0005596365,"about_ca_system_score_gemma":0.0010847517,"threshold_uncertainty_score":0.027174532},"labels":[],"label_agreement":null},{"id":"W4406588759","doi":"10.1007/s40262-025-01478-4","title":"Identifying the Optimal Sampling Strategy for the Bayesian Estimation of Vancomycin AUC0–24 in Adult Hematologic Cancer Patients","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Université de Montréal","funders":"","keywords":"Vancomycin; Bayesian probability; Hematologic Neoplasms; Sampling (signal processing); Estimation; Medicine; Hematologic malignancy; Cancer; Pediatric cancer; Computer science; Oncology; Statistics; Intensive care medicine; Internal medicine; Mathematics; Artificial intelligence; Biology; Engineering","score_opus":0.0969544238168686,"score_gpt":0.46395671915262554,"score_spread":0.36700229533575696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406588759","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41134343,0.0010525332,0.5833714,0.001508002,0.000040087027,0.00027581447,0.00040684437,0.00037315665,0.0016287813],"genre_scores_gemma":[0.927906,0.00038103122,0.06994252,0.00028138957,0.000048196493,0.00017964146,0.00049947924,0.00003863707,0.00072309497],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99847513,0.0010552139,0.00007040252,0.00016345523,0.00013937891,0.00009646848],"domain_scores_gemma":[0.986147,0.012149322,0.0006049748,0.00025922357,0.0005298347,0.00030974147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006470086,0.0005643702,0.0012199816,0.0007638744,0.0003068966,0.0010537158,0.0011319494,0.0009546657,0.0012618545],"category_scores_gemma":[0.029434532,0.00065597857,0.00064203684,0.0004346537,0.00048846414,0.0008618318,0.00084885006,0.0013861095,0.00022379287],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022599604,0.00054948684,0.060121436,0.00023190131,0.00043020403,0.00034754098,0.000340764,0.78246605,0.0030532824,0.011835256,0.002792204,0.13557199],"study_design_scores_gemma":[0.00007451593,0.00010953947,0.0037928103,0.000030808606,0.000030322142,0.00006108168,0.000035007477,0.9910944,0.00053394976,0.0039922246,0.00023273652,0.0000126899495],"about_ca_topic_score_codex":0.009093953,"about_ca_topic_score_gemma":0.0059223804,"teacher_disagreement_score":0.009093953,"about_ca_system_score_codex":0.00078637595,"about_ca_system_score_gemma":0.0020463383,"threshold_uncertainty_score":0.034217477},"labels":[],"label_agreement":null},{"id":"W4406801161","doi":"10.1007/s40262-025-01476-6","title":"Population Pharmacokinetic Modelling of Apixaban in End-Stage Kidney Disease Patients with Atrial Fibrillation Receiving Haemodialysis","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Apixaban; Atrial fibrillation; Medicine; End stage renal disease; Cardiology; Internal medicine; Population pharmacokinetics; Stage (stratigraphy); Pharmacokinetics; Kidney disease; End-stage kidney disease; Population; Disease; Warfarin; Rivaroxaban","score_opus":0.08437348808330872,"score_gpt":0.39597506357501255,"score_spread":0.31160157549170386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406801161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.951354,0.0008781547,0.04007191,0.0012674107,0.000061932165,0.00012896564,0.0013992393,0.00015059848,0.0046876855],"genre_scores_gemma":[0.9941298,0.00030762577,0.002724054,0.00015845791,0.0000272828,0.000105701794,0.00055818,0.00002236189,0.0019666401],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992398,0.00041604976,0.000037340957,0.00013418902,0.00007724309,0.00009551849],"domain_scores_gemma":[0.99622166,0.002821536,0.0003883988,0.00013781026,0.00027827427,0.00015237079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001932374,0.0006307557,0.00170957,0.00038131245,0.00029347633,0.0021252534,0.0011813146,0.001590511,0.0020606813],"category_scores_gemma":[0.00787951,0.00054577395,0.0018381219,0.0005227388,0.00042926107,0.00085433986,0.00065932615,0.0020171183,0.00040121283],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013039283,0.0003323245,0.03721074,0.00011377145,0.0010944027,0.00071968784,0.00025303068,0.94602007,0.0008714433,0.0033180944,0.0012864582,0.0074760895],"study_design_scores_gemma":[0.00022649192,0.00050650374,0.014848695,0.000025391315,0.00028818965,0.00045065593,0.00013794615,0.9782875,0.0002825374,0.003868017,0.0010251995,0.00005285321],"about_ca_topic_score_codex":0.017086701,"about_ca_topic_score_gemma":0.006008706,"teacher_disagreement_score":0.017086701,"about_ca_system_score_codex":0.0009653488,"about_ca_system_score_gemma":0.001488079,"threshold_uncertainty_score":0.03397453},"labels":[],"label_agreement":null},{"id":"W4408075922","doi":"10.1007/s40262-025-01490-8","title":"Pharmacokinetics of Opioid Infusions in the Adult Intensive Care Unit Setting—A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; University of Toronto; Mount Sinai Hospital; Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal; Hôpital du Sacré-Cœur de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Opioid; Intensive care unit; Medicine; Pharmacokinetics; Intensive care medicine; Anesthesia; Pharmacology; Internal medicine","score_opus":0.09064926341637812,"score_gpt":0.4697981256625187,"score_spread":0.3791488622461406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408075922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008074637,0.9988312,0.00006220482,0.000048903927,0.000036916877,0.000046278266,0.00009391501,0.0000026477683,0.000070412585],"genre_scores_gemma":[0.010359729,0.988853,0.00029437686,0.00025275332,0.00004774707,0.00006937081,0.00007359821,0.0000023412272,0.000047207322],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9974094,0.000731723,0.001044957,0.00030665754,0.00042220842,0.00008494111],"domain_scores_gemma":[0.98835385,0.008438794,0.0024286432,0.00012221531,0.00053609523,0.00012033902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028706875,0.0010798265,0.0062523326,0.002972776,0.00032540265,0.0018834134,0.0011955895,0.0014732429,0.0029562847],"category_scores_gemma":[0.016418803,0.0007031548,0.007579163,0.0042505264,0.0005521333,0.0013751031,0.00087312097,0.0014323116,0.00021625767],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008233087,0.00006015189,0.0016085717,0.8982596,0.032149497,0.00012935503,0.000112530586,0.00025244954,0.00024455768,0.0001579462,0.0014456981,0.06475636],"study_design_scores_gemma":[0.0014805521,0.00086453033,0.01715584,0.6192038,0.3317175,0.0010101786,0.00034269047,0.00032644323,0.00036893753,0.00045454522,0.02694865,0.00012630754],"about_ca_topic_score_codex":0.0059194216,"about_ca_topic_score_gemma":0.018141195,"teacher_disagreement_score":0.0062523326,"about_ca_system_score_codex":0.0015656509,"about_ca_system_score_gemma":0.004100634,"threshold_uncertainty_score":0.0151818395},"labels":[],"label_agreement":null},{"id":"W4409609531","doi":"10.1007/s40262-025-01505-4","title":"Anti-infectives in Pediatric Patients with Cystic Fibrosis: A Comprehensive Review of Population Pharmacokinetic Analyses","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Faculté de pharmacie, Université de Montréal; Fonds de Recherche du Québec - Santé","keywords":"Cystic fibrosis; Pharmacokinetics; Medicine; Intensive care medicine; Internal medicine","score_opus":0.09632779977673878,"score_gpt":0.5106266570309735,"score_spread":0.41429885725423476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409609531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012630761,0.99942917,0.000120600365,0.00013342676,0.00003214717,0.000004864957,0.000029850857,0.00000420994,0.000119415265],"genre_scores_gemma":[0.0010971443,0.9981577,0.00037979207,0.00017638877,0.000086818654,0.000009566391,0.000038738122,0.0000016572357,0.00005231026],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99931324,0.0001739278,0.00020607059,0.00011238557,0.00016757111,0.000026805648],"domain_scores_gemma":[0.9967133,0.0023491213,0.00049854524,0.000045682358,0.0003372242,0.000056111756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019254485,0.0009209009,0.0031459057,0.0023169694,0.0001565541,0.0011979069,0.00096819917,0.0009885342,0.0019107759],"category_scores_gemma":[0.004415034,0.00042860172,0.002124287,0.0021263014,0.00036351953,0.0013203424,0.0006003793,0.0017873206,0.00040056984],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003371815,0.000101065554,0.0012854155,0.045835756,0.0012993006,0.00016623196,0.00005168598,0.00054655847,0.0007716396,0.0010936126,0.009494117,0.93901736],"study_design_scores_gemma":[0.0006965025,0.0014928558,0.02002619,0.084640235,0.014142564,0.0076736445,0.00024688998,0.0017741167,0.0023290464,0.0055185338,0.8611891,0.00027023762],"about_ca_topic_score_codex":0.0012357244,"about_ca_topic_score_gemma":0.0027711105,"teacher_disagreement_score":0.0031459057,"about_ca_system_score_codex":0.0005568861,"about_ca_system_score_gemma":0.0018319715,"threshold_uncertainty_score":0.010182917},"labels":[],"label_agreement":null},{"id":"W4410702741","doi":"10.1007/s40262-025-01526-z","title":"Pharmacokinetic/Pharmacodynamic Modelling and Monte Carlo Simulations to Predict Cytomegalovirus Viral Load in Pediatric Transplant Recipients Treated with (val)Ganciclovir","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Université de Limoges; Association Nationale de la Recherche et de la Technologie; Agence Nationale de la Recherche","keywords":"Ganciclovir; Pharmacokinetics; Pharmacodynamics; Monte Carlo method; Viral load; Cytomegalovirus; Medicine; Pharmacology; Virology; Human cytomegalovirus; Human immunodeficiency virus (HIV); Mathematics; Statistics; Viral disease; Herpesviridae; Virus","score_opus":0.04303018919637127,"score_gpt":0.3813096390639319,"score_spread":0.33827944986756064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410702741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9117292,0.0005132892,0.08283573,0.0003141054,0.000023476225,0.00012097376,0.0003397559,0.00017698618,0.003946524],"genre_scores_gemma":[0.98574114,0.00021200764,0.012944229,0.000058848647,0.000008604573,0.00013016051,0.00016430998,0.00002200058,0.000718733],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997813,0.00012250638,0.0000105957,0.000026550544,0.000032573993,0.000026543657],"domain_scores_gemma":[0.99750984,0.0020616015,0.00020750823,0.000046837304,0.000115976516,0.00005831988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008082168,0.0004988318,0.0006763748,0.0003751279,0.0002768916,0.00058563234,0.0004695746,0.00081209926,0.00090069376],"category_scores_gemma":[0.003047364,0.00045460943,0.00068831316,0.00031913238,0.00028807425,0.00030693904,0.0002789672,0.00081034173,0.00012403184],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040995725,0.000022422433,0.0017682865,0.000007284978,0.000015737112,0.00003184959,0.000011657192,0.99660265,0.00027604494,0.00032749216,0.000044213593,0.0008513965],"study_design_scores_gemma":[0.0000066374005,0.000021653641,0.0002714482,0.0000017068459,0.000004493866,0.000009143528,0.0000032748615,0.99935883,0.00014174831,0.0001286601,0.000050149796,0.0000023257862],"about_ca_topic_score_codex":0.01797056,"about_ca_topic_score_gemma":0.008533871,"teacher_disagreement_score":0.01797056,"about_ca_system_score_codex":0.0009953296,"about_ca_system_score_gemma":0.0011539772,"threshold_uncertainty_score":0.03573191},"labels":[],"label_agreement":null},{"id":"W4413114046","doi":"10.1007/s40262-025-01559-4","title":"Double Peaking Phenomena in Pharmacokinetic Disposition Revisited","year":2025,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Mitacs","keywords":"Bioequivalence; Pharmacokinetics; Physiologically based pharmacokinetic modelling; Drug; Pharmacology; Dosing; Identification (biology); Medicine; Biology","score_opus":0.32786920923996526,"score_gpt":0.5741244713611369,"score_spread":0.2462552621211716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413114046","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031161617,0.9952675,0.0019219348,0.00086598156,0.0003068924,0.000005824994,0.000018809587,0.00002317563,0.0012783185],"genre_scores_gemma":[0.004561281,0.9909718,0.0014622395,0.0010801499,0.0007137275,0.000014069382,0.000024798848,0.0000103686025,0.001161573],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992588,0.0002305527,0.00009977503,0.000148346,0.00020829058,0.000054090728],"domain_scores_gemma":[0.99849904,0.0010219758,0.00014905835,0.000053439675,0.00023929453,0.000037318896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027021014,0.0010717236,0.0028381015,0.0015748267,0.00028362745,0.0021555708,0.0015960711,0.0021238138,0.0035764992],"category_scores_gemma":[0.0023698143,0.0005634033,0.001000067,0.002473782,0.0017353931,0.003913247,0.001237658,0.005831767,0.0017905573],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023932355,0.00013719194,0.00044700352,0.013927773,0.00014860957,0.00085950946,0.00020947718,0.0011826125,0.004019997,0.049923014,0.01913794,0.9097675],"study_design_scores_gemma":[0.00007686467,0.00038529877,0.0014618582,0.0036914377,0.00030519636,0.0053936495,0.00018926756,0.0015800819,0.0026390047,0.028108595,0.95608383,0.000084855834],"about_ca_topic_score_codex":0.0016009049,"about_ca_topic_score_gemma":0.0018442712,"teacher_disagreement_score":0.0035764992,"about_ca_system_score_codex":0.0010926281,"about_ca_system_score_gemma":0.0017732995,"threshold_uncertainty_score":0.014290273},"labels":[],"label_agreement":null},{"id":"W4414167921","doi":"10.1007/s40262-025-01571-8","title":"Population Pharmacokinetic Modeling of Canagliflozin in Advanced Chronic Kidney Disease","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University; Université de Montréal; McGill University Health Centre","funders":"Kidney Foundation of Canada","keywords":"Kidney disease; Canagliflozin; Population; Pharmacokinetics; Population pharmacokinetics; Clinical trial","score_opus":0.03396655612676739,"score_gpt":0.39832007449921975,"score_spread":0.36435351837245233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414167921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55822766,0.005927433,0.40499443,0.0040742108,0.00021909009,0.00025196632,0.0033216465,0.0010360915,0.02194749],"genre_scores_gemma":[0.9764397,0.0014727727,0.013385154,0.0004965908,0.00007211907,0.0001990235,0.00069085555,0.00009184039,0.0071519404],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99952614,0.00022747705,0.000014472889,0.00008962188,0.00007910235,0.00006321944],"domain_scores_gemma":[0.99874276,0.0008749574,0.0001426619,0.000042480937,0.0001449841,0.000052235006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013374608,0.00054857123,0.0013365949,0.000348581,0.00024769557,0.0016960801,0.00090748264,0.0011484907,0.0014203936],"category_scores_gemma":[0.00433761,0.00047232804,0.0010824044,0.0005828292,0.00033302692,0.00069255655,0.0004211463,0.0012218748,0.00039006042],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029864343,0.00008160953,0.004791078,0.00006671965,0.0003281774,0.00017326635,0.000056933743,0.9769713,0.0006063167,0.0047901985,0.001655149,0.010180627],"study_design_scores_gemma":[0.000057851714,0.00006831716,0.0014421995,0.00001209787,0.00008971706,0.00009586943,0.0000142379,0.9941484,0.0001516158,0.0027032914,0.0012015125,0.000014939873],"about_ca_topic_score_codex":0.023551906,"about_ca_topic_score_gemma":0.009551461,"teacher_disagreement_score":0.023551906,"about_ca_system_score_codex":0.0011843691,"about_ca_system_score_gemma":0.0019953023,"threshold_uncertainty_score":0.04682964},"labels":[],"label_agreement":null},{"id":"W4415664795","doi":"10.1007/s40262-025-01565-6","title":"Population Pharmacokinetics Analysis of Infliximab in up to 10-Year-Old Patients with Paediatric Inflammatory Bowel Disease: Label-Recommended Dose Fails to Achieve Therapeutic Target Concentration","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Hospital for Sick Children","funders":"","keywords":"Infliximab; Dosing; Therapeutic drug monitoring; Pharmacokinetics; Inflammatory bowel disease; Trough Concentration; Drug; Population","score_opus":0.014184174384500365,"score_gpt":0.33171271131038105,"score_spread":0.3175285369258807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415664795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544877,0.00145785,0.0015326675,0.00006552937,0.0000054101138,0.000032021646,0.00077008584,0.00002129067,0.000666307],"genre_scores_gemma":[0.9976682,0.00037058443,0.00085466227,0.00005802045,0.000005472097,0.000019081326,0.00090566446,0.000004875267,0.0001134461],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991856,0.00019948986,0.00007584747,0.00019670786,0.00027147133,0.00007078835],"domain_scores_gemma":[0.99800414,0.00056832127,0.0008253549,0.0001377746,0.00035747973,0.00010690806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017121311,0.00022262428,0.0005532206,0.00039813982,0.00021423596,0.00074620673,0.00031552473,0.00035689323,0.0005927503],"category_scores_gemma":[0.003970171,0.00016420425,0.0005623659,0.0005966315,0.00026266172,0.00024794837,0.0002487321,0.0004835035,0.00015792731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060291425,0.000038366255,0.9822334,0.00010191192,0.00028762454,0.00033264983,0.00032894182,0.0016911002,0.0015197936,0.00011903864,0.0003624463,0.012381909],"study_design_scores_gemma":[0.00002262938,0.00046305734,0.99364305,0.000030105062,0.0001912683,0.0010639924,0.00014132941,0.0025066328,0.0006406508,0.00006464715,0.001223034,0.000009655339],"about_ca_topic_score_codex":0.023066908,"about_ca_topic_score_gemma":0.021291148,"teacher_disagreement_score":0.023066908,"about_ca_system_score_codex":0.0012251408,"about_ca_system_score_gemma":0.0014404085,"threshold_uncertainty_score":0.045865297},"labels":[],"label_agreement":null},{"id":"W4416279814","doi":"10.1007/s40262-025-01579-0","title":"Population Pharmacokinetic Modeling of Oxcarbazepine and Its Active Metabolite 10-Monohydroxy Derivative to Inform Dosing in Children with Obesity","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institutes of Health","keywords":"Dosing; Active metabolite; Pharmacokinetics; Oxcarbazepine; Population; Obesity; Population pharmacokinetics","score_opus":0.0378900662495074,"score_gpt":0.3981287839557906,"score_spread":0.3602387177062832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416279814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79894334,0.0016209689,0.19009823,0.00095946767,0.000050478895,0.00026703335,0.00201846,0.00030761596,0.0057343952],"genre_scores_gemma":[0.97549284,0.00058282196,0.02055025,0.00014368285,0.000021696507,0.00026098193,0.0007690114,0.000040286606,0.0021383849],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99966145,0.00019141463,0.00001369863,0.00006351665,0.000036709258,0.000033190878],"domain_scores_gemma":[0.9990779,0.0006536051,0.0001332526,0.000022877568,0.000080894046,0.000031473188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014524795,0.0005590199,0.0005711006,0.00032848466,0.00017525777,0.0007016693,0.00062275113,0.0006145633,0.0015694175],"category_scores_gemma":[0.0032212466,0.00037808422,0.0010637535,0.00025120715,0.00021093352,0.00035372327,0.0005526072,0.00071453647,0.00022662595],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005665218,0.0001312844,0.038958687,0.000101206926,0.0003389408,0.00025834583,0.00012627435,0.9422268,0.0017527662,0.0019134018,0.00090167,0.012724131],"study_design_scores_gemma":[0.000045687524,0.00013246234,0.004283787,0.000014427653,0.00008433199,0.00006907807,0.000025482756,0.9935725,0.00029420192,0.000716266,0.00075220753,0.000009668844],"about_ca_topic_score_codex":0.016001232,"about_ca_topic_score_gemma":0.00872747,"teacher_disagreement_score":0.016001232,"about_ca_system_score_codex":0.0007981179,"about_ca_system_score_gemma":0.0016051901,"threshold_uncertainty_score":0.031816185},"labels":[],"label_agreement":null},{"id":"W4416295471","doi":"10.1007/s40262-025-01587-0","title":"Clinical Pharmacokinetic-Pharmacodynamic Relationships of Pharmacological Strategies for Attenuating p-Cresyl Sulfate in Patients with Kidney Disease","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Kidney disease; Dialysis; Renal function; Incidence (geometry); Kidney; Hemodialysis","score_opus":0.06037596835360987,"score_gpt":0.4167906962477419,"score_spread":0.35641472789413203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416295471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98072666,0.010781805,0.002598867,0.0010013079,0.00009493966,0.00025055124,0.0003539659,0.00009544806,0.0040964154],"genre_scores_gemma":[0.99738306,0.0009108505,0.00089760177,0.000293827,0.00006351425,0.000045283017,0.00012087891,0.00000935215,0.00027565582],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998689,0.0007896663,0.00008741426,0.00011214519,0.00022779017,0.000094103256],"domain_scores_gemma":[0.99554044,0.002310434,0.00090130564,0.00021336184,0.00045495012,0.0005794949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023028813,0.00038877554,0.0009283451,0.00023524974,0.00028702506,0.000889793,0.00029379298,0.0005462801,0.0012133936],"category_scores_gemma":[0.009940148,0.00021918464,0.00052022043,0.00035433198,0.0003748201,0.0006310486,0.00033300754,0.0012034125,0.00026329907],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20931329,0.008537573,0.32603917,0.0012157041,0.0030471762,0.001063753,0.00070776336,0.0072786943,0.06465267,0.002000575,0.004145576,0.37199804],"study_design_scores_gemma":[0.0074360706,0.11359383,0.8151676,0.00022302204,0.0018804953,0.0022743864,0.0006255231,0.01396015,0.031247767,0.0013276839,0.012138069,0.0001252623],"about_ca_topic_score_codex":0.00091974775,"about_ca_topic_score_gemma":0.0013725706,"teacher_disagreement_score":0.0023028813,"about_ca_system_score_codex":0.0005782452,"about_ca_system_score_gemma":0.0012499338,"threshold_uncertainty_score":0.012178957},"labels":[],"label_agreement":null},{"id":"W4416790434","doi":"10.1007/s40262-025-01599-w","title":"Correction: Population Pharmacokinetics Analysis of Infliximab in up to 10‑Year‑Old Patients with Paediatric Inflammatory Bowel Disease: Label‑Recommended Dose Fails to Achieve Therapeutic Target Concentration","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Hospital for Sick Children","funders":"","keywords":"Infliximab; Inflammatory bowel disease; Pharmacokinetics; Inflammatory Bowel Diseases; Population; Ulcerative colitis; Population pharmacokinetics","score_opus":0.01345729761559701,"score_gpt":0.3281512136513812,"score_spread":0.3146939160357842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416790434","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013246404,0.0024816869,0.0036240395,0.075623974,0.90987784,0.000052784875,0.002904053,0.001234969,0.0028759025],"genre_scores_gemma":[0.12916155,0.018568486,0.033310976,0.17847854,0.38756284,0.0005293476,0.008756418,0.00659791,0.23703393],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99409455,0.0011727787,0.0012472972,0.0007313586,0.0023416614,0.00041244834],"domain_scores_gemma":[0.9533855,0.016198572,0.0037419926,0.0026551166,0.022646151,0.0013726725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052060355,0.0018191298,0.0016148168,0.0023106083,0.0015861463,0.0034187136,0.0027566978,0.005530962,0.025038218],"category_scores_gemma":[0.09165783,0.00095934834,0.0015860301,0.0020784135,0.0021009613,0.0015738717,0.0013361571,0.0077550374,0.014996345],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014228973,0.000008758767,0.00035514848,0.00029835838,0.00004870195,0.000795094,0.00008538545,0.00016939777,0.00023426302,0.001074232,0.9864579,0.010330558],"study_design_scores_gemma":[0.00018687487,0.00007723998,0.0026013213,0.0007612106,0.00014269393,0.004022722,0.00014888821,0.0016028347,0.0015121701,0.0022800413,0.9865739,0.00009016302],"about_ca_topic_score_codex":0.013609481,"about_ca_topic_score_gemma":0.009780942,"teacher_disagreement_score":0.025038218,"about_ca_system_score_codex":0.0038459403,"about_ca_system_score_gemma":0.004858872,"threshold_uncertainty_score":0.083761156},"labels":[],"label_agreement":null},{"id":"W4416990044","doi":"10.1007/s40262-025-01602-4","title":"Guidance for External Evaluation and Selection of Population Pharmacokinetic Models for Precision Dosing","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Dosing; Selection (genetic algorithm); Population; Key (lock); Model selection; Clinical trial","score_opus":0.6026922687554581,"score_gpt":0.6569799012189769,"score_spread":0.054287632463518753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416990044","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018556503,0.0017827627,0.9524595,0.0068179066,0.00085855764,0.0045375396,0.005085796,0.010391932,0.016210364],"genre_scores_gemma":[0.021896197,0.001220805,0.95576096,0.0031478282,0.00048645414,0.006204657,0.0032156706,0.0035792321,0.0044881343],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8578594,0.120793566,0.0067089284,0.0019900016,0.011878537,0.0007696356],"domain_scores_gemma":[0.6012565,0.3001689,0.0146866,0.026796782,0.0540239,0.0030673756],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13910621,0.0030583998,0.0046743867,0.0051996703,0.0010826432,0.0081674075,0.0051666945,0.007058152,0.036465112],"category_scores_gemma":[0.4757479,0.0028866825,0.0046887244,0.0037545448,0.0018558247,0.0038833902,0.0034648175,0.0099816425,0.023907416],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035157541,0.0006217724,0.0029703807,0.0029544018,0.0008419763,0.0005647584,0.0009914347,0.04118612,0.0020646686,0.060280114,0.37917525,0.50483334],"study_design_scores_gemma":[0.0060560848,0.001215033,0.0063697943,0.011136757,0.0011547988,0.0016152523,0.00039676018,0.26806223,0.013430963,0.19104078,0.4990497,0.00047194553],"about_ca_topic_score_codex":0.0060056136,"about_ca_topic_score_gemma":0.0055195224,"teacher_disagreement_score":0.8608938,"about_ca_system_score_codex":0.0022929364,"about_ca_system_score_gemma":0.013178311,"threshold_uncertainty_score":0.7356728},"labels":[],"label_agreement":null},{"id":"W571503340","doi":"10.1007/s40262-015-0275-1","title":"The Impact of Sertraline Co-Administration on the Pharmacokinetics of Olanzapine: A Population Pharmacokinetic Analysis of the STOP-PD","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Centre for Addiction and Mental Health","funders":"","keywords":"Olanzapine; Sertraline; NONMEM; Population; Pharmacokinetics; Pharmacology; Medicine; Risperidone; Internal medicine; Psychology; Psychiatry; Antidepressant; Schizophrenia (object-oriented programming)","score_opus":0.13186095647084783,"score_gpt":0.4922751442849211,"score_spread":0.36041418781407325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W571503340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972096,0.0005275298,0.0011012709,0.00010224768,0.000017416312,0.000080980135,0.0003237065,0.000072901894,0.0005642767],"genre_scores_gemma":[0.998262,0.0001799488,0.00058730104,0.00010340649,0.000031437416,0.000045663324,0.00043234014,0.000042100095,0.000315792],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99641967,0.0022573275,0.00016036392,0.00039937842,0.0005676515,0.00019565327],"domain_scores_gemma":[0.9941889,0.003096596,0.0013113727,0.0006497296,0.0003561561,0.00039725093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036667697,0.0008165773,0.0022402902,0.0003915525,0.00030876577,0.001534875,0.00057272345,0.0009922558,0.00149261],"category_scores_gemma":[0.010138055,0.00057287794,0.0024209116,0.00039561512,0.0005766912,0.0013203274,0.00048681957,0.0018364289,0.00031856517],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54061276,0.003993806,0.25852013,0.00062200194,0.019675551,0.0015930069,0.00084095006,0.008756547,0.04576064,0.00084479555,0.0024056644,0.11637404],"study_design_scores_gemma":[0.0111854775,0.10986366,0.8099578,0.000052661784,0.01470006,0.0031981745,0.00033653394,0.03629569,0.009419933,0.0010171985,0.0036764173,0.0002965178],"about_ca_topic_score_codex":0.0013143265,"about_ca_topic_score_gemma":0.0012921448,"teacher_disagreement_score":0.0036667697,"about_ca_system_score_codex":0.00094868726,"about_ca_system_score_gemma":0.0010585826,"threshold_uncertainty_score":0.019391954},"labels":[],"label_agreement":null},{"id":"W572885427","doi":"10.1007/s40262-015-0297-8","title":"Therapeutic Drug Monitoring of Voriconazole in the Management of Invasive Fungal Infections: A Critical Review","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Voriconazole; Therapeutic drug monitoring; CYP2C19; Medicine; Intensive care medicine; Adverse effect; Drug; Pharmacogenetics; Internal medicine; Aspergillosis; Pharmacotherapy; Pharmacology; Antifungal; Immunology; Biology; Genotype","score_opus":0.2798601075472593,"score_gpt":0.532563529680355,"score_spread":0.2527034221330957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W572885427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059450966,0.99948466,0.0000734597,0.0001691949,0.00006702495,0.000002601778,0.0000064899987,0.0000024540918,0.00013459682],"genre_scores_gemma":[0.0007062378,0.9985605,0.00023108342,0.00023254627,0.00018227875,0.00000511265,0.000014585184,8.4552875e-7,0.00006683786],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994937,0.00011252826,0.00013961348,0.000075115626,0.00015262069,0.000026355243],"domain_scores_gemma":[0.9980736,0.0012132474,0.00032107017,0.000027692933,0.00029159428,0.00007276354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001342241,0.0009011114,0.002449043,0.0023630285,0.00025915552,0.0014116666,0.0012676977,0.0013544617,0.0022346836],"category_scores_gemma":[0.0024675627,0.0003194313,0.0009457641,0.0019412431,0.00062268495,0.0016853599,0.00067012664,0.0019782437,0.00063940405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016856292,0.00008790742,0.00041137246,0.035490934,0.0002617919,0.00036868738,0.000056582845,0.00030098084,0.0011980159,0.0014163867,0.016216213,0.94402254],"study_design_scores_gemma":[0.00015336886,0.0004679251,0.0032733718,0.03571772,0.0020006087,0.0061985953,0.0001764499,0.0005918547,0.0013258465,0.0031068781,0.94688547,0.00010200709],"about_ca_topic_score_codex":0.0010160436,"about_ca_topic_score_gemma":0.0020150046,"teacher_disagreement_score":0.002449043,"about_ca_system_score_codex":0.0005760031,"about_ca_system_score_gemma":0.0018351908,"threshold_uncertainty_score":0.0074757934},"labels":[],"label_agreement":null},{"id":"W604589405","doi":"10.1007/s40262-015-0281-3","title":"A Critical Review on the Clinical Pharmacokinetics, Pharmacodynamics, and Clinical Trials of Ceftaroline","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Plant-based Medicinal Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Pharmacodynamics; Pharmacokinetics; Medicine; Clinical trial; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.7822683514772697,"score_gpt":0.7117794201885322,"score_spread":0.07048893128873746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W604589405","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008193089,0.9992176,0.00007496078,0.00020733845,0.00012006571,0.000007967538,0.00003116735,0.000002863506,0.0002560493],"genre_scores_gemma":[0.0005865726,0.9985159,0.00020362435,0.00031107513,0.00012184457,0.0000091799375,0.00004300702,9.2998687e-7,0.00020786992],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99967575,0.00007409528,0.00008779779,0.000040306502,0.00010253057,0.000019503],"domain_scores_gemma":[0.9991554,0.0004770682,0.00014579998,0.00001638069,0.00017371004,0.000031657855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011236854,0.0007881168,0.0018566287,0.0020934022,0.000199092,0.0009860077,0.0008659703,0.00084486534,0.004096494],"category_scores_gemma":[0.0020850315,0.00026672875,0.0011365279,0.0019266492,0.00029876488,0.0009623257,0.00043052426,0.0012333128,0.0008454616],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000261341,0.00007651471,0.0001578256,0.07263441,0.0003709392,0.00016605335,0.000054156146,0.00022169974,0.0016138185,0.0012931533,0.036152545,0.88699746],"study_design_scores_gemma":[0.00016894573,0.00041323455,0.0015816294,0.028252495,0.0018575606,0.001466696,0.000085519205,0.0001407245,0.00094860344,0.0013979138,0.9636417,0.00004507125],"about_ca_topic_score_codex":0.0012818328,"about_ca_topic_score_gemma":0.0031423671,"teacher_disagreement_score":0.004096494,"about_ca_system_score_codex":0.0006046085,"about_ca_system_score_gemma":0.001933119,"threshold_uncertainty_score":0.013704181},"labels":[],"label_agreement":null},{"id":"W84398271","doi":"10.2165/00003088-200342090-00002","title":"Selecting Antibacterials for Outpatient Parenteral Antimicrobial Therapy","year":2003,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Antibiotics Pharmacokinetics and Efficacy","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Hospital and Health Sciences Centre","funders":"","keywords":"Pharmacokinetics; Medicine; Dosing; Antimicrobial; Pharmacodynamics; Therapeutic drug monitoring; Antibiotics; Regimen; Pharmacology; Pharmacotherapy; Minimum inhibitory concentration; Intensive care medicine; Drug; Internal medicine; Microbiology","score_opus":0.2975076247802764,"score_gpt":0.5252368200846177,"score_spread":0.22772919530434127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W84398271","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033658659,0.9985586,0.00022678704,0.00015446325,0.00007850117,0.000010906477,0.000016174286,0.000010662407,0.000607296],"genre_scores_gemma":[0.002307817,0.9957129,0.0010572739,0.00025986574,0.00013958979,0.000016450793,0.00003570209,0.0000034859909,0.000466857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99932075,0.00014359699,0.000205621,0.000093748815,0.00020658216,0.000029695462],"domain_scores_gemma":[0.99853575,0.0007468732,0.00041399398,0.00003251709,0.00022197404,0.00004881776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011598864,0.0013006292,0.00327264,0.0034300685,0.00020885521,0.0009868715,0.0009271579,0.0011748894,0.0027585693],"category_scores_gemma":[0.002258293,0.00041152764,0.0008643232,0.002646722,0.00043544042,0.0014250863,0.0004478116,0.0016261828,0.0010615805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002548885,0.000115882765,0.00032326128,0.02989586,0.00017541066,0.00028390295,0.000038918835,0.00024649006,0.0019037443,0.00056632166,0.007632871,0.95856243],"study_design_scores_gemma":[0.0005979562,0.0012460956,0.0068249386,0.031517915,0.0033339744,0.008451284,0.00022622298,0.0007031134,0.00617703,0.0018581472,0.93897265,0.00009056054],"about_ca_topic_score_codex":0.0010172543,"about_ca_topic_score_gemma":0.0024326304,"teacher_disagreement_score":0.0034300685,"about_ca_system_score_codex":0.00058833114,"about_ca_system_score_gemma":0.001276784,"threshold_uncertainty_score":0.009228289},"labels":[],"label_agreement":null},{"id":"W927468184","doi":"10.1007/s40262-015-0303-1","title":"A Critical Review of the Current Evidence for Measuring Drug Concentrations of First-Line Agents Used to Treat Tuberculosis in Children","year":2015,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Pyrazinamide; Tuberculosis; Ethambutol; Intensive care medicine; Drug; Dosing; Pharmacotherapy; Isoniazid; Adverse effect; Disease; Therapeutic drug monitoring; Psychological intervention; Rifapentine; Mycobacterium tuberculosis; Pharmacology; Latent tuberculosis; Internal medicine; Pathology; Psychiatry","score_opus":0.6292262917620522,"score_gpt":0.6064996879856832,"score_spread":0.022726603776369037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W927468184","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000049525403,0.9995654,0.000030760264,0.00016706952,0.000068305184,0.000007726925,0.000027468312,0.0000013860486,0.00008231433],"genre_scores_gemma":[0.0006223989,0.9987612,0.0001827957,0.0002791726,0.00007404776,0.0000118201715,0.000025495512,8.0611596e-7,0.000042263266],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99801755,0.00050793873,0.0007709749,0.00018885401,0.0004512407,0.000063385225],"domain_scores_gemma":[0.9912764,0.0064233565,0.0012771543,0.00009566489,0.0008239255,0.00010355586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037959628,0.0011623328,0.004073121,0.005049315,0.00031967135,0.0019254173,0.0016756736,0.0017750172,0.0037181159],"category_scores_gemma":[0.011121352,0.00062670436,0.0029574768,0.004233121,0.00069552107,0.0019385021,0.0009422406,0.0017338927,0.0005482641],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030767205,0.000058993784,0.0005053666,0.52587795,0.0022846328,0.00022961033,0.00015677774,0.00021854918,0.0005676162,0.0015564493,0.016444251,0.45179215],"study_design_scores_gemma":[0.00021071036,0.00038438276,0.004344072,0.4561813,0.014520286,0.0019857986,0.0003221454,0.00018045561,0.00061922474,0.0018808263,0.51927674,0.000094089046],"about_ca_topic_score_codex":0.0033183047,"about_ca_topic_score_gemma":0.007599656,"teacher_disagreement_score":0.005049315,"about_ca_system_score_codex":0.0014048624,"about_ca_system_score_gemma":0.0048929085,"threshold_uncertainty_score":0.020075202},"labels":[],"label_agreement":null},{"id":"W973722855","doi":"10.1007/s40262-015-0301-3","title":"Population Pharmacokinetics of Intravenous Paracetamol (Acetaminophen) in Preterm and Term Neonates: Model Development and External Evaluation","year":2015,"lang":"en","type":"article","venue":"Clinical Pharmacokinetics","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institute of Child Health and Human Development; National Institutes of Health; National Center for Advancing Translational Sciences; Children's National Hospital; Fonds Wetenschappelijk Onderzoek; American Foundation for Pharmaceutical Education; Vlaamse regering; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Howard Hughes Medical Institute","keywords":"NONMEM; Gestational age; Medicine; Acetaminophen; Population; Volume of distribution; Confidence interval; Coefficient of variation; Birth weight; Standard error; Anesthesia; Pharmacokinetics; Statistics; Internal medicine; Pregnancy; Mathematics","score_opus":0.3384928192421123,"score_gpt":0.5012615931518831,"score_spread":0.16276877390977085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W973722855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9228621,0.0005665623,0.0714366,0.00015869741,0.000020978356,0.00027963752,0.0016063462,0.0003238222,0.00274521],"genre_scores_gemma":[0.98629236,0.00054125255,0.010352783,0.00006638477,0.000009390147,0.00041937648,0.0011627105,0.000055606855,0.0010999806],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995459,0.00027050785,0.000019780126,0.00006221621,0.000076851386,0.000024731102],"domain_scores_gemma":[0.9986085,0.00083003246,0.00018850039,0.00012821284,0.00021599932,0.000028854314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019380879,0.00044268792,0.00048288796,0.00021782212,0.0001691317,0.00069504295,0.0006804613,0.0005131153,0.0005741655],"category_scores_gemma":[0.0047334973,0.00023648098,0.0005554331,0.00025536382,0.00022893584,0.00038158573,0.00042119392,0.000751335,0.00021428068],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005004772,0.0010968257,0.056741253,0.0004201188,0.0006780199,0.00038508634,0.000343737,0.83210516,0.023665972,0.004333386,0.002500406,0.07272528],"study_design_scores_gemma":[0.0003632505,0.0029785687,0.023995133,0.00003893186,0.00040232597,0.0003944805,0.000096340096,0.94490695,0.020871436,0.002767936,0.003116046,0.00006862049],"about_ca_topic_score_codex":0.005727568,"about_ca_topic_score_gemma":0.002019848,"teacher_disagreement_score":0.005727568,"about_ca_system_score_codex":0.00092760805,"about_ca_system_score_gemma":0.0014360312,"threshold_uncertainty_score":0.011388421},"labels":[],"label_agreement":null}]}